TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1474244	Extracellular matrix organization	3.32309230029398e-06	-12.6146147927832	267	37	0.072265625	512	8202	1299,3339,55214,3655,4038,6385,80781,1287,6382,780,2192,5154,3696,655,1291,59277,10491,10516,7077,1292,5045,4017,1605,1303,1514,4324,5352,4326,1515,649,140766,5650,4053,3685,1307,7093,170690	COL9A3,HSPG2,P3H2,ITGA6,LRP4,SDC4,COL18A1,COL4A5,SDC1,DDR1,FBLN1,PDGFA,ITGB8,BMP7,COL6A1,NTN4,CRTAP,FBLN5,TIMP2,COL6A2,FURIN,LOXL2,DAG1,COL12A1,CTSL,MMP15,PLOD2,MMP17,CTSV,BMP1,ADAMTS14,KLK7,LTBP2,ITGAV,COL16A1,TLL2,ADAMTS16
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	7.53118933984163e-06	-11.7964575817666	24	9	0.017578125	512	8202	3106,10484,6892,3134,6890,51752,3107,3105,64167	HLA-B,SEC23A,TAPBP,HLA-F,TAP1,ERAP1,HLA-C,HLA-A,ERAP2
R-HSA-1474290	Collagen formation	1.80041165033236e-05	-10.9249101315857	86	17	0.033203125	512	8202	1299,1292,55214,3655,80781,1287,4017,1303,1514,5352,1291,1515,649,140766,1307,10491,7093	COL9A3,COL6A2,P3H2,ITGA6,COL18A1,COL4A5,LOXL2,COL12A1,CTSL,PLOD2,COL6A1,CTSV,BMP1,ADAMTS14,COL16A1,CRTAP,TLL2
R-HSA-1236977	Endosomal/Vacuolar pathway	2.0275263832416e-05	-10.8061089453512	11	6	0.01171875	512	8202	1514,3106,3107,3134,1515,3105	CTSL,HLA-B,HLA-C,HLA-F,CTSV,HLA-A
R-HSA-422475	Axon guidance	2.63418789692069e-05	-10.5443505289919	516	56	0.109375	512	8202	10398,6331,1299,5721,6195,5922,2043,5716,9542,1287,5720,5361,6710,1947,9965,8828,4756,5154,6196,9048,53358,1808,1291,11221,7220,59277,2065,2050,6326,221002,7074,10125,10817,56896,64283,1292,9693,801,2902,5588,7525,2041,1846,214,10627,8851,8660,2263,10507,3984,1946,3084,3685,219699,10371,103910	MYL9,SCN5A,COL9A3,PSME2,RPS6KA1,RASA2,EPHA4,PSMD10,NRG2,COL4A5,PSME1,PLXNA1,SPTB,EFNB1,FGF19,NRP2,NEO1,PDGFA,RPS6KA2,ARTN,SHC3,DPYSL2,COL6A1,DUSP10,TRPC1,NTN4,ERBB3,EPHB4,SCN2A,RASGEF1A,TIAM1,RASGRP1,FRS3,DPYSL5,ARHGEF28,COL6A2,RAPGEF2,CALM1,GRIN1,PRKCQ,YES1,EPHA1,DUSP4,ALCAM,MYL12A,CDK5R1,IRS2,FGFR2,SEMA4D,LIMK1,EFNA5,NRG1,ITGAV,UNC5B,SEMA3A,MYL12B
R-HSA-166520	Signalling by NGF	5.05563381183117e-05	-9.89242223720604	430	48	0.09375	512	8202	50650,5721,6195,5922,5716,9542,5720,23239,5566,6710,9965,27237,5154,6196,53358,11221,1027,5600,5293,2065,221002,7074,10125,10817,207,3164,9693,801,5295,2902,5045,192670,5577,1846,3710,2002,29,9261,8660,2263,27018,4792,3065,3084,2549,5125,6300,50649	ARHGEF3,PSME2,RPS6KA1,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,ARHGEF16,PDGFA,RPS6KA2,SHC3,DUSP10,CDKN1B,MAPK11,PIK3CD,ERBB3,RASGEF1A,TIAM1,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,CALM1,PIK3R1,GRIN1,FURIN,AGO4,PRKAR2B,DUSP4,ITPR3,ELK1,ABR,MAPKAPK2,IRS2,FGFR2,NGFRAP1,NFKBIA,HDAC1,NRG1,GAB1,PCSK5,MAPK12,ARHGEF4
R-HSA-1280218	Adaptive Immune System	5.29948473772101e-05	-9.84531586843618	668	67	0.130859375	512	8202	5721,6890,26232,9542,221687,5720,29126,5566,30011,5154,5336,1027,7220,5293,10125,64167,10484,207,83737,5588,192670,79754,3710,9021,8660,6892,5795,3084,2549,9902,90293,3134,5716,9493,23239,9965,3105,151636,92912,1075,118788,51465,147700,5592,6737,11059,2065,3107,6850,3164,801,5295,7319,7525,10235,1514,3106,2263,5819,1515,4792,51752,5476,3685,1062,126433,11065	PSME2,TAP1,FBXO2,NRG2,RNF182,PSME1,CD274,PRKACA,SH3KBP1,PDGFA,PLCG2,CDKN1B,TRPC1,PIK3CD,RASGRP1,ERAP2,SEC23A,AKT1,ITCH,PRKCQ,AGO4,ASB13,ITPR3,SOCS3,IRS2,TAPBP,PTPRJ,NRG1,GAB1,MRC2,KLHL13,HLA-F,PSMD10,KIF23,PHLPP1,FGF19,HLA-A,DTX3L,UBE2Q2,CTSC,PIK3AP1,UBE2J1,KLC3,PRKG1,TRIM21,WWP1,ERBB3,HLA-C,SYK,NR4A1,CALM1,PIK3R1,UBE2A,YES1,RASGRP2,CTSL,HLA-B,FGFR2,PVRL2,CTSV,NFKBIA,ERAP1,CTSA,ITGAV,CENPE,FBXO27,UBE2C
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	9.45079880202174e-05	-9.26682619772251	198	27	0.052734375	512	8202	207,3164,5721,801,5295,5716,9542,192670,5720,23239,3710,9965,30011,5154,8660,118788,2263,4792,5336,1027,7220,3084,2065,5293,6850,2549,10125	AKT1,NR4A1,PSME2,CALM1,PIK3R1,PSMD10,NRG2,AGO4,PSME1,PHLPP1,ITPR3,FGF19,SH3KBP1,PDGFA,IRS2,PIK3AP1,FGFR2,NFKBIA,PLCG2,CDKN1B,TRPC1,NRG1,ERBB3,PIK3CD,SYK,GAB1,RASGRP1
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.000129778360993273	-8.9496824779674	64	13	0.025390625	512	8202	1299,1292,5352,55214,1291,649,140766,80781,1287,1307,10491,1303,7093	COL9A3,COL6A2,PLOD2,P3H2,COL6A1,BMP1,ADAMTS14,COL18A1,COL4A5,COL16A1,CRTAP,COL12A1,TLL2
R-HSA-186797	Signaling by PDGF	0.0002002482704903	-8.51595260880566	345	39	0.076171875	512	8202	1299,5721,5922,5716,9542,1287,5720,23239,5566,6710,9965,5154,53358,1291,11221,1027,5293,2065,221002,10125,10817,56034,1292,207,3164,9693,5295,801,2902,5045,192670,5577,1846,3710,9564,8660,2263,3084,2549	COL9A3,PSME2,RASA2,PSMD10,NRG2,COL4A5,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,COL6A1,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,PDGFC,COL6A2,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,FURIN,AGO4,PRKAR2B,DUSP4,ITPR3,BCAR1,IRS2,FGFR2,NRG1,GAB1
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.000276282888757646	-8.19408525789239	36	9	0.017578125	512	8202	118788,5336,801,5295,7220,5293,3710,6850,30011	PIK3AP1,PLCG2,CALM1,PIK3R1,TRPC1,PIK3CD,ITPR3,SYK,SH3KBP1
R-HSA-1266738	Developmental Biology	0.000327495886347981	-8.02403506373738	710	67	0.130859375	512	8202	10398,2034,5721,6195,2043,9542,5720,5361,6710,5154,6196,9048,53358,1808,11221,7220,59277,2050,6326,221002,7074,10125,10817,1292,207,130399,5588,1846,214,10627,8660,3984,688,1946,3084,219699,103910,6300,1299,6331,5922,5716,1287,9965,1947,8828,4756,1291,5600,2065,6837,56896,64283,57167,9693,801,5045,2902,5465,2041,7525,8851,8202,10507,2263,3685,10371	MYL9,EPAS1,PSME2,RPS6KA1,EPHA4,NRG2,PSME1,PLXNA1,SPTB,PDGFA,RPS6KA2,ARTN,SHC3,DPYSL2,DUSP10,TRPC1,NTN4,EPHB4,SCN2A,RASGEF1A,TIAM1,RASGRP1,FRS3,COL6A2,AKT1,ACVR1C,PRKCQ,DUSP4,ALCAM,MYL12A,IRS2,LIMK1,KLF5,EFNA5,NRG1,UNC5B,MYL12B,MAPK12,COL9A3,SCN5A,RASA2,PSMD10,COL4A5,FGF19,EFNB1,NRP2,NEO1,COL6A1,MAPK11,ERBB3,MED22,DPYSL5,ARHGEF28,SALL4,RAPGEF2,CALM1,FURIN,GRIN1,PPARA,EPHA1,YES1,CDK5R1,NCOA3,SEMA4D,FGFR2,ITGAV,SEMA3A
R-HSA-1474228	Degradation of the extracellular matrix	0.000359970180538919	-7.9294893617812	89	15	0.029296875	512	8202	1514,4324,1299,7077,3339,4326,1515,5045,649,80781,5650,1307,1303,170690,7093	CTSL,MMP15,COL9A3,TIMP2,HSPG2,MMP17,CTSV,FURIN,BMP1,COL18A1,KLK7,COL16A1,COL12A1,ADAMTS16,TLL2
R-HSA-168249	Innate Immune System	0.000591326975064927	-7.43314143624751	752	69	0.134765625	512	8202	59307,5721,6195,9542,5720,598,5566,6710,5154,6196,63916,53358,5336,1027,11221,3660,5293,221002,10125,10817,1604,207,83737,5588,192670,5577,1846,3710,837,8660,3984,64127,3084,2549,6300,23586,10810,5922,51191,5716,7006,23239,9965,6737,5600,2065,3107,6850,4644,3164,9693,801,5295,2902,7525,2002,2353,10235,1514,9261,3106,2263,57161,1515,4792,84166,23220,64135,340061	SIGIRR,PSME2,RPS6KA1,NRG2,PSME1,BCL2L1,PRKACA,SPTB,PDGFA,RPS6KA2,ELMO2,SHC3,PLCG2,CDKN1B,DUSP10,IRF2,PIK3CD,RASGEF1A,RASGRP1,FRS3,CD55,AKT1,ITCH,PRKCQ,AGO4,PRKAR2B,DUSP4,ITPR3,CASP4,IRS2,LIMK1,NOD2,NRG1,GAB1,MAPK12,DDX58,WASF3,RASA2,HERC5,PSMD10,TEC,PHLPP1,FGF19,TRIM21,MAPK11,ERBB3,HLA-C,SYK,MYO5A,NR4A1,RAPGEF2,CALM1,PIK3R1,GRIN1,YES1,ELK1,FOS,RASGRP2,CTSL,MAPKAPK2,HLA-B,FGFR2,PELI2,CTSV,NFKBIA,NLRC5,DTX4,IFIH1,TMEM173
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.000665644697379128	-7.31475451719766	104	16	0.03125	512	8202	207,3164,5295,9542,192670,23239,9965,5154,8660,2263,1027,3084,2065,5293,6850,2549	AKT1,NR4A1,PIK3R1,NRG2,AGO4,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,CDKN1B,NRG1,ERBB3,PIK3CD,SYK,GAB1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.00068239052825418	-7.28990844193269	342	37	0.072265625	512	8202	5721,5922,5716,9542,5720,7006,23239,9965,6710,5154,53358,5336,1027,11221,5293,2065,221002,6850,10125,10817,207,3164,9693,5295,801,2902,192670,5588,1846,3710,2353,10235,8660,2263,4792,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,TEC,PHLPP1,FGF19,SPTB,PDGFA,SHC3,PLCG2,CDKN1B,DUSP10,PIK3CD,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKCQ,DUSP4,ITPR3,FOS,RASGRP2,IRS2,FGFR2,NFKBIA,NRG1,GAB1
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.000710704069248751	-7.2492544324566	355	38	0.07421875	512	8202	5721,6195,5922,5716,9542,5720,23239,5566,6710,9965,5154,6196,53358,11221,1027,5600,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,192670,5577,1846,2002,3710,9261,8660,2263,3084,2549,6300	PSME2,RPS6KA1,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,RPS6KA2,SHC3,DUSP10,CDKN1B,MAPK11,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,AGO4,PRKAR2B,DUSP4,ELK1,ITPR3,MAPKAPK2,IRS2,FGFR2,NRG1,GAB1,MAPK12
R-HSA-936837	Ion transport by P-type ATPases	0.000740781053761358	-7.2078054503355	49	10	0.01953125	512	8202	476,10079,540,10396,5349,9914,5205,148229,481,490	ATP1A1,ATP9A,ATP7B,ATP8A1,FXYD3,ATP2C2,ATP8B1,ATP8B3,ATP1B1,ATP2B1
R-HSA-194138	Signaling by VEGF	0.000778671412430626	-7.15792140797173	320	35	0.068359375	512	8202	10810,5721,5922,5716,9542,5720,5566,6710,9965,8828,5154,63916,53358,11221,5600,2065,221002,10125,10817,207,9693,5295,801,2902,1846,3710,9564,8660,9261,2263,558,3084,3685,3315,6300	WASF3,PSME2,RASA2,PSMD10,NRG2,PSME1,PRKACA,SPTB,FGF19,NRP2,PDGFA,ELMO2,SHC3,DUSP10,MAPK11,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,DUSP4,ITPR3,BCAR1,IRS2,MAPKAPK2,FGFR2,AXL,NRG1,ITGAV,HSPB1,MAPK12
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.000858369844909527	-7.06047549668058	8	4	0.0078125	512	8202	7855,89780,8322,8323	FZD5,WNT3A,FZD4,FZD6
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.000935894065092162	-6.97400826621217	42	9	0.017578125	512	8202	5154,3339,3655,6385,59277,3685,6382,780,1605	PDGFA,HSPG2,ITGA6,SDC4,NTN4,ITGAV,SDC1,DDR1,DAG1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.00098410661075882	-6.92377632251374	312	34	0.06640625	512	8202	10810,5721,5922,5716,9542,5720,5566,6710,9965,5154,63916,53358,11221,5600,2065,221002,10125,10817,207,9693,5295,801,2902,1846,3710,9564,8660,9261,2263,558,3084,3685,3315,6300	WASF3,PSME2,RASA2,PSMD10,NRG2,PSME1,PRKACA,SPTB,FGF19,PDGFA,ELMO2,SHC3,DUSP10,MAPK11,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,PIK3R1,CALM1,GRIN1,DUSP4,ITPR3,BCAR1,IRS2,MAPKAPK2,FGFR2,AXL,NRG1,ITGAV,HSPB1,MAPK12
R-HSA-1250342	PI3K events in ERBB4 signaling	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-5654720	PI-3K cascade:FGFR4	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-5654689	PI-3K cascade:FGFR1	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-5654695	PI-3K cascade:FGFR2	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-5654710	PI-3K cascade:FGFR3	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-1257604	PIP3 activates AKT signaling	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,1027,9542,3084,192670,2065,5293,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,CDKN1B,NRG2,NRG1,AGO4,ERBB3,PIK3CD,PHLPP1,GAB1,FGF19
R-HSA-1963642	PI3K events in ERBB2 signaling	0.00102575836806946	-6.88232306867432	98	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-383280	Nuclear Receptor transcription pathway	0.00102933692370062	-6.87884044744268	51	10	0.01953125	512	8202	7068,2908,3164,7067,5465,4929,4306,5916,29959,7181	THRB,NR3C1,NR4A1,THRA,PPARA,NR4A2,NR3C2,RARG,NRBP1,NR2C1
R-HSA-168256	Immune System	0.0010475013156107	-6.86134765021584	1371	112	0.21875	512	8202	59307,23321,5721,6195,6890,26232,9542,221687,3606,5720,29126,598,5566,6710,30011,5154,6196,63916,53358,3572,5336,1027,11221,7220,3660,3434,5293,4940,221002,10125,64167,10817,10484,81603,1604,207,11274,83737,5588,192670,5577,1846,3710,79754,837,9021,8660,6892,5795,3984,64127,3084,2549,6300,23586,10810,9902,90293,3134,5922,9493,5716,51191,7006,23239,9965,3105,151636,92912,118788,1075,147700,51465,5592,6737,970,11059,5600,2065,3107,55223,6850,4644,3164,9693,801,5295,2902,7319,7525,3437,2002,2353,10235,9261,1514,3106,5819,2263,57161,4792,1515,84166,23220,51752,5476,1062,3685,126433,11065,64135,340061	SIGIRR,TRIM2,PSME2,RPS6KA1,TAP1,FBXO2,NRG2,RNF182,IL18,PSME1,CD274,BCL2L1,PRKACA,SPTB,SH3KBP1,PDGFA,RPS6KA2,ELMO2,SHC3,IL6ST,PLCG2,CDKN1B,DUSP10,TRPC1,IRF2,IFIT1,PIK3CD,OAS3,RASGEF1A,RASGRP1,ERAP2,FRS3,SEC23A,TRIM8,CD55,AKT1,USP18,ITCH,PRKCQ,AGO4,PRKAR2B,DUSP4,ITPR3,ASB13,CASP4,SOCS3,IRS2,TAPBP,PTPRJ,LIMK1,NOD2,NRG1,GAB1,MAPK12,DDX58,WASF3,MRC2,KLHL13,HLA-F,RASA2,KIF23,PSMD10,HERC5,TEC,PHLPP1,FGF19,HLA-A,DTX3L,UBE2Q2,PIK3AP1,CTSC,KLC3,UBE2J1,PRKG1,TRIM21,CD70,WWP1,MAPK11,ERBB3,HLA-C,TRIM62,SYK,MYO5A,NR4A1,RAPGEF2,CALM1,PIK3R1,GRIN1,UBE2A,YES1,IFIT3,ELK1,FOS,RASGRP2,MAPKAPK2,CTSL,HLA-B,PVRL2,FGFR2,PELI2,NFKBIA,CTSV,NLRC5,DTX4,ERAP1,CTSA,CENPE,ITGAV,FBXO27,UBE2C,IFIH1,TMEM173
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.00118740862022191	-6.73598197640846	267	30	0.05859375	512	8202	10484,9902,90293,5721,3134,83737,6890,26232,7319,5716,221687,5720,79754,3105,9021,151636,1514,3106,6892,92912,1515,51465,6737,51752,11059,3685,3107,126433,11065,64167	SEC23A,MRC2,KLHL13,PSME2,HLA-F,ITCH,TAP1,FBXO2,UBE2A,PSMD10,RNF182,PSME1,ASB13,HLA-A,SOCS3,DTX3L,CTSL,HLA-B,TAPBP,UBE2Q2,CTSV,UBE2J1,TRIM21,ERAP1,WWP1,ITGAV,HLA-C,FBXO27,UBE2C,ERAP2
R-HSA-2172127	DAP12 interactions	0.00118918651395356	-6.73448580734059	340	36	0.0703125	512	8202	5721,5922,5716,9542,5720,23239,5566,9965,6710,5154,53358,5336,1027,11221,5293,2065,3107,221002,6850,10125,10817,207,3164,9693,5295,801,2902,5577,192670,1846,3710,8660,3106,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,FGF19,SPTB,PDGFA,SHC3,PLCG2,CDKN1B,DUSP10,PIK3CD,ERBB3,HLA-C,RASGEF1A,SYK,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,DUSP4,ITPR3,IRS2,HLA-B,FGFR2,NRG1,GAB1
R-HSA-1236975	Antigen processing-Cross presentation	0.00140064537671235	-6.57082216521515	81	13	0.025390625	512	8202	1514,3106,6892,9902,5721,3134,1515,6890,5716,5720,3685,3107,3105	CTSL,HLA-B,TAPBP,MRC2,PSME2,HLA-F,CTSV,TAP1,PSMD10,PSME1,ITGAV,HLA-C,HLA-A
R-HSA-198203	PI3K/AKT activation	0.00140551608424815	-6.56735072389224	101	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-180292	GAB1 signalosome	0.00155576454699881	-6.46578818408538	102	15	0.029296875	512	8202	8660,5154,207,2263,3164,5295,9542,1027,192670,3084,5293,2065,23239,2549,9965	IRS2,PDGFA,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,AGO4,NRG1,PIK3CD,ERBB3,PHLPP1,GAB1,FGF19
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.00162903607667799	-6.41976680308936	54	10	0.01953125	512	8202	1514,1292,3655,1515,1291,649,80781,1287,4017,7093	CTSL,COL6A2,ITGA6,CTSV,COL6A1,BMP1,COL18A1,COL4A5,LOXL2,TLL2
R-HSA-2424491	DAP12 signaling	0.0019793014081897	-6.22501132067939	325	34	0.06640625	512	8202	5721,5922,5716,9542,5720,23239,5566,9965,6710,5154,53358,5336,1027,11221,2065,5293,221002,6850,10125,10817,207,3164,9693,5295,801,2902,5577,192670,1846,3710,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,FGF19,SPTB,PDGFA,SHC3,PLCG2,CDKN1B,DUSP10,ERBB3,PIK3CD,RASGEF1A,SYK,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,DUSP4,ITPR3,IRS2,FGFR2,NRG1,GAB1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.00204723447331509	-6.19126543400926	30	7	0.013671875	512	8202	9261,5600,6196,1846,2002,2353,6195	MAPKAPK2,MAPK11,RPS6KA2,DUSP4,ELK1,FOS,RPS6KA1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.00219436602573731	-6.12186210071679	85	13	0.025390625	512	8202	5154,8660,207,2263,3164,5295,9542,1027,3084,2065,5293,9965,2549	PDGFA,IRS2,AKT1,FGFR2,NR4A1,PIK3R1,NRG2,CDKN1B,NRG1,ERBB3,PIK3CD,FGF19,GAB1
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.00219944873124785	-6.11954852672298	5	3	0.005859375	512	8202	9542,3084,2065	NRG2,NRG1,ERBB3
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.00219944873124785	-6.11954852672298	5	3	0.005859375	512	8202	3159,11168,60489	HMGA1,PSIP1,APOBEC3G
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.00219944873124785	-6.11954852672298	5	3	0.005859375	512	8202	6102,27031,192668	RP2,NPHP3,CYS1
R-HSA-399956	CRMPs in Sema3A signaling	0.00228138585054824	-6.0829721914813	16	5	0.009765625	512	8202	56896,5361,10371,1808,8851	DPYSL5,PLXNA1,SEMA3A,DPYSL2,CDK5R1
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.00232843850222154	-6.06255740678968	10	4	0.0078125	512	8202	5563,5600,51422,6300	PRKAA2,MAPK11,PRKAG2,MAPK12
R-HSA-2428924	IGF1R signaling cascade	0.00263515984032959	-5.93881143836194	281	30	0.05859375	512	8202	5563,207,5721,9693,5922,801,5295,2902,5716,55437,9542,5720,1846,6710,9965,6009,8660,5154,51422,3480,2263,53358,11221,51719,3084,2065,221002,2549,10125,10817	PRKAA2,AKT1,PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,STRADB,NRG2,PSME1,DUSP4,SPTB,FGF19,RHEB,IRS2,PDGFA,PRKAG2,IGF1R,FGFR2,SHC3,DUSP10,CAB39,NRG1,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-2428928	IRS-related events triggered by IGF1R	0.00263515984032959	-5.93881143836194	281	30	0.05859375	512	8202	5563,207,5721,9693,5922,801,5295,2902,5716,55437,9542,5720,1846,6710,9965,6009,8660,5154,51422,3480,2263,53358,11221,51719,3084,2065,221002,2549,10125,10817	PRKAA2,AKT1,PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,STRADB,NRG2,PSME1,DUSP4,SPTB,FGF19,RHEB,IRS2,PDGFA,PRKAG2,IGF1R,FGFR2,SHC3,DUSP10,CAB39,NRG1,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.00263515984032959	-5.93881143836194	281	30	0.05859375	512	8202	5563,207,5721,9693,5922,801,5295,2902,5716,55437,9542,5720,1846,6710,9965,6009,8660,5154,51422,3480,2263,53358,11221,51719,3084,2065,221002,2549,10125,10817	PRKAA2,AKT1,PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,STRADB,NRG2,PSME1,DUSP4,SPTB,FGF19,RHEB,IRS2,PDGFA,PRKAG2,IGF1R,FGFR2,SHC3,DUSP10,CAB39,NRG1,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-1433557	Signaling by SCF-KIT	0.00281532940430094	-5.87267600672284	307	32	0.0625	512	8202	5721,5922,5716,9542,5720,7006,23239,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,10076,9693,3164,5295,801,2902,192670,7525,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,TEC,PHLPP1,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,PTPRU,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,AGO4,YES1,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-1227986	Signaling by ERBB2	0.0028890018612391	-5.84684421324795	320	33	0.064453125	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,5577,192670,7525,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,YES1,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.00293983037141259	-5.82940339609451	24	6	0.01171875	512	8202	9261,5600,6196,1846,2002,6195	MAPKAPK2,MAPK11,RPS6KA2,DUSP4,ELK1,RPS6KA1
R-HSA-186763	Downstream signal transduction	0.00318913940839789	-5.74800417651369	322	33	0.064453125	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,5577,192670,3710,1846,9564,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,BCAR1,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654716	Downstream signaling of activated FGFR4	0.00327562001999199	-5.72124810873199	310	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654687	Downstream signaling of activated FGFR1	0.00327562001999199	-5.72124810873199	310	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654708	Downstream signaling of activated FGFR3	0.00327562001999199	-5.72124810873199	310	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.00327562001999199	-5.72124810873199	310	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-177929	Signaling by EGFR	0.00341074167721226	-5.68082551068779	336	34	0.06640625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,30011,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,3164,9693,5295,801,2902,5577,192670,1846,3710,8660,2263,26018,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,SH3KBP1,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,NR4A1,RAPGEF2,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,DUSP4,ITPR3,IRS2,FGFR2,LRIG1,NRG1,GAB1
R-HSA-449147	Signaling by Interleukins	0.00344267761242261	-5.67150573466985	311	32	0.0625	512	8202	5721,5922,5716,9542,3606,5720,7006,5566,9965,6710,5154,53358,3572,11221,5293,2065,221002,6850,10125,10817,9693,5295,801,2902,7525,1846,9021,8660,2263,57161,64127,3084	PSME2,RASA2,PSMD10,NRG2,IL18,PSME1,TEC,PRKACA,FGF19,SPTB,PDGFA,SHC3,IL6ST,DUSP10,PIK3CD,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3,RAPGEF2,PIK3R1,CALM1,GRIN1,YES1,DUSP4,SOCS3,IRS2,FGFR2,PELI2,NOD2,NRG1
R-HSA-5654741	Signaling by FGFR3	0.00379866392694674	-5.57310587224684	313	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-5654743	Signaling by FGFR4	0.00379866392694674	-5.57310587224684	313	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.00387289511066776	-5.55375296100893	51	9	0.017578125	512	8202	337876,126792,3339,6385,3074,29940,6382,411,79586	CHSY3,B3GALT6,HSPG2,SDC4,HEXB,DSE,SDC1,ARSB,CHPF
R-HSA-1566948	Elastic fibre formation	0.00390816967802632	-5.54468612762072	42	8	0.015625	512	8202	10516,3696,655,5045,3685,4017,4053,2192	FBLN5,ITGB8,BMP7,FURIN,ITGAV,LOXL2,LTBP2,FBLN1
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.00391309511784981	-5.54342662788426	168	20	0.0390625	512	8202	207,3164,5721,5295,5716,9542,192670,5720,23239,9965,5154,8660,2263,4792,1027,3084,2065,5293,2549,10125	AKT1,NR4A1,PSME2,PIK3R1,PSMD10,NRG2,AGO4,PSME1,PHLPP1,FGF19,PDGFA,IRS2,FGFR2,NFKBIA,CDKN1B,NRG1,ERBB3,PIK3CD,GAB1,RASGRP1
R-HSA-1630316	Glycosaminoglycan metabolism	0.00397055852230678	-5.52884850845875	123	16	0.03125	512	8202	3161,337876,126792,9060,3339,6385,3074,29940,6382,79586,26035,2799,9394,9061,9953,411	HMMR,CHSY3,B3GALT6,PAPSS2,HSPG2,SDC4,HEXB,DSE,SDC1,CHPF,GLCE,GNS,HS6ST1,PAPSS1,HS3ST3B1,ARSB
R-HSA-5654736	Signaling by FGFR1	0.00398808822761849	-5.52444330385282	314	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-112399	IRS-mediated signalling	0.00409496484522176	-5.49799714651939	277	29	0.056640625	512	8202	5563,207,5721,9693,5922,801,5295,2902,5716,55437,9542,5720,1846,6710,9965,6009,8660,5154,51422,2263,53358,11221,51719,3084,2065,221002,2549,10125,10817	PRKAA2,AKT1,PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,STRADB,NRG2,PSME1,DUSP4,SPTB,FGF19,RHEB,IRS2,PDGFA,PRKAG2,FGFR2,SHC3,DUSP10,CAB39,NRG1,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.00414944040260364	-5.48478179657774	61	10	0.01953125	512	8202	5154,8660,2263,5295,9542,3084,2065,5293,2549,9965	PDGFA,IRS2,FGFR2,PIK3R1,NRG2,NRG1,ERBB3,PIK3CD,GAB1,FGF19
R-HSA-5654738	Signaling by FGFR2	0.0043910786538511	-5.4281803750485	316	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.00448384942499577	-5.40727335484548	254	27	0.052734375	512	8202	5721,9693,5922,801,5295,2902,5716,9542,5720,7006,7525,1846,5566,9965,6710,8660,5154,53358,2263,11221,3084,2065,5293,221002,6850,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,NRG2,PSME1,TEC,YES1,DUSP4,PRKACA,FGF19,SPTB,IRS2,PDGFA,SHC3,FGFR2,DUSP10,NRG1,ERBB3,PIK3CD,RASGEF1A,SYK,RASGRP1,FRS3
R-HSA-190236	Signaling by FGFR	0.00460517282921773	-5.38057507920438	317	32	0.0625	512	8202	5721,5922,5716,9542,5720,23239,5566,6710,9965,5154,53358,11221,1027,5293,2065,221002,10125,10817,207,9693,3164,5295,801,2902,5577,192670,3710,1846,8660,2263,3084,2549	PSME2,RASA2,PSMD10,NRG2,PSME1,PHLPP1,PRKACA,SPTB,FGF19,PDGFA,SHC3,DUSP10,CDKN1B,PIK3CD,ERBB3,RASGEF1A,RASGRP1,FRS3,AKT1,RAPGEF2,NR4A1,PIK3R1,CALM1,GRIN1,PRKAR2B,AGO4,ITPR3,DUSP4,IRS2,FGFR2,NRG1,GAB1
R-HSA-74751	Insulin receptor signalling cascade	0.00477299974228536	-5.34478029495265	280	29	0.056640625	512	8202	5563,207,5721,9693,5922,801,5295,2902,5716,55437,9542,5720,1846,6710,9965,6009,8660,5154,51422,2263,53358,11221,51719,3084,2065,221002,2549,10125,10817	PRKAA2,AKT1,PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,STRADB,NRG2,PSME1,DUSP4,SPTB,FGF19,RHEB,IRS2,PDGFA,PRKAG2,FGFR2,SHC3,DUSP10,CAB39,NRG1,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-5663202	Diseases of signal transduction	0.0048852751614549	-5.32152966724265	268	28	0.0546875	512	8202	27248,207,8322,3164,5721,5295,5716,9542,7046,5720,84441,54492,83999,9965,9372,8323,9734,8660,5154,2263,1027,3065,3084,2065,5293,7855,89780,2549	ERLEC1,AKT1,FZD4,NR4A1,PSME2,PIK3R1,PSMD10,NRG2,TGFBR1,PSME1,MAML2,NEURL1B,KREMEN1,FGF19,ZFYVE9,FZD6,HDAC9,IRS2,PDGFA,FGFR2,CDKN1B,HDAC1,NRG1,ERBB3,PIK3CD,FZD5,WNT3A,GAB1
R-HSA-2682334	EPH-Ephrin signaling	0.00587061731795891	-5.13779548577227	95	13	0.025390625	512	8202	10398,64283,3984,2043,2902,1946,7525,2041,2050,7074,10627,1947,103910	MYL9,ARHGEF28,LIMK1,EPHA4,GRIN1,EFNA5,YES1,EPHA1,EPHB4,TIAM1,MYL12A,EFNB1,MYL12B
R-HSA-5683057	MAPK family signaling cascades	0.00628744973629965	-5.06919973781493	273	28	0.0546875	512	8202	5721,9693,5922,801,2902,5716,9542,192670,5720,1846,5566,983,6710,9965,8660,5154,8202,2263,53358,3572,11221,3084,2065,221002,3315,2118,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,NRG2,AGO4,PSME1,DUSP4,PRKACA,CDK1,SPTB,FGF19,IRS2,PDGFA,NCOA3,FGFR2,SHC3,IL6ST,DUSP10,NRG1,ERBB3,RASGEF1A,HSPB1,ETV4,RASGRP1,FRS3
R-HSA-1236394	Signaling by ERBB4	0.00659775702300435	-5.0210255327095	312	31	0.060546875	512	8202	207,3164,5721,9693,83737,5922,801,5295,2902,5716,9542,192670,5720,1846,23239,6710,9965,8660,5154,2263,53358,11221,1027,11059,3084,5293,2065,221002,2549,10125,10817	AKT1,NR4A1,PSME2,RAPGEF2,ITCH,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,NRG2,AGO4,PSME1,DUSP4,PHLPP1,SPTB,FGF19,IRS2,PDGFA,FGFR2,SHC3,DUSP10,CDKN1B,WWP1,NRG1,PIK3CD,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.00682228689049075	-4.98756054214802	13	4	0.0078125	512	8202	9542,3084,2065,207	NRG2,NRG1,ERBB3,AKT1
R-HSA-199920	CREB phosphorylation	0.00700335510923133	-4.96136594343625	7	3	0.005859375	512	8202	9261,6196,6195	MAPKAPK2,RPS6KA2,RPS6KA1
R-HSA-428157	Sphingolipid metabolism	0.00715610029553135	-4.93979009784817	76	11	0.021484375	512	8202	221,22901,8613,3074,5476,2717,411,80772,224,2760,8879	ALDH3B1,ARSG,PLPP3,HEXB,CTSA,GLA,ARSB,CPTP,ALDH3A2,GM2A,SGPL1
R-HSA-1280215	Cytokine Signaling in Immune system	0.00727024530340562	-4.92396524613448	539	48	0.09375	512	8202	23586,23321,5721,3134,5922,5716,9542,51191,3606,5720,7006,5566,9965,6710,3105,5154,53358,3572,11221,6737,3660,970,3434,5293,3107,2065,4940,221002,55223,6850,10125,10817,81603,11274,9693,5295,801,2902,7525,1846,3437,9021,8660,3106,2263,57161,64127,3084	DDX58,TRIM2,PSME2,HLA-F,RASA2,PSMD10,NRG2,HERC5,IL18,PSME1,TEC,PRKACA,FGF19,SPTB,HLA-A,PDGFA,SHC3,IL6ST,DUSP10,TRIM21,IRF2,CD70,IFIT1,PIK3CD,HLA-C,ERBB3,OAS3,RASGEF1A,TRIM62,SYK,RASGRP1,FRS3,TRIM8,USP18,RAPGEF2,PIK3R1,CALM1,GRIN1,YES1,DUSP4,IFIT3,SOCS3,IRS2,HLA-B,FGFR2,PELI2,NOD2,NRG1
R-HSA-4641263	Regulation of FZD by ubiquitination	0.00820232950484942	-4.80333707909946	21	5	0.009765625	512	8202	7855,89780,55366,8322,8323	FZD5,WNT3A,LGR4,FZD4,FZD6
R-HSA-198753	ERK/MAPK targets	0.00820232950484942	-4.80333707909946	21	5	0.009765625	512	8202	5600,6196,1846,2002,6195	MAPK11,RPS6KA2,DUSP4,ELK1,RPS6KA1
R-HSA-1442490	Collagen degradation	0.00823727943054829	-4.79908515577321	38	7	0.013671875	512	8202	1514,80781,4324,1299,1307,1303,5045	CTSL,COL18A1,MMP15,COL9A3,COL16A1,COL12A1,FURIN
R-HSA-382551	Transmembrane transport of small molecules	0.00887307556635658	-4.72473380472695	586	51	0.099609375	512	8202	10079,1831,10396,5349,9914,9429,2495,6542,6507,338440,5566,6574,55107,6549,84679,120,6337,28965,10681,23446,23678,261729,20,6446,5205,7220,215,11059,57181,6558,53373,490,4645,64116,55343,4891,5577,148229,481,28231,476,8671,22841,540,10479,5243,6508,376497,123606,79901,9619	ATP9A,TSC22D3,ATP8A1,FXYD3,ATP2C2,ABCG2,FTH1,SLC7A2,SLC1A3,ANO9,PRKACA,SLC20A1,ANO1,SLC9A2,SLC9A7,ADD3,SCNN1A,SLC27A6,GNB5,SLC44A1,SGK3,STEAP2,ABCA2,SGK1,ATP8B1,TRPC1,ABCD1,WWP1,SLC39A10,SLC12A2,TPCN1,ATP2B1,MYO5B,SLC39A8,SLC35C1,SLC11A2,PRKAR2B,ATP8B3,ATP1B1,SLCO4A1,ATP1A1,SLC4A4,RAB11FIP2,ATP7B,SLC9A6,ABCB1,SLC4A3,SLC27A1,NIPA1,CYBRD1,ABCG1
R-HSA-909733	Interferon alpha/beta signaling	0.00906058861998034	-4.7038211919449	68	10	0.01953125	512	8202	3106,3134,11274,3660,3434,4940,3107,3437,3105,9021	HLA-B,HLA-F,USP18,IRF2,IFIT1,OAS3,HLA-C,IFIT3,HLA-A,SOCS3
R-HSA-109704	PI3K Cascade	0.0095463951035069	-4.6515916718241	79	11	0.021484375	512	8202	8660,5563,51422,207,2263,5295,51719,55437,2549,9965,6009	IRS2,PRKAA2,PRKAG2,AKT1,FGFR2,PIK3R1,CAB39,STRADB,GAB1,FGF19,RHEB
R-HSA-1660662	Glycosphingolipid metabolism	0.0109291398771376	-4.51632267365621	40	7	0.013671875	512	8202	5476,2717,411,22901,80772,2760,3074	CTSA,GLA,ARSB,ARSG,CPTP,GM2A,HEXB
R-HSA-2129379	Molecules associated with elastic fibres	0.0110994507886947	-4.50085965038392	31	6	0.01171875	512	8202	4053,3685,10516,3696,2192,655	LTBP2,ITGAV,FBLN5,ITGB8,FBLN1,BMP7
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.0110994507886947	-4.50085965038392	31	6	0.01171875	512	8202	80781,4324,7077,4326,1515,5045	COL18A1,MMP15,TIMP2,MMP17,CTSV,FURIN
R-HSA-2022928	HS-GAG biosynthesis	0.0110994507886947	-4.50085965038392	31	6	0.01171875	512	8202	9394,9953,3339,6382,6385,26035	HS6ST1,HS3ST3B1,HSPG2,SDC1,SDC4,GLCE
R-HSA-177539	Autointegration results in viral DNA circles	0.0111849547804741	-4.49318572692045	3	2	0.00390625	512	8202	3159,11168	HMGA1,PSIP1
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.0111849547804741	-4.49318572692045	3	2	0.00390625	512	8202	3159,11168	HMGA1,PSIP1
R-HSA-4086398	Ca2+ pathway	0.0127191010081697	-4.36465039902615	61	9	0.017578125	512	8202	10681,8322,801,5592,192670,6932,3710,7855,8323	GNB5,FZD4,CALM1,PRKG1,AGO4,TCF7,ITPR3,FZD5,FZD6
R-HSA-167044	Signalling to RAS	0.0139636704862411	-4.2712962873938	239	24	0.046875	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,9261,8660,5154,2263,53358,11221,5600,3084,2065,221002,10125,10817,6300	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,MAPKAPK2,IRS2,PDGFA,FGFR2,SHC3,DUSP10,MAPK11,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3,MAPK12
R-HSA-3928662	EPHB-mediated forward signaling	0.0142077983478906	-4.25396428568984	42	7	0.013671875	512	8202	7525,2050,64283,7074,3984,1947,2902	YES1,EPHB4,ARHGEF28,TIAM1,LIMK1,EFNB1,GRIN1
R-HSA-74752	Signaling by Insulin receptor	0.0143618846257143	-4.24317748262844	304	29	0.056640625	512	8202	5563,207,5721,9693,5922,801,5295,2902,5716,55437,9542,5720,1846,6710,9965,6009,8660,5154,51422,2263,53358,11221,51719,3084,2065,221002,2549,10125,10817	PRKAA2,AKT1,PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,STRADB,NRG2,PSME1,DUSP4,SPTB,FGF19,RHEB,IRS2,PDGFA,PRKAG2,FGFR2,SHC3,DUSP10,CAB39,NRG1,ERBB3,RASGEF1A,GAB1,RASGRP1,FRS3
R-HSA-375165	NCAM signaling for neurite out-growth	0.0149148282670589	-4.20539937519107	266	26	0.05078125	512	8202	1299,1292,5721,9693,5922,801,2902,5716,9542,1287,5720,1846,6710,9965,8660,5154,9048,2263,53358,1291,11221,3084,2065,221002,10125,10817	COL9A3,COL6A2,PSME2,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,NRG2,COL4A5,PSME1,DUSP4,SPTB,FGF19,IRS2,PDGFA,ARTN,FGFR2,SHC3,COL6A1,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-392517	Rap1 signalling	0.0149602050035224	-4.20236160308568	16	4	0.0078125	512	8202	5566,10125,5592,10235	PRKACA,RASGRP1,PRKG1,RASGRP2
R-HSA-5625900	RHO GTPases activate CIT	0.0149602050035224	-4.20236160308568	16	4	0.0078125	512	8202	10398,1027,103910,9928	MYL9,CDKN1B,MYL12B,KIF14
R-HSA-2243919	Crosslinking of collagen fibrils	0.0153009600587935	-4.17983970361163	9	3	0.005859375	512	8202	4017,649,7093	LOXL2,BMP1,TLL2
R-HSA-425986	Sodium/Proton exchangers	0.0153009600587935	-4.17983970361163	9	3	0.005859375	512	8202	10479,6549,84679	SLC9A6,SLC9A2,SLC9A7
R-HSA-1236974	ER-Phagosome pathway	0.0171356530668663	-4.06659401134617	64	9	0.017578125	512	8202	3106,6892,5721,3134,6890,5716,5720,3107,3105	HLA-B,TAPBP,PSME2,HLA-F,TAP1,PSMD10,PSME1,HLA-C,HLA-A
R-HSA-3928663	EPHA-mediated growth cone collapse	0.0173154970591333	-4.05615339468831	34	6	0.01171875	512	8202	10398,1946,7525,2041,103910,2043	MYL9,EFNA5,YES1,EPHA1,MYL12B,EPHA4
R-HSA-451927	Interleukin-2 signaling	0.0184172286806971	-3.99446871111907	245	24	0.046875	512	8202	5721,9693,5922,801,5295,2902,5716,9542,5720,1846,9965,6710,5154,8660,53358,2263,11221,3084,2065,5293,221002,6850,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,NRG2,PSME1,DUSP4,FGF19,SPTB,PDGFA,IRS2,SHC3,FGFR2,DUSP10,NRG1,ERBB3,PIK3CD,RASGEF1A,SYK,RASGRP1,FRS3
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.0186192842368063	-3.98355744843028	17	4	0.0078125	512	8202	2548,5236,5256,801	GAA,PGM1,PHKA2,CALM1
R-HSA-187687	Signalling to ERKs	0.0192575703037223	-3.94985103302476	246	24	0.046875	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,9261,8660,5154,2263,53358,11221,5600,3084,2065,221002,10125,10817,6300	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,MAPKAPK2,IRS2,PDGFA,FGFR2,SHC3,DUSP10,MAPK11,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3,MAPK12
R-HSA-5684996	MAPK1/MAPK3 signaling	0.0200138636892585	-3.9113300611066	234	23	0.044921875	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,983,6710,9965,8660,5154,2263,53358,3572,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,CDK1,SPTB,FGF19,IRS2,PDGFA,FGFR2,SHC3,IL6ST,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-2871796	FCERI mediated MAPK activation	0.0210283619684665	-3.86188318253097	248	24	0.046875	512	8202	5721,9693,5922,801,2902,5716,9542,5720,1846,2353,6710,9965,5154,8660,2263,53358,5336,11221,3084,2065,221002,6850,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,NRG2,PSME1,DUSP4,FOS,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,PLCG2,DUSP10,NRG1,ERBB3,RASGEF1A,SYK,RASGRP1,FRS3
R-HSA-167060	NGF processing	0.0214473090011611	-3.84215609596951	4	2	0.00390625	512	8202	5045,5125	FURIN,PCSK5
R-HSA-2586552	Signaling by Leptin	0.0218926138305872	-3.82160596705704	236	23	0.044921875	512	8202	5721,9693,5922,801,2902,5716,9542,5720,1846,6710,9965,3953,9021,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,NRG2,PSME1,DUSP4,SPTB,FGF19,LEPR,SOCS3,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-373755	Semaphorin interactions	0.0225789550310451	-3.79073699985032	67	9	0.017578125	512	8202	10398,56896,10507,1808,3984,5361,10371,103910,8851	MYL9,DPYSL5,SEMA4D,DPYSL2,LIMK1,PLXNA1,SEMA3A,MYL12B,CDK5R1
R-HSA-912631	Regulation of signaling by CBL	0.022786687776396	-3.7815787829962	18	4	0.0078125	512	8202	5293,7525,6850,5295	PIK3CD,YES1,SYK,PIK3R1
R-HSA-912526	Interleukin receptor SHC signaling	0.0239055831683134	-3.73364324195739	238	23	0.044921875	512	8202	5721,9693,5922,801,5295,2902,5716,9542,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,5293,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,NRG2,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,PIK3CD,RASGEF1A,RASGRP1,FRS3
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.0239194822988196	-3.73306199315985	27	5	0.009765625	512	8202	207,9564,6850,10125,10235	AKT1,BCAR1,SYK,RASGRP1,RASGRP2
R-HSA-114508	Effects of PIP2 hydrolysis	0.0239194822988196	-3.73306199315985	27	5	0.009765625	512	8202	5588,3710,10125,8526,10235	PRKCQ,ITPR3,RASGRP1,DGKE,RASGRP2
R-HSA-438064	Post NMDA receptor activation events	0.0255815266463092	-3.66588480336487	37	6	0.01171875	512	8202	6196,5566,84254,6195,801,2902	RPS6KA2,PRKACA,CAMKK1,RPS6KA1,CALM1,GRIN1
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0273783744608953	-3.59800183046443	11	3	0.005859375	512	8202	5563,32,51422	PRKAA2,ACACB,PRKAG2
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.027539048121876	-3.59215034975478	92	11	0.021484375	512	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.027539048121876	-3.59215034975478	92	11	0.021484375	512	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.027539048121876	-3.59215034975478	92	11	0.021484375	512	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.027539048121876	-3.59215034975478	92	11	0.021484375	512	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-877300	Interferon gamma signaling	0.027539048121876	-3.59215034975478	92	11	0.021484375	512	8202	3106,81603,23321,3134,6737,3660,4940,3107,55223,3105,9021	HLA-B,TRIM8,TRIM2,HLA-F,TRIM21,IRF2,OAS3,HLA-C,TRIM62,HLA-A,SOCS3
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.0276727306558887	-3.58730780353682	28	5	0.009765625	512	8202	51719,5563,55437,51422,6009	CAB39,PRKAA2,STRADB,PRKAG2,RHEB
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.0281597369077034	-3.56986209050215	48	7	0.013671875	512	8202	1946,7525,2050,2041,7074,1947,2043	EFNA5,YES1,EPHB4,EPHA1,TIAM1,EFNB1,EPHA4
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.028541550430178	-3.55639434359546	81	10	0.01953125	512	8202	80321,4751,10733,6790,5577,54820,95681,9133,5566,983	CEP70,NEK2,PLK4,AURKA,PRKAR2B,NDE1,CEP41,CCNB2,PRKACA,CDK1
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.0307682009198149	-3.48127356000184	82	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.0307682009198149	-3.48127356000184	82	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.0307682009198149	-3.48127356000184	82	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-445355	Smooth Muscle Contraction	0.031779921873056	-3.44892057624487	29	5	0.009765625	512	8202	10398,10580,10627,103910,801	MYL9,SORBS1,MYL12A,MYL12B,CALM1
R-HSA-450294	MAP kinase activation in TLR cascade	0.031880420594027	-3.44576323210992	60	8	0.015625	512	8202	9261,6196,6195,64127,5600,2002,1846,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NOD2,MAPK11,ELK1,DUSP4,FOS
R-HSA-165159	mTOR signalling	0.0323462543089917	-3.43125705116893	39	6	0.01171875	512	8202	51719,5563,55437,51422,207,6009	CAB39,PRKAA2,STRADB,PRKAG2,AKT1,RHEB
R-HSA-3000170	Syndecan interactions	0.0327013049827644	-3.42034029414542	20	4	0.0078125	512	8202	3685,6382,3655,6385	ITGAV,SDC1,ITGA6,SDC4
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.0331147410380736	-3.40777674715508	83	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-2161517	Abacavir transmembrane transport	0.0342792158477564	-3.37321606043378	5	2	0.00390625	512	8202	5243,9429	ABCB1,ABCG2
R-HSA-157881	Cyclin B2 mediated events	0.0342792158477564	-3.37321606043378	5	2	0.00390625	512	8202	9133,983	CCNB2,CDK1
R-HSA-69478	G2/M DNA replication checkpoint	0.0342792158477564	-3.37321606043378	5	2	0.00390625	512	8202	9133,983	CCNB2,CDK1
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.0342792158477564	-3.37321606043378	5	2	0.00390625	512	8202	5563,51422	PRKAA2,PRKAG2
R-HSA-3858494	Beta-catenin independent WNT signaling	0.0347124486320003	-3.36065690616305	144	15	0.029296875	512	8202	10681,8322,5721,801,5592,144165,5716,192670,6932,5720,4919,7855,3710,8324,8323	GNB5,FZD4,PSME2,CALM1,PRKG1,PRICKLE1,PSMD10,AGO4,TCF7,PSME1,ROR1,FZD5,ITPR3,FZD7,FZD6
R-HSA-203615	eNOS activation	0.034849500635481	-3.35671647084581	12	3	0.005859375	512	8202	207,801,340481	AKT1,CALM1,ZDHHC21
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.034849500635481	-3.35671647084581	12	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-211958	Miscellaneous substrates	0.034849500635481	-3.35671647084581	12	3	0.005859375	512	8202	113612,57834,4051	CYP2U1,CYP4F11,CYP4F3
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.034849500635481	-3.35671647084581	12	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.034849500635481	-3.35671647084581	12	3	0.005859375	512	8202	207,6697,801	AKT1,SPR,CALM1
R-HSA-71387	Metabolism of carbohydrates	0.0353831432862975	-3.3415197506045	274	25	0.048828125	512	8202	3161,337876,126792,2548,5236,9060,2026,3339,10165,801,6385,3074,29940,6382,5566,79586,26035,2799,9394,5634,9061,2805,9953,5256,411	HMMR,CHSY3,B3GALT6,GAA,PGM1,PAPSS2,ENO2,HSPG2,SLC25A13,CALM1,SDC4,HEXB,DSE,SDC1,PRKACA,CHPF,GLCE,GNS,HS6ST1,PRPS2,PAPSS1,GOT1,HS3ST3B1,PHKA2,ARSB
R-HSA-109703	PKB-mediated events	0.0361257450905618	-3.32074950741797	40	6	0.01171875	512	8202	51719,5563,55437,51422,207,6009	CAB39,PRKAA2,STRADB,PRKAG2,AKT1,RHEB
R-HSA-174824	Lipoprotein metabolism	0.0362487147679251	-3.31735135298791	30	5	0.009765625	512	8202	3339,6382,19,9619,649	HSPG2,SDC1,ABCA1,ABCG1,BMP1
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.0362487147679251	-3.31735135298791	30	5	0.009765625	512	8202	7006,3710,6850,5336,801	TEC,ITPR3,SYK,PLCG2,CALM1
R-HSA-2559585	Oncogene Induced Senescence	0.0362487147679251	-3.31735135298791	30	5	0.009765625	512	8202	1031,192670,2113,1032,7157	CDKN2C,AGO4,ETS1,CDKN2D,TP53
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.0381784262994691	-3.26548467946306	85	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.0381784262994691	-3.26548467946306	85	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-983712	Ion channel transport	0.0401102178960442	-3.2161241667531	198	19	0.037109375	512	8202	10079,1831,10396,5349,9914,148229,481,338440,55107,6337,476,540,23678,7220,5205,6446,11059,53373,490	ATP9A,TSC22D3,ATP8A1,FXYD3,ATP2C2,ATP8B3,ATP1B1,ANO9,ANO1,SCNN1A,ATP1A1,ATP7B,SGK3,TRPC1,ATP8B1,SGK1,WWP1,TPCN1,ATP2B1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.0401773824937111	-3.21445106622429	41	6	0.01171875	512	8202	6196,5566,84254,6195,801,2902	RPS6KA2,PRKACA,CAMKK1,RPS6KA1,CALM1,GRIN1
R-HSA-157118	Signaling by NOTCH	0.0409897751928693	-3.19443262891935	110	12	0.0234375	512	8202	4192,83737,7157,5045,23220,7088,3065,192670,84441,54492,92737,9734	MDK,ITCH,TP53,FURIN,DTX4,TLE1,HDAC1,AGO4,MAML2,NEURL1B,DNER,HDAC9
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.0410787163306398	-3.19226514244701	63	8	0.015625	512	8202	80321,4751,10733,5577,54820,95681,5566,983	CEP70,NEK2,PLK4,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.0410787163306398	-3.19226514244701	63	8	0.015625	512	8202	80321,4751,10733,5577,54820,95681,5566,983	CEP70,NEK2,PLK4,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-168638	NOD1/2 Signaling Pathway	0.0410851116862398	-3.1921094691838	31	5	0.009765625	512	8202	5600,837,83737,6300,64127	MAPK11,CASP4,ITCH,MAPK12,NOD2
R-HSA-109582	Hemostasis	0.0430799389846852	-3.14469784302074	515	42	0.08203125	512	8202	5270,3655,22927,7157,9493,5566,5154,10681,2624,5336,928,5592,147700,3660,5293,6850,10125,490,3920,207,5329,5295,801,10362,8654,5588,5577,481,7525,2161,3710,80005,9564,8526,10235,27345,5265,5547,3065,5269,3685,1062	SERPINE2,ITGA6,HABP4,TP53,KIF23,PRKACA,PDGFA,GNB5,GATA2,PLCG2,CD9,PRKG1,KLC3,IRF2,PIK3CD,SYK,RASGRP1,ATP2B1,LAMP2,AKT1,PLAUR,PIK3R1,CALM1,HMG20B,PDE5A,PRKCQ,PRKAR2B,ATP1B1,YES1,F12,ITPR3,DOCK5,BCAR1,DGKE,RASGRP2,KCNMB4,SERPINA1,PRCP,HDAC1,SERPINB6,ITGAV,CENPE
R-HSA-75205	Dissolution of Fibrin Clot	0.0432576647593115	-3.14058084143736	13	3	0.005859375	512	8202	5269,5270,5329	SERPINB6,SERPINE2,PLAUR
R-HSA-5210891	Uptake and function of anthrax toxins	0.0432576647593115	-3.14058084143736	13	3	0.005859375	512	8202	84168,801,5045	ANTXR1,CALM1,FURIN
R-HSA-171007	p38MAPK events	0.0432576647593115	-3.14058084143736	13	3	0.005859375	512	8202	9261,5600,6300	MAPKAPK2,MAPK11,MAPK12
R-HSA-4641265	Repression of WNT target genes	0.0432576647593115	-3.14058084143736	13	3	0.005859375	512	8202	3065,7088,6932	HDAC1,TLE1,TCF7
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.0445056465181682	-3.11213920981083	42	6	0.01171875	512	8202	3065,7088,6932,26108,207,6662	HDAC1,TLE1,TCF7,PYGO1,AKT1,SOX9
R-HSA-203765	eNOS activation and regulation	0.0447733762439052	-3.10614159648568	22	4	0.0078125	512	8202	207,6697,801,340481	AKT1,SPR,CALM1,ZDHHC21
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.0447733762439052	-3.10614159648568	22	4	0.0078125	512	8202	2517,11320,2530,11282	FUCA1,MGAT4A,FUT8,MGAT4B
R-HSA-202131	Metabolism of nitric oxide	0.0447733762439052	-3.10614159648568	22	4	0.0078125	512	8202	207,6697,801,340481	AKT1,SPR,CALM1,ZDHHC21
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.0461651584852866	-3.07552991074521	241	22	0.04296875	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,3710,6710,9965,8660,5154,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,ITPR3,SPTB,FGF19,IRS2,PDGFA,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-180336	SHC1 events in EGFR signaling	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5673001	RAF/MAP kinase cascade	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,5716,9542,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,PSMD10,NRG2,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-179812	GRB2 events in EGFR signaling	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-112412	SOS-mediated signalling	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.0467274020680954	-3.06342451833491	228	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.0485787470562598	-3.02456914708983	229	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.0485787470562598	-3.02456914708983	229	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.0485787470562598	-3.02456914708983	229	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.0485787470562598	-3.02456914708983	229	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.0493146986995864	-3.00953309430616	54	7	0.013671875	512	8202	126792,9394,9953,3339,6382,6385,26035	B3GALT6,HS6ST1,HS3ST3B1,HSPG2,SDC1,SDC4,GLCE
R-HSA-70921	Histidine catabolism	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	144193,3034	AMDHD1,HAL
R-HSA-174362	Transport and synthesis of PAPS	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	9060,9061	PAPSS2,PAPSS1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	2517,2530	FUCA1,FUT8
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	340061,23220	TMEM173,DTX4
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	84254,801	CAMKK1,CALM1
R-HSA-444257	RSK activation	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	6196,6195	RPS6KA2,RPS6KA1
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.0493211317816971	-3.00940265322631	6	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.0498568446904642	-2.99859948627339	89	10	0.01953125	512	8202	9261,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-5627123	RHO GTPases activate PAKs	0.0516233508022816	-2.96378117392973	23	4	0.0078125	512	8202	10398,3984,103910,801	MYL9,LIMK1,MYL12B,CALM1
R-HSA-112409	RAF-independent MAPK1/3 activation	0.0516233508022816	-2.96378117392973	23	4	0.0078125	512	8202	11221,1846,983,3572	DUSP10,DUSP4,CDK1,IL6ST
R-HSA-3000157	Laminin interactions	0.0516233508022816	-2.96378117392973	23	4	0.0078125	512	8202	80781,3685,3339,3655	COL18A1,ITGAV,HSPG2,ITGA6
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.0516233508022816	-2.96378117392973	23	4	0.0078125	512	8202	9261,4048,57834,4051	MAPKAPK2,LTA4H,CYP4F11,CYP4F3
R-HSA-2142753	Arachidonic acid metabolism	0.0536093172184437	-2.92603239730953	55	7	0.013671875	512	8202	9261,127281,113612,1543,4048,57834,4051	MAPKAPK2,FAM213B,CYP2U1,CYP1A1,LTA4H,CYP4F11,CYP4F3
R-HSA-168898	Toll-Like Receptors Cascades	0.0538535144784462	-2.92148761328566	140	14	0.02734375	512	8202	9261,1514,59307,6196,6195,57161,4792,5336,1515,64127,5600,1846,2002,2353	MAPKAPK2,CTSL,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,PLCG2,CTSV,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-170984	ARMS-mediated activation	0.0544487838005655	-2.91049476593039	232	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-187706	Signalling to p38 via RIT and RIN	0.0544487838005655	-2.91049476593039	232	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-216083	Integrin cell surface interactions	0.0558634316510757	-2.88484528728588	67	8	0.015625	512	8202	1299,3696,3339,3655,80781,3685,1605,1307	COL9A3,ITGB8,HSPG2,ITGA6,COL18A1,ITGAV,DAG1,COL16A1
R-HSA-170968	Frs2-mediated activation	0.0565128757781134	-2.87328677691458	233	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-4791275	Signaling by WNT in cancer	0.0578352672293707	-2.85015652969784	34	5	0.009765625	512	8202	7855,89780,8322,83999,8323	FZD5,WNT3A,FZD4,KREMEN1,FZD6
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.0578352672293707	-2.85015652969784	34	5	0.009765625	512	8202	23586,51191,64135,83737,84166	DDX58,HERC5,IFIH1,ITCH,NLRC5
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.0590115496120886	-2.83002209809705	24	4	0.0078125	512	8202	10398,10507,3984,103910	MYL9,SEMA4D,LIMK1,MYL12B
R-HSA-1614635	Sulfur amino acid metabolism	0.0590115496120886	-2.83002209809705	24	4	0.0078125	512	8202	2805,2730,2729,1491	GOT1,GCLM,GCLC,CTH
R-HSA-169893	Prolonged ERK activation events	0.0608056993310134	-2.80007175540631	235	21	0.041015625	512	8202	5721,9693,5922,801,2902,9542,5716,5720,1846,6710,9965,5154,8660,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RAPGEF2,RASA2,CALM1,GRIN1,NRG2,PSMD10,PSME1,DUSP4,SPTB,FGF19,PDGFA,IRS2,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-389542	NADPH regeneration	0.0624237990725905	-2.77380868092541	1	1	0.001953125	512	8202	3417	IDH1
R-HSA-171286	Synthesis and processing of ENV and VPU	0.0624237990725905	-2.77380868092541	1	1	0.001953125	512	8202	5045	FURIN
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.0624237990725905	-2.77380868092541	1	1	0.001953125	512	8202	2263	FGFR2
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.0624237990725905	-2.77380868092541	1	1	0.001953125	512	8202	3417	IDH1
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.0627735514950194	-2.76822144875637	15	3	0.005859375	512	8202	6737,340061,23220	TRIM21,TMEM173,DTX4
R-HSA-194223	HDL-mediated lipid transport	0.0627735514950194	-2.76822144875637	15	3	0.005859375	512	8202	19,9619,649	ABCA1,ABCG1,BMP1
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-3323169	Defects in biotin (Btn) metabolism	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	32,64087	ACACB,MCCC2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	32,64087	ACACB,MCCC2
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	81607,5819	PVRL4,PVRL2
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-2214320	Anchoring fibril formation	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	649,7093	BMP1,TLL2
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	9133,983	CCNB2,CDK1
R-HSA-164843	2-LTR circle formation	0.0662482424513846	-2.71434634350341	7	2	0.00390625	512	8202	3159,11168	HMGA1,PSIP1
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.0703919983529434	-2.65367568203723	47	6	0.01171875	512	8202	5600,598,837,83737,6300,64127	MAPK11,BCL2L1,CASP4,ITCH,MAPK12,NOD2
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.0738074006843963	-2.60629627212707	16	3	0.005859375	512	8202	3159,3005,7157	HMGA1,H1F0,TP53
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.0738074006843963	-2.60629627212707	16	3	0.005859375	512	8202	5361,10371,3984	PLXNA1,SEMA3A,LIMK1
R-HSA-1834941	STING mediated induction of host immune responses	0.0738074006843963	-2.60629627212707	16	3	0.005859375	512	8202	6737,340061,23220	TRIM21,TMEM173,DTX4
R-HSA-1369062	ABC transporters in lipid homeostasis	0.0738074006843963	-2.60629627212707	16	3	0.005859375	512	8202	215,9619,20	ABCD1,ABCG1,ABCA2
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.0742489173527628	-2.6003320825132	121	12	0.0234375	512	8202	9261,59307,6196,6195,57161,4792,5336,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,PLCG2,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.0753706723152839	-2.58533704096907	26	4	0.0078125	512	8202	126792,3339,6382,6385	B3GALT6,HSPG2,SDC1,SDC4
R-HSA-2029485	Role of phospholipids in phagocytosis	0.0753706723152839	-2.58533704096907	26	4	0.0078125	512	8202	3710,6850,5336,5295	ITPR3,SYK,PLCG2,PIK3R1
R-HSA-2559583	Cellular Senescence	0.075439759610434	-2.58442082716209	187	17	0.033203125	512	8202	9134,6195,7157,23466,192670,2353,2113,1031,9261,6196,3005,1027,5600,3159,4217,11065,1032	CCNE2,RPS6KA1,TP53,CBX6,AGO4,FOS,ETS1,CDKN2C,MAPKAPK2,RPS6KA2,H1F0,CDKN1B,MAPK11,HMGA1,MAP3K5,UBE2C,CDKN2D
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.0779542258021111	-2.55163347324652	37	5	0.009765625	512	8202	207,9564,6850,10125,10235	AKT1,BCAR1,SYK,RASGRP1,RASGRP2
R-HSA-419037	NCAM1 interactions	0.0779542258021111	-2.55163347324652	37	5	0.009765625	512	8202	1287,1299,1292,9048,1291	COL4A5,COL9A3,COL6A2,ARTN,COL6A1
R-HSA-73923	Lipid digestion, mobilization, and transport	0.0785119062103371	-2.54450499422547	60	7	0.013671875	512	8202	3339,6382,5566,19,2172,9619,649	HSPG2,SDC1,PRKACA,ABCA1,FABP6,ABCG1,BMP1
R-HSA-1980143	Signaling by NOTCH1	0.0785891375649787	-2.54352178801617	72	8	0.015625	512	8202	83737,23220,7088,3065,84441,54492,92737,9734	ITCH,DTX4,TLE1,HDAC1,MAML2,NEURL1B,DNER,HDAC9
R-HSA-1643685	Disease	0.0795186233847633	-2.53176402834348	657	50	0.09765625	512	8202	32,3339,5721,5611,6385,5716,9542,7046,5720,6382,83999,9965,11168,3105,9372,8323,9734,5154,6170,5902,928,2963,1027,2065,5293,89780,60489,64087,27248,207,8322,3164,801,5295,5045,84441,2958,54492,84168,3417,292,8660,6136,2263,4792,3065,3084,3159,7855,2549	ACACB,HSPG2,PSME2,DNAJC3,SDC4,PSMD10,NRG2,TGFBR1,PSME1,SDC1,KREMEN1,FGF19,PSIP1,HLA-A,ZFYVE9,FZD6,HDAC9,PDGFA,RPL39,RANBP1,CD9,GTF2F2,CDKN1B,ERBB3,PIK3CD,WNT3A,APOBEC3G,MCCC2,ERLEC1,AKT1,FZD4,NR4A1,CALM1,PIK3R1,FURIN,MAML2,GTF2A2,NEURL1B,ANTXR1,IDH1,SLC25A5,IRS2,RPL12,FGFR2,NFKBIA,HDAC1,NRG1,HMGA1,FZD5,GAB1
R-HSA-380287	Centrosome maturation	0.0837102276645967	-2.48039411463167	73	8	0.015625	512	8202	80321,4751,10733,5577,54820,95681,5566,983	CEP70,NEK2,PLK4,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.0837102276645967	-2.48039411463167	73	8	0.015625	512	8202	80321,4751,10733,5577,54820,95681,5566,983	CEP70,NEK2,PLK4,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-400685	Sema4D in semaphorin signaling	0.0843187053611976	-2.4731515481827	27	4	0.0078125	512	8202	10398,10507,3984,103910	MYL9,SEMA4D,LIMK1,MYL12B
R-HSA-1253288	Downregulation of ERBB4 signaling	0.084767541178451	-2.46784257858112	8	2	0.00390625	512	8202	11059,83737	WWP1,ITCH
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.084767541178451	-2.46784257858112	8	2	0.00390625	512	8202	90427,598	BMF,BCL2L1
R-HSA-804914	Transport of fatty acids	0.084767541178451	-2.46784257858112	8	2	0.00390625	512	8202	376497,28965	SLC27A1,SLC27A6
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.084767541178451	-2.46784257858112	8	2	0.00390625	512	8202	23239,207	PHLPP1,AKT1
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.084767541178451	-2.46784257858112	8	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.0856334256394203	-2.4576795856126	17	3	0.005859375	512	8202	9261,5600,64127	MAPKAPK2,MAPK11,NOD2
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.0856334256394203	-2.4576795856126	17	3	0.005859375	512	8202	9261,207,167227	MAPKAPK2,AKT1,DCP2
R-HSA-5627117	RHO GTPases Activate ROCKs	0.0856334256394203	-2.4576795856126	17	3	0.005859375	512	8202	10398,3984,103910	MYL9,LIMK1,MYL12B
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.0856334256394203	-2.4576795856126	17	3	0.005859375	512	8202	5600,207,167227	MAPK11,AKT1,DCP2
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.0869246581400954	-2.44271353391049	86	9	0.017578125	512	8202	10810,63916,3984,5336,5295,7525,3710,6850,4644	WASF3,ELMO2,LIMK1,PLCG2,PIK3R1,YES1,ITPR3,SYK,MYO5A
R-HSA-166054	Activated TLR4 signalling	0.0895898018931541	-2.41251378363579	112	11	0.021484375	512	8202	9261,59307,6196,6195,57161,4792,64127,5600,1846,2002,2353	MAPKAPK2,SIGIRR,RPS6KA2,RPS6KA1,PELI2,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.0931982922851874	-2.37302588057877	39	5	0.009765625	512	8202	5625,10157,144193,3034,2184	PRODH,AASS,AMDHD1,HAL,FAH
R-HSA-4608870	Asymmetric localization of PCP proteins	0.0962053335590459	-2.34127048044562	63	7	0.013671875	512	8202	144165,5716,5720,7855,8322,5721,8324	PRICKLE1,PSMD10,PSME1,FZD5,FZD4,PSME2,FZD7
R-HSA-5687128	MAPK6/MAPK4 signaling	0.0970517355983637	-2.33251108597871	88	9	0.017578125	512	8202	8202,5721,5716,5720,192670,3315,2118,5566,983	NCOA3,PSME2,PSMD10,PSME1,AGO4,HSPB1,ETV4,PRKACA,CDK1
R-HSA-156584	Cytosolic sulfonation of small molecules	0.0982027732095474	-2.32072082359738	18	3	0.005859375	512	8202	9060,6820,9061	PAPSS2,SULT2B1,PAPSS1
R-HSA-418457	cGMP effects	0.0982027732095474	-2.32072082359738	18	3	0.005859375	512	8202	8654,27345,5592	PDE5A,KCNMB4,PRKG1
R-HSA-69275	G2/M Transition	0.103182993165291	-2.27125123442482	115	11	0.021484375	512	8202	80321,2305,4751,10733,6790,5577,54820,95681,9133,5566,983	CEP70,FOXM1,NEK2,PLK4,AURKA,PRKAR2B,NDE1,CEP41,CCNB2,PRKACA,CDK1
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.103676465830872	-2.26648013423855	29	4	0.0078125	512	8202	860,1490,7005,5465	RUNX2,CTGF,TEAD3,PPARA
R-HSA-5339562	Uptake and actions of bacterial toxins	0.103676465830872	-2.26648013423855	29	4	0.0078125	512	8202	84168,801,5045,928	ANTXR1,CALM1,FURIN,CD9
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.103676465830872	-2.26648013423855	29	4	0.0078125	512	8202	6196,6195,801,2902	RPS6KA2,RPS6KA1,CALM1,GRIN1
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.104615135783857	-2.25746703625307	9	2	0.00390625	512	8202	113612,1543	CYP2U1,CYP1A1
R-HSA-162592	Integration of provirus	0.104615135783857	-2.25746703625307	9	2	0.00390625	512	8202	3159,11168	HMGA1,PSIP1
R-HSA-425381	Bicarbonate transporters	0.104615135783857	-2.25746703625307	9	2	0.00390625	512	8202	8671,6508	SLC4A4,SLC4A3
R-HSA-73614	Pyrimidine salvage reactions	0.104615135783857	-2.25746703625307	9	2	0.00390625	512	8202	1633,978	DCK,CDA
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.104615135783857	-2.25746703625307	9	2	0.00390625	512	8202	207,3164	AKT1,NR4A1
R-HSA-1296052	Ca2+ activated K+ channels	0.104615135783857	-2.25746703625307	9	2	0.00390625	512	8202	27345,3783	KCNMB4,KCNN4
R-HSA-70326	Glucose metabolism	0.106105038954498	-2.24332574198759	77	8	0.015625	512	8202	2548,5236,2026,10165,801,2805,5256,5566	GAA,PGM1,ENO2,SLC25A13,CALM1,GOT1,PHKA2,PRKACA
R-HSA-556833	Metabolism of lipids and lipoproteins	0.107065551256079	-2.23431400353902	628	47	0.091796875	512	8202	5563,127281,32,3339,3074,64900,6382,5566,7005,8879,1543,1490,29841,57834,22901,23446,2172,215,5293,8309,2182,224,2760,6837,10484,9926,5295,5465,3417,80772,4051,9261,8202,221,51422,10555,8613,649,376497,5287,5476,113612,2717,411,4048,19,9619	PRKAA2,FAM213B,ACACB,HSPG2,HEXB,LPIN3,SDC1,PRKACA,TEAD3,SGPL1,CYP1A1,CTGF,GRHL1,CYP4F11,ARSG,SLC44A1,FABP6,ABCD1,PIK3CD,ACOX2,ACSL4,ALDH3A2,GM2A,MED22,SEC23A,LPGAT1,PIK3R1,PPARA,IDH1,CPTP,CYP4F3,MAPKAPK2,NCOA3,ALDH3B1,PRKAG2,AGPAT2,PLPP3,BMP1,SLC27A1,PIK3C2B,CTSA,CYP2U1,GLA,ARSB,LTA4H,ABCA1,ABCG1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.111463826538879	-2.19405516637964	19	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.111463826538879	-2.19405516637964	19	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.111463826538879	-2.19405516637964	19	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-3928664	Ephrin signaling	0.111463826538879	-2.19405516637964	19	3	0.005859375	512	8202	2050,10627,1947	EPHB4,MYL12A,EFNB1
R-HSA-453274	Mitotic G2-G2/M phases	0.112883565001675	-2.18139838971025	117	11	0.021484375	512	8202	80321,2305,4751,10733,6790,5577,54820,95681,9133,5566,983	CEP70,FOXM1,NEK2,PLK4,AURKA,PRKAR2B,NDE1,CEP41,CCNB2,PRKACA,CDK1
R-HSA-4086400	PCP/CE pathway	0.113466855299231	-2.17624450850325	91	9	0.017578125	512	8202	8322,5721,5716,144165,5720,4919,7855,8324,8323	FZD4,PSME2,PSMD10,PRICKLE1,PSME1,ROR1,FZD5,FZD7,FZD6
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.11404996599208	-2.17111862843609	30	4	0.0078125	512	8202	54492,92737,83737,23220	NEURL1B,DNER,ITCH,DTX4
R-HSA-195721	Signaling by Wnt	0.116611890275435	-2.14890403534687	326	26	0.05078125	512	8202	55366,207,8322,5721,801,6662,144165,5716,192670,6932,5720,4919,26108,3710,83999,8323,9559,8324,10681,51339,5592,7088,3065,7855,89780,81847	LGR4,AKT1,FZD4,PSME2,CALM1,SOX9,PRICKLE1,PSMD10,AGO4,TCF7,PSME1,ROR1,PYGO1,ITPR3,KREMEN1,FZD6,VPS26A,FZD7,GNB5,DACT1,PRKG1,TLE1,HDAC1,FZD5,WNT3A,RNF146
R-HSA-373752	Netrin-1 signaling	0.118677957374792	-2.13134169490757	42	5	0.009765625	512	8202	7220,5588,59277,219699,4756	TRPC1,PRKCQ,NTN4,UNC5B,NEO1
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.118677957374792	-2.13134169490757	42	5	0.009765625	512	8202	5577,3710,10681,5566,3790	PRKAR2B,ITPR3,GNB5,PRKACA,KCNS3
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	7157	TP53
R-HSA-1614603	Cysteine formation from homocysteine	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	1491	CTH
R-HSA-380612	Metabolism of serotonin	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	217	ALDH2
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	7157	TP53
R-HSA-888568	GABA synthesis	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	2571	GAD1
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	217	ALDH2
R-HSA-70688	Proline catabolism	0.120958004029806	-2.1123118677634	2	1	0.001953125	512	8202	5625	PRODH
R-HSA-70263	Gluconeogenesis	0.124859574037769	-2.08056558087311	31	4	0.0078125	512	8202	2805,2026,5566,10165	GOT1,ENO2,PRKACA,SLC25A13
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.125553766691226	-2.07502119230548	10	2	0.00390625	512	8202	57181,64116	SLC39A10,SLC39A8
R-HSA-110056	MAPK3 (ERK1) activation	0.125553766691226	-2.07502119230548	10	2	0.00390625	512	8202	983,3572	CDK1,IL6ST
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.125553766691226	-2.07502119230548	10	2	0.00390625	512	8202	5600,2353	MAPK11,FOS
R-HSA-5621480	Dectin-2 family	0.125553766691226	-2.07502119230548	10	2	0.00390625	512	8202	6850,5336	SYK,PLCG2
R-HSA-2161522	Abacavir transport and metabolism	0.125553766691226	-2.07502119230548	10	2	0.00390625	512	8202	5243,9429	ABCB1,ABCG2
R-HSA-917937	Iron uptake and transport	0.127831090357582	-2.0570454930914	43	5	0.009765625	512	8202	4891,2495,79901,261729,9429	SLC11A2,FTH1,CYBRD1,STEAP2,ABCG2
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.127831090357582	-2.0570454930914	43	5	0.009765625	512	8202	4645,5577,10681,5566,22841	MYO5B,PRKAR2B,GNB5,PRKACA,RAB11FIP2
R-HSA-193704	p75 NTR receptor-mediated signalling	0.138276138675379	-1.97850258827449	82	8	0.015625	512	8202	50650,27018,4792,3065,7074,29,27237,50649	ARHGEF3,NGFRAP1,NFKBIA,HDAC1,TIAM1,ABR,ARHGEF16,ARHGEF4
R-HSA-2024096	HS-GAG degradation	0.139845982593274	-1.96721358628755	21	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-390918	Peroxisomal lipid metabolism	0.139845982593274	-1.96721358628755	21	3	0.005859375	512	8202	215,8309,3417	ABCD1,ACOX2,IDH1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.143043952006272	-1.9446033392594	57	6	0.01171875	512	8202	9134,1027,5716,5720,5721,7157	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,TP53
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.143043952006272	-1.9446033392594	57	6	0.01171875	512	8202	9134,1027,5716,5720,5721,7157	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,TP53
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.143995656674261	-1.93797214184532	96	9	0.017578125	512	8202	8671,10479,6508,6542,6507,6574,6558,84679,6549	SLC4A4,SLC9A6,SLC4A3,SLC7A2,SLC1A3,SLC20A1,SLC12A2,SLC9A7,SLC9A2
R-HSA-453276	Regulation of mitotic cell cycle	0.145242080873225	-1.92935340540268	83	8	0.015625	512	8202	5721,9232,4751,6790,5716,5720,11065,983	PSME2,PTTG1,NEK2,AURKA,PSMD10,PSME1,UBE2C,CDK1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.145242080873225	-1.92935340540268	83	8	0.015625	512	8202	5721,9232,4751,6790,5716,5720,11065,983	PSME2,PTTG1,NEK2,AURKA,PSMD10,PSME1,UBE2C,CDK1
R-HSA-193648	NRAGE signals death through JNK	0.147060143633063	-1.91691363551752	45	5	0.009765625	512	8202	50650,7074,27237,29,50649	ARHGEF3,TIAM1,ARHGEF16,ABR,ARHGEF4
R-HSA-196780	Biotin transport and metabolism	0.147370520520601	-1.91480531569697	11	2	0.00390625	512	8202	32,64087	ACACB,MCCC2
R-HSA-376172	DSCAM interactions	0.147370520520601	-1.91480531569697	11	2	0.00390625	512	8202	5600,6300	MAPK11,MAPK12
R-HSA-1059683	Interleukin-6 signaling	0.147370520520601	-1.91480531569697	11	2	0.00390625	512	8202	3572,9021	IL6ST,SOCS3
R-HSA-5655291	Signaling by FGFR4 in disease	0.147370520520601	-1.91480531569697	11	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.147370520520601	-1.91480531569697	11	2	0.00390625	512	8202	9133,983	CCNB2,CDK1
R-HSA-5694530	Cargo concentration in the ER	0.147698039134127	-1.91258536553749	33	4	0.0078125	512	8202	10484,90411,5265,1075	SEC23A,MCFD2,SERPINA1,CTSC
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.150558101219543	-1.89340621467821	97	9	0.017578125	512	8202	9261,6196,6195,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.150558101219543	-1.89340621467821	97	9	0.017578125	512	8202	9261,6196,6195,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-373760	L1CAM interactions	0.150558101219543	-1.89340621467821	97	9	0.017578125	512	8202	6331,6196,1808,6195,3685,6326,214,6710,8828	SCN5A,RPS6KA2,DPYSL2,RPS6KA1,ITGAV,SCN2A,ALCAM,SPTB,NRP2
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.150558101219543	-1.89340621467821	97	9	0.017578125	512	8202	9261,6196,6195,4792,64127,5600,1846,2002,2353	MAPKAPK2,RPS6KA2,RPS6KA1,NFKBIA,NOD2,MAPK11,DUSP4,ELK1,FOS
R-HSA-194840	Rho GTPase cycle	0.150755910895154	-1.89209323422543	124	11	0.021484375	512	8202	9824,83478,116984,50650,9322,23221,397,7074,29,27237,50649	ARHGAP11A,ARHGAP24,ARAP2,ARHGEF3,TRIP10,RHOBTB2,ARHGDIB,TIAM1,ABR,ARHGEF16,ARHGEF4
R-HSA-913531	Interferon Signaling	0.154033643483889	-1.87058423624723	194	16	0.03125	512	8202	23586,81603,23321,3134,11274,51191,3437,3105,9021,3106,3660,6737,3107,4940,3434,55223	DDX58,TRIM8,TRIM2,HLA-F,USP18,HERC5,IFIT3,HLA-A,SOCS3,HLA-B,IRF2,TRIM21,HLA-C,OAS3,IFIT1,TRIM62
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.154857446748897	-1.86525028363916	22	3	0.005859375	512	8202	2161,5270,5547	F12,SERPINE2,PRCP
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.154857446748897	-1.86525028363916	22	3	0.005859375	512	8202	2305,9133,983	FOXM1,CCNB2,CDK1
R-HSA-1489509	DAG and IP3 signaling	0.159679742055214	-1.83458508180597	34	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.159679742055214	-1.83458508180597	34	4	0.0078125	512	8202	5588,10681,801,10988	PRKCQ,GNB5,CALM1,METAP2
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.161033617773164	-1.82614212975013	72	7	0.013671875	512	8202	5716,5720,11065,5721,983,9232,4751	PSMD10,PSME1,UBE2C,PSME2,CDK1,PTTG1,NEK2
R-HSA-2672351	Stimuli-sensing channels	0.164117916443973	-1.8071701068094	99	9	0.017578125	512	8202	6337,1831,23678,7220,6446,11059,338440,53373,55107	SCNN1A,TSC22D3,SGK3,TRPC1,SGK1,WWP1,ANO9,TPCN1,ANO1
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.169234583392498	-1.77646945912285	73	7	0.013671875	512	8202	5716,5720,11065,5721,983,9232,4751	PSMD10,PSME1,UBE2C,PSME2,CDK1,PTTG1,NEK2
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.169234583392498	-1.77646945912285	73	7	0.013671875	512	8202	5563,51422,143686,1345,207,6009,7157	PRKAA2,PRKAG2,SESN3,COX6C,AKT1,RHEB,TP53
R-HSA-3700989	Transcriptional Regulation by TP53	0.169234583392498	-1.77646945912285	73	7	0.013671875	512	8202	5563,51422,143686,1345,207,6009,7157	PRKAA2,PRKAG2,SESN3,COX6C,AKT1,RHEB,TP53
R-HSA-69615	G1/S DNA Damage Checkpoints	0.169745714935843	-1.77345375624432	60	6	0.01171875	512	8202	9134,1027,5716,5720,5721,7157	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,TP53
R-HSA-2160916	Hyaluronan uptake and degradation	0.169874724501846	-1.772694028282	12	2	0.00390625	512	8202	3161,3074	HMMR,HEXB
R-HSA-2022857	Keratan sulfate degradation	0.169874724501846	-1.772694028282	12	2	0.00390625	512	8202	2799,3074	GNS,HEXB
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.169874724501846	-1.772694028282	12	2	0.00390625	512	8202	23586,64135	DDX58,IFIH1
R-HSA-210990	PECAM1 interactions	0.169874724501846	-1.772694028282	12	2	0.00390625	512	8202	7525,3685	YES1,ITGAV
R-HSA-211979	Eicosanoids	0.169874724501846	-1.772694028282	12	2	0.00390625	512	8202	57834,4051	CYP4F11,CYP4F3
R-HSA-2514856	The phototransduction cascade	0.172003660371239	-1.76023952116699	35	4	0.0078125	512	8202	5588,10681,801,10988	PRKCQ,GNB5,CALM1,METAP2
R-HSA-71291	Metabolism of amino acids and derivatives	0.172102098396735	-1.75966738294685	212	17	0.033203125	512	8202	2730,5625,1728,10157,2729,5721,3034,6303,5716,5720,4942,144193,53905,2805,64087,1491,2184	GCLM,PRODH,NQO1,AASS,GCLC,PSME2,HAL,SAT1,PSMD10,PSME1,OAT,AMDHD1,DUOX1,GOT1,MCCC2,CTH,FAH
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.174758583169719	-1.74434978222337	87	8	0.015625	512	8202	9261,207,5721,5716,5720,5600,3315,167227	MAPKAPK2,AKT1,PSME2,PSMD10,PSME1,MAPK11,HSPB1,DCP2
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	5634	PRPS2
R-HSA-844455	The NLRP1 inflammasome	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	598	BCL2L1
R-HSA-5357572	Lysosomal glycogen catabolism	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	2548	GAA
R-HSA-3249367	STAT6-mediated induction of chemokines	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	340061	TMEM173
R-HSA-351200	Interconversion of polyamines	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	6303	SAT1
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	292	SLC25A5
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	90427	BMF
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	983	CDK1
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	2034	EPAS1
R-HSA-1307965	betaKlotho-mediated ligand binding	0.17584452865725	-1.73815503423825	3	1	0.001953125	512	8202	9965	FGF19
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.178017059047137	-1.72587589593869	48	5	0.009765625	512	8202	5577,3710,5566,9965,801	PRKAR2B,ITPR3,PRKACA,FGF19,CALM1
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.179079959772708	-1.71992287024248	61	6	0.01171875	512	8202	50650,7074,27018,27237,29,50649	ARHGEF3,TIAM1,NGFRAP1,ARHGEF16,ABR,ARHGEF4
R-HSA-167021	PLC-gamma1 signalling	0.184644513661433	-1.6893228502212	36	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.184644513661433	-1.6893228502212	36	4	0.0078125	512	8202	411,22901,56648,5045	ARSB,ARSG,EIF5A2,FURIN
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.184644513661433	-1.6893228502212	36	4	0.0078125	512	8202	221,8613,224,8879	ALDH3B1,PLPP3,ALDH3A2,SGPL1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.184644513661433	-1.6893228502212	36	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-416482	G alpha (12/13) signalling events	0.186167974664395	-1.68110592321548	75	7	0.013671875	512	8202	50650,10681,7074,27237,5295,29,50649	ARHGEF3,GNB5,TIAM1,ARHGEF16,PIK3R1,ABR,ARHGEF4
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.186246991361128	-1.6806815756187	24	3	0.005859375	512	8202	1027,207,3164	CDKN1B,AKT1,NR4A1
R-HSA-933542	TRAF6 mediated NF-kB activation	0.186246991361128	-1.6806815756187	24	3	0.005859375	512	8202	23586,64135,4792	DDX58,IFIH1,NFKBIA
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.186246991361128	-1.6806815756187	24	3	0.005859375	512	8202	8654,27345,5592	PDE5A,KCNMB4,PRKG1
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.188615653260085	-1.6680439150896	62	6	0.01171875	512	8202	5563,51422,207,9882,801,4644	PRKAA2,PRKAG2,AKT1,TBC1D4,CALM1,MYO5A
R-HSA-76002	Platelet activation, signaling and aggregation	0.189634701280487	-1.66265568227674	230	18	0.03515625	512	8202	3920,207,801,5295,22927,5588,3710,9564,8526,10235,5154,10681,5265,5336,928,5293,6850,10125	LAMP2,AKT1,CALM1,PIK3R1,HABP4,PRKCQ,ITPR3,BCAR1,DGKE,RASGRP2,PDGFA,GNB5,SERPINA1,PLCG2,CD9,PIK3CD,SYK,RASGRP1
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	1514,1515	CTSL,CTSV
R-HSA-2029481	FCGR activation	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	7525,6850	YES1,SYK
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	340061,23220	TMEM173,DTX4
R-HSA-174403	Glutathione synthesis and recycling	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	2730,2729	GCLM,GCLC
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	1027,207	CDKN1B,AKT1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	4919,7855	ROR1,FZD5
R-HSA-5626467	RHO GTPases activate IQGAPs	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	128239,801	IQGAP3,CALM1
R-HSA-1663150	The activation of arylsulfatases	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	411,22901	ARSB,ARSG
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.192896008091497	-1.6456040534707	13	2	0.00390625	512	8202	3710,801	ITPR3,CALM1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.197576669769994	-1.62162856860456	37	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.198506990935204	-1.61693096065791	90	8	0.015625	512	8202	80321,10733,4751,5577,54820,95681,5566,983	CEP70,PLK4,NEK2,PRKAR2B,NDE1,CEP41,PRKACA,CDK1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.2004591742047	-1.60714467289555	424	31	0.060546875	512	8202	5721,6195,9693,5922,801,5295,2902,5716,9542,5588,5720,1846,3710,6710,9965,8526,2915,10235,1909,8660,5154,6196,10681,2263,53358,11221,3084,2065,221002,10125,10817	PSME2,RPS6KA1,RAPGEF2,RASA2,CALM1,PIK3R1,GRIN1,PSMD10,NRG2,PRKCQ,PSME1,DUSP4,ITPR3,SPTB,FGF19,DGKE,GRM5,RASGRP2,EDNRA,IRS2,PDGFA,RPS6KA2,GNB5,FGFR2,SHC3,DUSP10,NRG1,ERBB3,RASGEF1A,RASGRP1,FRS3
R-HSA-114452	Activation of BH3-only proteins	0.202517394265648	-1.59692949851639	25	3	0.005859375	512	8202	90427,207,7157	BMF,AKT1,TP53
R-HSA-1538133	G0 and Early G1	0.202517394265648	-1.59692949851639	25	3	0.005859375	512	8202	9134,3065,983	CCNE2,HDAC1,CDK1
R-HSA-425410	Metal ion SLC transporters	0.202517394265648	-1.59692949851639	25	3	0.005859375	512	8202	4891,57181,64116	SLC11A2,SLC39A10,SLC39A8
R-HSA-2871837	FCERI mediated NF-kB activation	0.203765345438658	-1.59078621466084	77	7	0.013671875	512	8202	5716,5588,5720,5721,4792,10125,10235	PSMD10,PRKCQ,PSME1,PSME2,NFKBIA,RASGRP1,RASGRP2
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.210774307513712	-1.55696735060775	38	4	0.0078125	512	8202	90427,598,207,7157	BMF,BCL2L1,AKT1,TP53
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.210774307513712	-1.55696735060775	38	4	0.0078125	512	8202	55343,376497,28231,28965	SLC35C1,SLC27A1,SLCO4A1,SLC27A6
R-HSA-445717	Aquaporin-mediated transport	0.211169717564951	-1.55509312017203	51	5	0.009765625	512	8202	4645,5577,10681,5566,22841	MYO5B,PRKAR2B,GNB5,PRKACA,RAB11FIP2
R-HSA-1592230	Mitochondrial biogenesis	0.211169717564951	-1.55509312017203	51	5	0.009765625	512	8202	5563,5600,51422,5465,6300	PRKAA2,MAPK11,PRKAG2,PPARA,MAPK12
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.211169717564951	-1.55509312017203	51	5	0.009765625	512	8202	5577,3710,5566,2263,801	PRKAR2B,ITPR3,PRKACA,FGFR2,CALM1
R-HSA-162594	Early Phase of HIV Life Cycle	0.216282519229391	-1.5311697665364	14	2	0.00390625	512	8202	3159,11168	HMGA1,PSIP1
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.216282519229391	-1.5311697665364	14	2	0.00390625	512	8202	9133,983	CCNB2,CDK1
R-HSA-2024101	CS/DS degradation	0.216282519229391	-1.5311697665364	14	2	0.00390625	512	8202	411,3074	ARSB,HEXB
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.216282519229391	-1.5311697665364	14	2	0.00390625	512	8202	5361,10371	PLXNA1,SEMA3A
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.216282519229391	-1.5311697665364	14	2	0.00390625	512	8202	23586,64135	DDX58,IFIH1
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.219101749302894	-1.51821904837382	26	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-3781865	Diseases of glycosylation	0.219101749302894	-1.51821904837382	26	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.219101749302894	-1.51821904837382	26	3	0.005859375	512	8202	4792,340061,23220	NFKBIA,TMEM173,DTX4
R-HSA-983189	Kinesins	0.219101749302894	-1.51821904837382	26	3	0.005859375	512	8202	9493,1062,147700	KIF23,CENPE,KLC3
R-HSA-5358351	Signaling by Hedgehog	0.221511040205278	-1.50728284782584	135	11	0.021484375	512	8202	79809,27248,5721,23288,83737,5716,5720,5577,147111,5566,23432	TTC21B,ERLEC1,PSME2,IQCE,ITCH,PSMD10,PSME1,PRKAR2B,NOTUM,PRKACA,GPR161
R-HSA-163685	Integration of energy metabolism	0.223641695023288	-1.49771008360323	107	9	0.017578125	512	8202	5563,32,51422,10681,3790,5577,3710,292,5566	PRKAA2,ACACB,PRKAG2,GNB5,KCNS3,PRKAR2B,ITPR3,SLC25A5,PRKACA
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	7046	TGFBR1
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	7046	TGFBR1
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	56648	EIF5A2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	6507	SLC1A3
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	7157	TP53
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	7046	TGFBR1
R-HSA-1296053	Classical Kir channels	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	9134	CCNE2
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	8828	NRP2
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	207	AKT1
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	7157	TP53
R-HSA-442745	Activation of CaMK IV	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	801	CALM1
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.22731026854489	-1.48143937296768	4	1	0.001953125	512	8202	6507	SLC1A3
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.228818457076984	-1.4748263536873	223	17	0.033203125	512	8202	90293,5721,83737,26232,7319,5716,221687,5720,79754,9021,151636,92912,51465,6737,11059,126433,11065	KLHL13,PSME2,ITCH,FBXO2,UBE2A,PSMD10,RNF182,PSME1,ASB13,SOCS3,DTX3L,UBE2Q2,UBE2J1,TRIM21,WWP1,FBXO27,UBE2C
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.235649451563002	-1.44540995295225	137	11	0.021484375	512	8202	2624,7157,147700,10362,9493,3065,3660,5577,1062,80005,5566	GATA2,TP53,KLC3,HMG20B,KIF23,HDAC1,IRF2,PRKAR2B,CENPE,DOCK5,PRKACA
R-HSA-180024	DARPP-32 events	0.235949629792053	-1.44413692982113	27	3	0.005859375	512	8202	5577,5566,801	PRKAR2B,PRKACA,CALM1
R-HSA-5655253	Signaling by FGFR2 in disease	0.235949629792053	-1.44413692982113	27	3	0.005859375	512	8202	2263,2549,5295	FGFR2,GAB1,PIK3R1
R-HSA-437239	Recycling pathway of L1	0.235949629792053	-1.44413692982113	27	3	0.005859375	512	8202	6196,1808,6195	RPS6KA2,DPYSL2,RPS6KA1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.235949629792053	-1.44413692982113	27	3	0.005859375	512	8202	3706,5336,801	ITPKA,PLCG2,CALM1
R-HSA-1632852	Macroautophagy	0.238965861222207	-1.43143457732769	67	6	0.01171875	512	8202	5563,51422,55062,6009,23710,115201	PRKAA2,PRKAG2,WIPI1,RHEB,GABARAPL1,ATG4A
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.239899283494791	-1.42753609582377	15	2	0.00390625	512	8202	64900,983	LPIN3,CDK1
R-HSA-211935	Fatty acids	0.239899283494791	-1.42753609582377	15	2	0.00390625	512	8202	57834,4051	CYP4F11,CYP4F3
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.239899283494791	-1.42753609582377	15	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-975577	N-Glycan antennae elongation	0.239899283494791	-1.42753609582377	15	2	0.00390625	512	8202	11320,11282	MGAT4A,MGAT4B
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.239899283494791	-1.42753609582377	15	2	0.00390625	512	8202	89780,83999	WNT3A,KREMEN1
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.239899283494791	-1.42753609582377	15	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.240721412752389	-1.42411497781587	81	7	0.013671875	512	8202	23586,51191,3660,64135,83737,4792,84166	DDX58,HERC5,IRF2,IFIH1,ITCH,NFKBIA,NLRC5
R-HSA-948021	Transport to the Golgi and subsequent modification	0.240746141195572	-1.42401225669582	95	8	0.015625	512	8202	2517,10484,5265,1075,11320,2530,11282,90411	FUCA1,SEC23A,SERPINA1,CTSC,MGAT4A,FUT8,MGAT4B,MCFD2
R-HSA-114604	GPVI-mediated activation cascade	0.246107748122821	-1.40198583844472	54	5	0.009765625	512	8202	5293,207,6850,5336,5295	PIK3CD,AKT1,SYK,PLCG2,PIK3R1
R-HSA-111933	Calmodulin induced events	0.253012421233818	-1.37431669567394	28	3	0.005859375	512	8202	5577,5566,801	PRKAR2B,PRKACA,CALM1
R-HSA-111997	CaM pathway	0.253012421233818	-1.37431669567394	28	3	0.005859375	512	8202	5577,5566,801	PRKAR2B,PRKACA,CALM1
R-HSA-162582	Signal Transduction	0.259204924595716	-1.35013631547263	2357	154	0.30078125	512	8202	10398,3339,55366,9542,5720,92737,6382,6710,83999,30011,2915,3352,6196,63916,53358,23288,3572,220,11221,5293,7074,10125,10988,1604,1058,130399,83737,192670,397,5577,4919,983,6009,29,1909,4192,3984,26018,51719,3065,3315,2549,103910,5125,5563,5922,6662,7006,23239,3480,1291,5592,89780,23432,56603,801,55437,6932,2002,10235,9261,8202,51422,4792,23221,54820,5916,81847,9824,9322,5721,6195,8601,7157,83540,5566,27237,9372,5154,79809,9928,51339,1027,221002,2118,10817,1292,27248,207,8322,10076,5734,5588,26108,1846,3710,8324,9021,8660,27018,558,7088,3084,6300,10810,1299,50650,2491,6385,5716,7046,1287,147111,1382,5585,9965,8323,8828,9559,9734,58191,10681,147700,699,5600,11059,2065,128239,6850,51421,56034,7050,116984,3164,9693,5295,5045,2902,1730,144165,84441,7525,54492,9564,3953,8526,83478,2263,23220,2852,1062,3685,7855,50649	MYL9,HSPG2,LGR4,NRG2,PSME1,DNER,SDC1,SPTB,KREMEN1,SH3KBP1,GRM5,HTR1D,RPS6KA2,ELMO2,SHC3,IQCE,IL6ST,ALDH1A3,DUSP10,PIK3CD,TIAM1,RASGRP1,METAP2,CD55,CENPA,ACVR1C,ITCH,AGO4,ARHGDIB,PRKAR2B,ROR1,CDK1,RHEB,ABR,EDNRA,MDK,LIMK1,LRIG1,CAB39,HDAC1,HSPB1,GAB1,MYL12B,PCSK5,PRKAA2,RASA2,SOX9,TEC,PHLPP1,IGF1R,COL6A1,PRKG1,WNT3A,GPR161,CYP26B1,CALM1,STRADB,TCF7,ELK1,RASGRP2,MAPKAPK2,NCOA3,PRKAG2,NFKBIA,RHOBTB2,NDE1,RARG,RNF146,ARHGAP11A,TRIP10,PSME2,RPS6KA1,RGS20,TP53,NUF2,PRKACA,ARHGEF16,ZFYVE9,PDGFA,TTC21B,KIF14,DACT1,CDKN1B,RASGEF1A,ETV4,FRS3,COL6A2,ERLEC1,AKT1,FZD4,PTPRU,PTGER4,PRKCQ,PYGO1,DUSP4,ITPR3,FZD7,SOCS3,IRS2,NGFRAP1,AXL,TLE1,NRG1,MAPK12,WASF3,COL9A3,ARHGEF3,CENPI,SDC4,PSMD10,TGFBR1,COL4A5,NOTUM,CRABP2,PKN1,FGF19,FZD6,NRP2,VPS26A,HDAC9,CXCL16,GNB5,KLC3,BUB1,MAPK11,WWP1,ERBB3,IQGAP3,SYK,AMOTL2,PDGFC,TGIF1,ARAP2,NR4A1,RAPGEF2,PIK3R1,FURIN,GRIN1,DIAPH2,PRICKLE1,MAML2,YES1,NEURL1B,BCAR1,LEPR,DGKE,ARHGAP24,FGFR2,DTX4,GPER1,CENPE,ITGAV,FZD5,ARHGEF4
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.2601571725956	-1.34646932062609	69	6	0.01171875	512	8202	5716,6790,5720,11065,5721,9232	PSMD10,AURKA,PSME1,UBE2C,PSME2,PTTG1
R-HSA-2262752	Cellular responses to stress	0.262545063249015	-1.33733254216393	379	27	0.052734375	512	8202	9134,5563,2034,6195,259217,7157,23466,192670,2950,2353,2113,6009,23710,115201,9261,1031,6196,51422,55062,3005,1027,5600,3159,4217,1032,11065,54583	CCNE2,PRKAA2,EPAS1,RPS6KA1,HSPA12A,TP53,CBX6,AGO4,GSTP1,FOS,ETS1,RHEB,GABARAPL1,ATG4A,MAPKAPK2,CDKN2C,RPS6KA2,PRKAG2,WIPI1,H1F0,CDKN1B,MAPK11,HMGA1,MAP3K5,CDKN2D,UBE2C,EGLN1
R-HSA-201681	TCF dependent signaling in response to WNT	0.262771687133982	-1.33646973358658	229	17	0.033203125	512	8202	55366,207,8322,5721,6662,5716,6932,5720,26108,83999,8323,51339,7088,3065,89780,7855,81847	LGR4,AKT1,FZD4,PSME2,SOX9,PSMD10,TCF7,PSME1,PYGO1,KREMEN1,FZD6,DACT1,TLE1,HDAC1,WNT3A,FZD5,RNF146
R-HSA-156711	Polo-like kinase mediated events	0.26362669532405	-1.33322120938718	16	2	0.00390625	512	8202	2305,9133	FOXM1,CCNB2
R-HSA-163615	PKA activation	0.26362669532405	-1.33322120938718	16	2	0.00390625	512	8202	5577,5566	PRKAR2B,PRKACA
R-HSA-1989781	PPARA activates gene expression	0.26446495407783	-1.33004653522309	112	9	0.017578125	512	8202	8202,1543,1490,29841,5465,376497,19,6837,7005	NCOA3,CYP1A1,CTGF,GRHL1,PPARA,SLC27A1,ABCA1,MED22,TEAD3
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.270182369763722	-1.30865810442376	56	5	0.009765625	512	8202	9134,1027,5716,5720,5721	CCNE2,CDKN1B,PSMD10,PSME1,PSME2
R-HSA-375170	CDO in myogenesis	0.270243493010428	-1.30843190041993	29	3	0.005859375	512	8202	5600,4756,6300	MAPK11,NEO1,MAPK12
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.270243493010428	-1.30843190041993	29	3	0.005859375	512	8202	192670,84441,7157	AGO4,MAML2,TP53
R-HSA-445095	Interaction between L1 and Ankyrins	0.270243493010428	-1.30843190041993	29	3	0.005859375	512	8202	6331,6326,6710	SCN5A,SCN2A,SPTB
R-HSA-525793	Myogenesis	0.270243493010428	-1.30843190041993	29	3	0.005859375	512	8202	5600,4756,6300	MAPK11,NEO1,MAPK12
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.270934953713279	-1.30587651011085	70	6	0.01171875	512	8202	5716,5720,11065,5721,983,4751	PSMD10,PSME1,UBE2C,PSME2,CDK1,NEK2
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	801	CALM1
R-HSA-74713	IRS activation	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	8660	IRS2
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	928	CD9
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	5566	PRKACA
R-HSA-70370	Galactose catabolism	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	5236	PGM1
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	6574	SLC20A1
R-HSA-112303	Electric Transmission Across Gap Junctions	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	56666	PANX2
R-HSA-1169092	Activation of RAS in B cells	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	10125	RASGRP1
R-HSA-112307	Transmission across Electrical Synapses	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	56666	PANX2
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.275568031719625	-1.28892074178241	5	1	0.001953125	512	8202	2673	GFPT1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.27651471592816	-1.28549123727267	99	8	0.015625	512	8202	5721,4792,5336,801,5716,5720,3710,6850	PSME2,NFKBIA,PLCG2,CALM1,PSMD10,PSME1,ITPR3,SYK
R-HSA-5610787	Hedgehog 'off' state	0.27651471592816	-1.28549123727267	99	8	0.015625	512	8202	79809,5721,83737,5716,5720,5577,5566,23432	TTC21B,PSME2,ITCH,PSMD10,PSME1,PRKAR2B,PRKACA,GPR161
R-HSA-194315	Signaling by Rho GTPases	0.284509856454563	-1.25698738118437	399	28	0.0546875	512	8202	10398,9824,10810,116984,50650,1058,9322,2491,801,1730,397,83540,5585,27237,29,83478,3984,9928,147700,1027,23221,699,1062,128239,54820,7074,103910,50649	MYL9,ARHGAP11A,WASF3,ARAP2,ARHGEF3,CENPA,TRIP10,CENPI,CALM1,DIAPH2,ARHGDIB,NUF2,PKN1,ARHGEF16,ABR,ARHGAP24,LIMK1,KIF14,KLC3,CDKN1B,RHOBTB2,BUB1,CENPE,IQGAP3,NDE1,TIAM1,MYL12B,ARHGEF4
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.285680438547132	-1.25288144059795	100	8	0.015625	512	8202	1058,2491,83540,699,1062,54820,9133,983	CENPA,CENPI,NUF2,BUB1,CENPE,NDE1,CCNB2,CDK1
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	5577,5566	PRKAR2B,PRKACA
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	801,2902	CALM1,GRIN1
R-HSA-176412	Phosphorylation of the APC/C	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	11065,983	UBE2C,CDK1
R-HSA-435354	Zinc transporters	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	57181,64116	SLC39A10,SLC39A8
R-HSA-2142845	Hyaluronan metabolism	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	3161,3074	HMMR,HEXB
R-HSA-164378	PKA activation in glucagon signalling	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	5577,5566	PRKAR2B,PRKACA
R-HSA-174800	Chylomicron-mediated lipid transport	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	3339,6382	HSPG2,SDC1
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.287359131285624	-1.2470225169602	17	2	0.00390625	512	8202	9261,167227	MAPKAPK2,DCP2
R-HSA-111996	Ca-dependent events	0.287598329345407	-1.24619046210411	30	3	0.005859375	512	8202	5577,5566,801	PRKAR2B,PRKACA,CALM1
R-HSA-446728	Cell junction organization	0.289581128844226	-1.23931978342448	86	7	0.013671875	512	8202	1364,1001,81607,54751,64398,5819,3655	CLDN4,CDH3,PVRL4,FBLIM1,MPP5,PVRL2,ITGA6
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.289996353032128	-1.23788693183198	115	9	0.017578125	512	8202	8202,1543,1490,29841,5465,376497,19,6837,7005	NCOA3,CYP1A1,CTGF,GRHL1,PPARA,SLC27A1,ABCA1,MED22,TEAD3
R-HSA-5362517	Signaling by Retinoic Acid	0.294100503810285	-1.2238337203659	44	4	0.0078125	512	8202	56603,1382,5916,220	CYP26B1,CRABP2,RARG,ALDH1A3
R-HSA-382556	ABC-family proteins mediated transport	0.294100503810285	-1.2238337203659	44	4	0.0078125	512	8202	215,9619,5243,20	ABCD1,ABCG1,ABCB1,ABCA2
R-HSA-109581	Apoptosis	0.296790413520378	-1.21472906767019	160	12	0.0234375	512	8202	90427,207,51765,3005,5721,7157,5716,5720,5588,598,219699,100506658	BMF,AKT1,STK26,H1F0,PSME2,TP53,PSMD10,PSME1,PRKCQ,BCL2L1,UNC5B,OCLN
R-HSA-373080	Class B/2 (Secretin family receptors)	0.299628101594886	-1.20521323469206	87	7	0.013671875	512	8202	1604,7855,89780,10681,8322,8323,8324	CD55,FZD5,WNT3A,GNB5,FZD4,FZD6,FZD7
R-HSA-1500931	Cell-Cell communication	0.301244112210136	-1.19983433889894	131	10	0.01953125	512	8202	81607,54751,5819,3655,5295,1001,1364,5600,64398,6300	PVRL4,FBLIM1,PVRL2,ITGA6,PIK3R1,CDH3,CLDN4,MAPK11,MPP5,MAPK12
R-HSA-2467813	Separation of Sister Chromatids	0.304169732444875	-1.19016940297357	161	12	0.0234375	512	8202	1058,5721,2491,9232,5716,5720,83540,699,1062,54820,11065,9700	CENPA,PSME2,CENPI,PTTG1,PSMD10,PSME1,NUF2,BUB1,CENPE,NDE1,UBE2C,ESPL1
R-HSA-2132295	MHC class II antigen presentation	0.304235929237025	-1.18995179555609	102	8	0.015625	512	8202	1514,10484,1075,1515,147700,9493,5476,1062	CTSL,SEC23A,CTSC,CTSV,KLC3,KIF23,CTSA,CENPE
R-HSA-418990	Adherens junctions interactions	0.305034624554154	-1.18732998568961	31	3	0.005859375	512	8202	1001,81607,5819	CDH3,PVRL4,PVRL2
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.30715426787436	-1.18040515638698	59	5	0.009765625	512	8202	5716,5720,5566,5721,83737	PSMD10,PSME1,PRKACA,PSME2,ITCH
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.308445904805627	-1.17620880010249	45	4	0.0078125	512	8202	192670,84441,7157,5045	AGO4,MAML2,TP53,FURIN
R-HSA-5223345	Miscellaneous transport and binding events	0.311003676042496	-1.16795054680043	18	2	0.00390625	512	8202	120,123606	ADD3,NIPA1
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.311003676042496	-1.16795054680043	18	2	0.00390625	512	8202	2034,54583	EPAS1,EGLN1
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.311003676042496	-1.16795054680043	18	2	0.00390625	512	8202	32,64087	ACACB,MCCC2
R-HSA-5357801	Programmed Cell Death	0.319071180737714	-1.14234106397985	163	12	0.0234375	512	8202	90427,207,51765,3005,5721,7157,5716,5720,5588,598,219699,100506658	BMF,AKT1,STK26,H1F0,PSME2,TP53,PSMD10,PSME1,PRKCQ,BCL2L1,UNC5B,OCLN
R-HSA-5336415	Uptake and function of diphtheria toxin	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	928	CD9
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	3065	HDAC1
R-HSA-68952	DNA replication initiation	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	5557	PRIM1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	215	ABCD1
R-HSA-176417	Phosphorylation of Emi1	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	983	CDK1
R-HSA-1237112	Methionine salvage pathway	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	2805	GOT1
R-HSA-205025	NADE modulates death signalling	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	27018	NGFRAP1
R-HSA-111957	Cam-PDE 1 activation	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	801	CALM1
R-HSA-174430	Telomere C-strand synthesis initiation	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	5557	PRIM1
R-HSA-211916	Vitamins	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	56603	CYP26B1
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.320817411704938	-1.13688312857445	6	1	0.001953125	512	8202	83999	KREMEN1
R-HSA-1980145	Signaling by NOTCH2	0.322512347330738	-1.13161385718235	32	3	0.005859375	512	8202	4192,84441,54492	MDK,MAML2,NEURL1B
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.322512347330738	-1.13161385718235	32	3	0.005859375	512	8202	7046,9372,5045	TGFBR1,ZFYVE9,FURIN
R-HSA-389356	CD28 co-stimulation	0.322512347330738	-1.13161385718235	32	3	0.005859375	512	8202	7525,207,5295	YES1,AKT1,PIK3R1
R-HSA-112043	PLC beta mediated events	0.322858763027438	-1.13054031755713	46	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-1483249	Inositol phosphate metabolism	0.322858763027438	-1.13054031755713	46	4	0.0078125	512	8202	51477,3706,5336,801	ISYNA1,ITPKA,PLCG2,CALM1
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.322858763027438	-1.13054031755713	46	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-2559580	Oxidative Stress Induced Senescence	0.324965506291383	-1.12403623677311	119	9	0.017578125	512	8202	9261,1031,7157,23466,5600,192670,4217,1032,2353	MAPKAPK2,CDKN2C,TP53,CBX6,MAPK11,AGO4,MAP3K5,CDKN2D,FOS
R-HSA-1430728	Metabolism	0.325506250824099	-1.12237361375723	1691	110	0.21484375	512	8202	2548,32,9060,1728,3339,10157,5721,10165,3074,5720,64900,4942,6382,5566,79586,1543,1490,29841,57834,5336,9061,23446,2172,3790,2805,5293,8309,2182,5256,6820,2760,1491,10484,207,6303,978,5577,3710,292,3417,4051,9394,221,53905,10555,649,376497,5287,113612,9953,2717,3706,4048,19,5563,127281,2730,2026,6385,3034,9429,5716,4697,51477,29940,1345,6697,2950,7005,340481,8879,2799,760,10681,22901,215,55967,224,64087,6837,2184,3161,56603,337876,126792,5236,5625,217,2729,9926,5295,801,5465,4682,144193,80772,1528,26035,9261,131870,8202,51422,1633,8613,5634,5243,5476,411,7498,9619	GAA,ACACB,PAPSS2,NQO1,HSPG2,AASS,PSME2,SLC25A13,HEXB,PSME1,LPIN3,OAT,SDC1,PRKACA,CHPF,CYP1A1,CTGF,GRHL1,CYP4F11,PLCG2,PAPSS1,SLC44A1,FABP6,KCNS3,GOT1,PIK3CD,ACOX2,ACSL4,PHKA2,SULT2B1,GM2A,CTH,SEC23A,AKT1,SAT1,CDA,PRKAR2B,ITPR3,SLC25A5,IDH1,CYP4F3,HS6ST1,ALDH3B1,DUOX1,AGPAT2,BMP1,SLC27A1,PIK3C2B,CYP2U1,HS3ST3B1,GLA,ITPKA,LTA4H,ABCA1,PRKAA2,FAM213B,GCLM,ENO2,SDC4,HAL,ABCG2,PSMD10,NDUFA4,ISYNA1,DSE,COX6C,SPR,GSTP1,TEAD3,ZDHHC21,SGPL1,GNS,CA2,GNB5,ARSG,ABCD1,NDUFA12,ALDH3A2,MCCC2,MED22,FAH,HMMR,CYP26B1,CHSY3,B3GALT6,PGM1,PRODH,ALDH2,GCLC,LPGAT1,PIK3R1,CALM1,PPARA,NUBP1,AMDHD1,CPTP,CYB5A,GLCE,MAPKAPK2,NUDT16,NCOA3,PRKAG2,DCK,PLPP3,PRPS2,ABCB1,CTSA,ARSB,XDH,ABCG1
R-HSA-421270	Cell-cell junction organization	0.332196489752704	-1.10202864852733	61	5	0.009765625	512	8202	1364,1001,81607,64398,5819	CLDN4,CDH3,PVRL4,MPP5,PVRL2
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.332196489752704	-1.10202864852733	61	5	0.009765625	512	8202	10810,63916,3984,6850,4644	WASF3,ELMO2,LIMK1,SYK,MYO5A
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.332196489752704	-1.10202864852733	61	5	0.009765625	512	8202	56603,113612,1543,57834,4051	CYP26B1,CYP2U1,CYP1A1,CYP4F11,CYP4F3
R-HSA-5617833	Assembly of the primary cilium	0.333525313317026	-1.09803651450679	180	13	0.025390625	512	8202	79809,83658,80321,192668,10733,4751,5577,6102,95681,27031,54820,5566,983	TTC21B,DYNLRB1,CEP70,CYS1,PLK4,NEK2,PRKAR2B,RP2,CEP41,NPHP3,NDE1,PRKACA,CDK1
R-HSA-453279	Mitotic G1-G1/S phases	0.334415546280187	-1.09537090877989	135	10	0.01953125	512	8202	9134,1031,5721,5716,1027,3065,5720,1032,983,5557	CCNE2,CDKN2C,PSME2,PSMD10,CDKN1B,HDAC1,PSME1,CDKN2D,CDK1,PRIM1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-416700	Other semaphorin interactions	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	5361,10507	PLXNA1,SEMA4D
R-HSA-1181150	Signaling by NODAL	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	130399,5045	ACVR1C,FURIN
R-HSA-418360	Platelet calcium homeostasis	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	3710,490	ITPR3,ATP2B1
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	801,2902	CALM1,GRIN1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-1643713	Signaling by EGFR in Cancer	0.334478952449455	-1.09518132381671	19	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-112040	G-protein mediated events	0.337316827356841	-1.08673264976034	47	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.337316827356841	-1.08673264976034	47	4	0.0078125	512	8202	3065,7088,84441,9734	HDAC1,TLE1,MAML2,HDAC9
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.339993778147201	-1.07882796110642	33	3	0.005859375	512	8202	2041,2034,57167	EPHA1,EPAS1,SALL4
R-HSA-933541	TRAF6 mediated IRF7 activation	0.339993778147201	-1.07882796110642	33	3	0.005859375	512	8202	23586,3660,64135	DDX58,IRF2,IFIH1
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.339993778147201	-1.07882796110642	33	3	0.005859375	512	8202	5287,5293,5295	PIK3C2B,PIK3CD,PIK3R1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.34512860758555	-1.06383815580405	212	15	0.029296875	512	8202	5563,8202,32,1543,51422,10555,1490,29841,5465,376497,2182,64900,19,7005,6837	PRKAA2,NCOA3,ACACB,CYP1A1,PRKAG2,AGPAT2,CTGF,GRHL1,PPARA,SLC27A1,ACSL4,LPIN3,ABCA1,TEAD3,MED22
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.351798624475554	-1.04469635664779	48	4	0.0078125	512	8202	5293,10681,207,5295	PIK3CD,GNB5,AKT1,PIK3R1
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.357443523580352	-1.02877790532661	34	3	0.005859375	512	8202	3159,292,11168	HMGA1,SLC25A5,PSIP1
R-HSA-1483191	Synthesis of PC	0.357714047718792	-1.02802136114055	20	2	0.00390625	512	8202	64900,23446	LPIN3,SLC44A1
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.357714047718792	-1.02802136114055	20	2	0.00390625	512	8202	5566,2172	PRKACA,FABP6
R-HSA-418346	Platelet homeostasis	0.360094087690637	-1.02138992698296	78	6	0.01171875	512	8202	8654,27345,10681,3710,490,5592	PDE5A,KCNMB4,GNB5,ITPR3,ATP2B1,PRKG1
R-HSA-5621481	C-type lectin receptors (CLRs)	0.360691416351139	-1.01973248855253	123	9	0.017578125	512	8202	5721,4792,5336,801,5716,5720,3710,5566,6850	PSME2,NFKBIA,PLCG2,CALM1,PSMD10,PSME1,ITPR3,PRKACA,SYK
R-HSA-68877	Mitotic Prometaphase	0.361235845514304	-1.01822422229045	108	8	0.015625	512	8202	1058,2491,83540,699,1062,54820,9133,983	CENPA,CENPI,NUF2,BUB1,CENPE,NDE1,CCNB2,CDK1
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	5566	PRKACA
R-HSA-447038	NrCAM interactions	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	8828	NRP2
R-HSA-162791	Attachment of GPI anchor to uPAR	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	5329	PLAUR
R-HSA-426117	Cation-coupled Chloride cotransporters	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	6558	SLC12A2
R-HSA-5603029	IkBA variant leads to EDA-ID	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	79661	NEIL1
R-HSA-448706	Interleukin-1 processing	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	3606	IL18
R-HSA-426496	Post-transcriptional silencing by small RNAs	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	192670	AGO4
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	131870	NUDT16
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.363245606585548	-1.01267607134529	7	1	0.001953125	512	8202	6932	TCF7
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.366283500055947	-1.00434765510423	49	4	0.0078125	512	8202	5716,5720,9902,5721	PSMD10,PSME1,MRC2,PSME2
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.366283500055947	-1.00434765510423	49	4	0.0078125	512	8202	5577,3710,5566,801	PRKAR2B,ITPR3,PRKACA,CALM1
R-HSA-5358346	Hedgehog ligand biogenesis	0.370057166138903	-0.994097782200122	64	5	0.009765625	512	8202	5716,5720,147111,27248,5721	PSMD10,PSME1,NOTUM,ERLEC1,PSME2
R-HSA-913709	O-linked glycosylation of mucins	0.370057166138903	-0.994097782200122	64	5	0.009765625	512	8202	29071,2591,94025,79695,2650	C1GALT1C1,GALNT3,MUC16,GALNT12,GCNT1
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.370057166138903	-0.994097782200122	64	5	0.009765625	512	8202	5716,5720,11065,5721,9232	PSMD10,PSME1,UBE2C,PSME2,PTTG1
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.380647528267005	-0.965881454704289	21	2	0.00390625	512	8202	337876,79586	CHSY3,CHPF
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.380647528267005	-0.965881454704289	21	2	0.00390625	512	8202	4192,54492	MDK,NEURL1B
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.380647528267005	-0.965881454704289	21	2	0.00390625	512	8202	207,5295	AKT1,PIK3R1
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.380647528267005	-0.965881454704289	21	2	0.00390625	512	8202	3485,3489	IGFBP2,IGFBP6
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.380647528267005	-0.965881454704289	21	2	0.00390625	512	8202	11065,983	UBE2C,CDK1
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.380751652135119	-0.965607948056414	50	4	0.0078125	512	8202	5716,5720,1728,5721	PSMD10,PSME1,NQO1,PSME2
R-HSA-69202	Cyclin E associated events during G1/S transition	0.382700876074114	-0.960501597360225	65	5	0.009765625	512	8202	9134,1027,5716,5720,5721	CCNE2,CDKN1B,PSMD10,PSME1,PSME2
R-HSA-397014	Muscle contraction	0.382700876074114	-0.960501597360225	65	5	0.009765625	512	8202	10398,10580,10627,103910,801	MYL9,SORBS1,MYL12A,MYL12B,CALM1
R-HSA-422356	Regulation of insulin secretion	0.382811553172911	-0.960212439156282	80	6	0.01171875	512	8202	5577,3710,10681,292,5566,3790	PRKAR2B,ITPR3,GNB5,SLC25A5,PRKACA,KCNS3
R-HSA-68882	Mitotic Anaphase	0.387859819544551	-0.947111294473391	172	12	0.0234375	512	8202	1058,5721,2491,9232,5716,5720,83540,699,1062,54820,11065,9700	CENPA,PSME2,CENPI,PTTG1,PSMD10,PSME1,NUF2,BUB1,CENPE,NDE1,UBE2C,ESPL1
R-HSA-114608	Platelet degranulation	0.394178764412216	-0.930950755800264	81	6	0.01171875	512	8202	3920,5154,5265,801,22927,928	LAMP2,PDGFA,SERPINA1,CALM1,HABP4,CD9
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.394178764412216	-0.930950755800264	81	6	0.01171875	512	8202	3065,5716,7088,6932,5720,5721	HDAC1,PSMD10,TLE1,TCF7,PSME1,PSME2
R-HSA-397795	G-protein beta:gamma signalling	0.39518415719932	-0.928403401970372	51	4	0.0078125	512	8202	5293,10681,207,5295	PIK3CD,GNB5,AKT1,PIK3R1
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.39518415719932	-0.928403401970372	51	4	0.0078125	512	8202	5716,5720,5721,7157	PSMD10,PSME1,PSME2,TP53
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.395334218487738	-0.928023749087313	66	5	0.009765625	512	8202	9134,1027,5716,5720,5721	CCNE2,CDKN1B,PSMD10,PSME1,PSME2
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.395614726398062	-0.927314454451048	173	12	0.0234375	512	8202	1058,5721,2491,9232,5716,5720,83540,699,1062,54820,11065,9700	CENPA,PSME2,CENPI,PTTG1,PSMD10,PSME1,NUF2,BUB1,CENPE,NDE1,UBE2C,ESPL1
R-HSA-162909	Host Interactions of HIV factors	0.396845616188519	-0.924207950026315	127	9	0.017578125	512	8202	5721,5902,5716,5720,3159,292,60489,11168,3105	PSME2,RANBP1,PSMD10,PSME1,HMGA1,SLC25A5,APOBEC3G,PSIP1,HLA-A
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	1528	CYB5A
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	10507	SEMA4D
R-HSA-73928	Depyrimidination	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	79661	NEIL1
R-HSA-110329	Cleavage of the damaged pyrimidine	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	79661	NEIL1
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	8309	ACOX2
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	217	ALDH2
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	1543	CYP1A1
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	147111	NOTUM
R-HSA-1614558	Degradation of cysteine and homocysteine	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	1491	CTH
R-HSA-2046105	Linoleic acid (LA) metabolism	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	215	ABCD1
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	3685	ITGAV
R-HSA-163765	ChREBP activates metabolic gene expression	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	32	ACACB
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.403028187354315	-0.908748775674174	8	1	0.001953125	512	8202	79661	NEIL1
R-HSA-5655332	Signaling by FGFR3 in disease	0.403226536412917	-0.908256749874496	22	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-389513	CTLA4 inhibitory signaling	0.403226536412917	-0.908256749874496	22	2	0.00390625	512	8202	7525,207	YES1,AKT1
R-HSA-156590	Glutathione conjugation	0.409283373446569	-0.893347518232722	37	3	0.005859375	512	8202	2730,2950,2729	GCLM,GSTP1,GCLC
R-HSA-75153	Apoptotic execution  phase	0.409562989672181	-0.892664566584953	52	4	0.0078125	512	8202	5588,51765,3005,100506658	PRKCQ,STK26,H1F0,OCLN
R-HSA-69541	Stabilization of p53	0.409562989672181	-0.892664566584953	52	4	0.0078125	512	8202	5716,5720,5721,7157	PSMD10,PSME1,PSME2,TP53
R-HSA-2187338	Visual phototransduction	0.413184907637604	-0.883860067966157	98	7	0.013671875	512	8202	5588,10681,3339,6382,801,6385,10988	PRKCQ,GNB5,HSPG2,SDC1,CALM1,SDC4,METAP2
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.42387103516351	-0.858326032367141	53	4	0.0078125	512	8202	5716,5720,5721,60489	PSMD10,PSME1,PSME2,APOBEC3G
R-HSA-381038	XBP1(S) activates chaperone genes	0.42387103516351	-0.858326032367141	53	4	0.0078125	512	8202	2673,55062,10106,5611	GFPT1,WIPI1,CTDSP2,DNAJC3
R-HSA-73980	RNA Polymerase III Transcription Termination	0.42540596263197	-0.854711359783976	23	2	0.00390625	512	8202	4781,4784	NFIB,NFIX
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.42540596263197	-0.854711359783976	23	2	0.00390625	512	8202	2805,4942	GOT1,OAT
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.42540596263197	-0.854711359783976	23	2	0.00390625	512	8202	3065,7050	HDAC1,TGIF1
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.42540596263197	-0.854711359783976	23	2	0.00390625	512	8202	11065,4751	UBE2C,NEK2
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.42540596263197	-0.854711359783976	23	2	0.00390625	512	8202	9965,10817	FGF19,FRS3
R-HSA-69236	G1 Phase	0.426298436241421	-0.852615623429238	38	3	0.005859375	512	8202	1031,1027,1032	CDKN2C,CDKN1B,CDKN2D
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.426298436241421	-0.852615623429238	38	3	0.005859375	512	8202	5588,51765,100506658	PRKCQ,STK26,OCLN
R-HSA-69231	Cyclin D associated events in G1	0.426298436241421	-0.852615623429238	38	3	0.005859375	512	8202	1031,1027,1032	CDKN2C,CDKN1B,CDKN2D
R-HSA-5632684	Hedgehog 'on' state	0.428201800861053	-0.848160697181374	84	6	0.01171875	512	8202	5716,5720,5721,23288,83737,23432	PSMD10,PSME1,PSME2,IQCE,ITCH,GPR161
R-HSA-351202	Metabolism of polyamines	0.428201800861053	-0.848160697181374	84	6	0.01171875	512	8202	5716,2805,5720,1728,5721,6303	PSMD10,GOT1,PSME1,NQO1,PSME2,SAT1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.433048087429691	-0.836906500726346	69	5	0.009765625	512	8202	5716,5720,11065,5721,983	PSMD10,PSME1,UBE2C,PSME2,CDK1
R-HSA-4641257	Degradation of AXIN	0.438092098125355	-0.825326121016674	54	4	0.0078125	512	8202	5716,5720,5721,81847	PSMD10,PSME1,PSME2,RNF146
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.438092098125355	-0.825326121016674	54	4	0.0078125	512	8202	1362,2495,6272,54885	CPD,FTH1,SORT1,TBC1D8B
R-HSA-391908	Prostanoid ligand receptors	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	5734	PTGER4
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	760	CA2
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	192670	AGO4
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	760	CA2
R-HSA-112411	MAPK1 (ERK2) activation	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	3572	IL6ST
R-HSA-446107	Type I hemidesmosome assembly	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	3655	ITGA6
R-HSA-727802	Transport of nucleotide sugars	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	55343	SLC35C1
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	2034	EPAS1
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	760	CA2
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	3710	ITPR3
R-HSA-2428933	SHC-related events triggered by IGF1R	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	3480	IGF1R
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.440329818800508	-0.820231244687765	9	1	0.001953125	512	8202	5045	FURIN
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.443139008728235	-0.813871768704361	39	3	0.005859375	512	8202	2161,5270,5547	F12,SERPINE2,PRCP
R-HSA-1852241	Organelle biogenesis and maintenance	0.444310857906148	-0.811230831107625	321	21	0.041015625	512	8202	5563,83658,65080,80321,64960,192668,5465,5577,27031,5566,983,79809,51422,4751,10733,28957,5600,6102,95681,54820,6300	PRKAA2,DYNLRB1,MRPL44,CEP70,MRPS15,CYS1,PPARA,PRKAR2B,NPHP3,PRKACA,CDK1,TTC21B,PRKAG2,NEK2,PLK4,MRPS28,MAPK11,RP2,CEP41,NDE1,MAPK12
R-HSA-421837	Clathrin derived vesicle budding	0.445518328486884	-0.808516891532856	70	5	0.009765625	512	8202	1362,2799,2495,6272,54885	CPD,GNS,FTH1,SORT1,TBC1D8B
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.445518328486884	-0.808516891532856	70	5	0.009765625	512	8202	1362,2799,2495,6272,54885	CPD,GNS,FTH1,SORT1,TBC1D8B
R-HSA-73848	Pyrimidine metabolism	0.44714768728845	-0.804866342319056	24	2	0.00390625	512	8202	1633,978	DCK,CDA
R-HSA-5365859	RA biosynthesis pathway	0.44714768728845	-0.804866342319056	24	2	0.00390625	512	8202	56603,220	CYP26B1,ALDH1A3
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.450729806339656	-0.79688721803614	86	6	0.01171875	512	8202	3920,5154,5265,801,22927,928	LAMP2,PDGFA,SERPINA1,CALM1,HABP4,CD9
R-HSA-381070	IRE1alpha activates chaperones	0.45221090446418	-0.793606605178283	55	4	0.0078125	512	8202	2673,55062,10106,5611	GFPT1,WIPI1,CTDSP2,DNAJC3
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.45221090446418	-0.793606605178283	55	4	0.0078125	512	8202	5716,5720,27248,5721	PSMD10,PSME1,ERLEC1,PSME2
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.45221090446418	-0.793606605178283	55	4	0.0078125	512	8202	5716,5720,27248,5721	PSMD10,PSME1,ERLEC1,PSME2
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.45221090446418	-0.793606605178283	55	4	0.0078125	512	8202	5716,5720,3315,5721	PSMD10,PSME1,HSPB1,PSME2
R-HSA-5173105	O-linked glycosylation	0.464922621272619	-0.765884293107109	103	7	0.013671875	512	8202	29071,140766,2591,94025,79695,2650,170690	C1GALT1C1,ADAMTS14,GALNT3,MUC16,GALNT12,GCNT1,ADAMTS16
R-HSA-4641258	Degradation of DVL	0.466213099442734	-0.763112454442469	56	4	0.0078125	512	8202	5716,5720,5721,51339	PSMD10,PSME1,PSME2,DACT1
R-HSA-3000178	ECM proteoglycans	0.466213099442734	-0.763112454442469	56	4	0.0078125	512	8202	1299,3685,1605,4038	COL9A3,ITGAV,DAG1,LRP4
R-HSA-982772	Growth hormone receptor signaling	0.468419886692239	-0.758390191515429	25	2	0.00390625	512	8202	8660,9021	IRS2,SOCS3
R-HSA-210991	Basigin interactions	0.468419886692239	-0.758390191515429	25	2	0.00390625	512	8202	481,3655	ATP1B1,ITGA6
R-HSA-2262749	Cellular response to hypoxia	0.468419886692239	-0.758390191515429	25	2	0.00390625	512	8202	2034,54583	EPAS1,EGLN1
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.468419886692239	-0.758390191515429	25	2	0.00390625	512	8202	2034,54583	EPAS1,EGLN1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.470242109230163	-0.754507590888272	72	5	0.009765625	512	8202	3065,7050,7046,9372,5045	HDAC1,TGIF1,TGFBR1,ZFYVE9,FURIN
R-HSA-74259	Purine catabolism	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	7498	XDH
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	57161	PELI2
R-HSA-209968	Thyroxine biosynthesis	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	53905	DUOX1
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	79661	NEIL1
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	490	ATP2B1
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	983	CDK1
R-HSA-937039	IRAK1 recruits IKK complex	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	57161	PELI2
R-HSA-74749	Signal attenuation	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	8660	IRS2
R-HSA-418886	Netrin mediated repulsion signals	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	219699	UNC5B
R-HSA-430116	GP1b-IX-V activation signalling	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	5295	PIK3R1
R-HSA-1433617	Regulation of signaling by NODAL	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	130399	ACVR1C
R-HSA-190377	FGFR2b ligand binding and activation	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	2263	FGFR2
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	983	CDK1
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	3105	HLA-A
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	7220	TRPC1
R-HSA-418889	Ligand-independent caspase activation via DCC	0.475304935701824	-0.743798711023446	10	1	0.001953125	512	8202	219699	UNC5B
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.480085241457846	-0.73379160447628	57	4	0.0078125	512	8202	3065,84441,54492,9734	HDAC1,MAML2,NEURL1B,HDAC9
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.480085241457846	-0.73379160447628	57	4	0.0078125	512	8202	3065,84441,54492,9734	HDAC1,MAML2,NEURL1B,HDAC9
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.480085241457846	-0.73379160447628	57	4	0.0078125	512	8202	3065,84441,54492,9734	HDAC1,MAML2,NEURL1B,HDAC9
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.480085241457846	-0.73379160447628	57	4	0.0078125	512	8202	3065,84441,54492,9734	HDAC1,MAML2,NEURL1B,HDAC9
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.480085241457846	-0.73379160447628	57	4	0.0078125	512	8202	3065,84441,54492,9734	HDAC1,MAML2,NEURL1B,HDAC9
R-HSA-425407	SLC-mediated transmembrane transport	0.483745944501145	-0.726195418133452	264	17	0.033203125	512	8202	64116,55343,4891,6542,6507,6574,84679,6549,28231,8671,28965,10479,23446,6508,376497,57181,6558	SLC39A8,SLC35C1,SLC11A2,SLC7A2,SLC1A3,SLC20A1,SLC9A7,SLC9A2,SLCO4A1,SLC4A4,SLC27A6,SLC9A6,SLC44A1,SLC4A3,SLC27A1,SLC39A10,SLC12A2
R-HSA-211945	Phase 1 - Functionalization of compounds	0.484126564026373	-0.725408910527346	89	6	0.01171875	512	8202	56603,113612,1543,217,57834,4051	CYP26B1,CYP2U1,CYP1A1,ALDH2,CYP4F11,CYP4F3
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.485348700020093	-0.722887677265537	105	7	0.013671875	512	8202	1031,1027,6196,2353,11065,1032,6195	CDKN2C,CDKN1B,RPS6KA2,FOS,UBE2C,CDKN2D,RPS6KA1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.489196398137766	-0.71499123795631	26	2	0.00390625	512	8202	4792,64127	NFKBIA,NOD2
R-HSA-912694	Regulation of IFNA signaling	0.489196398137766	-0.71499123795631	26	2	0.00390625	512	8202	11274,9021	USP18,SOCS3
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.489196398137766	-0.71499123795631	26	2	0.00390625	512	8202	2263,10817	FGFR2,FRS3
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.489196398137766	-0.71499123795631	26	2	0.00390625	512	8202	89780,9559	WNT3A,VPS26A
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.489196398137766	-0.71499123795631	26	2	0.00390625	512	8202	7046,9372	TGFBR1,ZFYVE9
R-HSA-975634	Retinoid metabolism and transport	0.492403231023991	-0.708457322906219	42	3	0.005859375	512	8202	3339,6382,6385	HSPG2,SDC1,SDC4
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.492403231023991	-0.708457322906219	42	3	0.005859375	512	8202	2908,79365,5465	NR3C1,BHLHE41,PPARA
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.507390102984494	-0.678475137358993	59	4	0.0078125	512	8202	5716,5720,5566,5721	PSMD10,PSME1,PRKACA,PSME2
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.507390102984494	-0.678475137358993	59	4	0.0078125	512	8202	5716,5720,5566,5721	PSMD10,PSME1,PRKACA,PSME2
R-HSA-879518	Transport of organic anions	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	28231	SLCO4A1
R-HSA-2022923	Dermatan sulfate biosynthesis	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	29940	DSE
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	2184	FAH
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	983	CDK1
R-HSA-5625970	RHO GTPases activate KTN1	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	147700	KLC3
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	100506658	OCLN
R-HSA-71064	Lysine catabolism	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	10157	AASS
R-HSA-1266695	Interleukin-7 signaling	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	5295	PIK3R1
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	51477	ISYNA1
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.508098377223774	-0.677080194200238	11	1	0.001953125	512	8202	5045	FURIN
R-HSA-69278	Cell Cycle, Mitotic	0.511420239014998	-0.670563641204203	477	30	0.05859375	512	8202	9134,1058,80321,2305,5721,2491,9232,9493,5716,5577,83540,5720,64900,5566,983,5557,1031,10733,4751,3065,6790,1027,699,1062,95681,54820,9133,1032,11065,9700	CCNE2,CENPA,CEP70,FOXM1,PSME2,CENPI,PTTG1,KIF23,PSMD10,PRKAR2B,NUF2,PSME1,LPIN3,PRKACA,CDK1,PRIM1,CDKN2C,PLK4,NEK2,HDAC1,AURKA,CDKN1B,BUB1,CENPE,CEP41,NDE1,CCNB2,CDKN2D,UBE2C,ESPL1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.520800399310422	-0.65238842136299	60	4	0.0078125	512	8202	5716,5720,11065,5721	PSMD10,PSME1,UBE2C,PSME2
R-HSA-69206	G1/S Transition	0.525480546779897	-0.643442107847199	109	7	0.013671875	512	8202	9134,1027,5716,5720,5721,983,5557	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,CDK1,PRIM1
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.529182579479351	-0.636421765878496	28	2	0.00390625	512	8202	207,801	AKT1,CALM1
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.530344665894589	-0.634228170789186	77	5	0.009765625	512	8202	9134,1027,3159,3005,7157	CCNE2,CDKN1B,HMGA1,H1F0,TP53
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.530344665894589	-0.634228170789186	77	5	0.009765625	512	8202	5716,5720,11065,5721,983	PSMD10,PSME1,UBE2C,PSME2,CDK1
R-HSA-1475029	Reversible hydration of carbon dioxide	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	760	CA2
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	983	CDK1
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	801	CALM1
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	801	CALM1
R-HSA-390666	Serotonin receptors	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	3352	HTR1D
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	84441	MAML2
R-HSA-71384	Ethanol oxidation	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	217	ALDH2
R-HSA-202670	ERKs are inactivated	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	1846	DUSP4
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.538845982026937	-0.618325496537688	12	1	0.001953125	512	8202	5557	PRIM1
R-HSA-5668914	Diseases of metabolism	0.539419744681312	-0.617261264049691	45	3	0.005859375	512	8202	32,3417,64087	ACACB,IDH1,MCCC2
R-HSA-1226099	Signaling by FGFR in disease	0.539419744681312	-0.617261264049691	45	3	0.005859375	512	8202	2263,2549,5295	FGFR2,GAB1,PIK3R1
R-HSA-418597	G alpha (z) signalling events	0.554528650380594	-0.589636804670609	46	3	0.005859375	512	8202	5588,10681,8601	PRKCQ,GNB5,RGS20
R-HSA-211859	Biological oxidations	0.556492445618271	-0.586101683168611	194	12	0.0234375	512	8202	56603,2730,1543,217,9060,57834,2729,9061,113612,2950,6820,4051	CYP26B1,GCLM,CYP1A1,ALDH2,PAPSS2,CYP4F11,GCLC,PAPSS1,CYP2U1,GSTP1,SULT2B1,CYP4F3
R-HSA-202424	Downstream TCR signaling	0.559218718217252	-0.581214615415934	96	6	0.01171875	512	8202	5716,5588,5720,5721,4792,5295	PSMD10,PRKCQ,PSME1,PSME2,NFKBIA,PIK3R1
R-HSA-420029	Tight junction interactions	0.566989318495819	-0.567414814063547	30	2	0.00390625	512	8202	1364,64398	CLDN4,MPP5
R-HSA-5683826	Surfactant metabolism	0.566989318495819	-0.567414814063547	30	2	0.00390625	512	8202	10970,29995	CKAP4,LMCD1
R-HSA-1502540	Signaling by Activin	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	130399	ACVR1C
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	215	ABCD1
R-HSA-209560	NF-kB is activated and signals survival	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-211227	Activation of DNA fragmentation factor	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	3005	H1F0
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	215	ABCD1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	60559	SPCS3
R-HSA-350054	Notch-HLH transcription pathway	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	84441	MAML2
R-HSA-74217	Purine salvage	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	1633	DCK
R-HSA-140342	Apoptosis induced DNA fragmentation	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	3005	H1F0
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	4682	NUBP1
R-HSA-1483213	Synthesis of PE	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	64900	LPIN3
R-HSA-190375	FGFR2c ligand binding and activation	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	2263	FGFR2
R-HSA-175474	Assembly Of The HIV Virion	0.567675146521115	-0.566205949011435	13	1	0.001953125	512	8202	5045	FURIN
R-HSA-5663220	RHO GTPases Activate Formins	0.573879276866682	-0.555336223830315	114	7	0.013671875	512	8202	1730,699,83540,1062,1058,54820,2491	DIAPH2,BUB1,NUF2,CENPE,CENPA,NDE1,CENPI
R-HSA-1640170	Cell Cycle	0.577108487826587	-0.549725009650992	572	35	0.068359375	512	8202	9134,80321,55355,2305,5721,2491,9232,7157,9493,5716,83540,5720,64900,5566,580,1031,10733,4751,1027,699,1032,25777,1058,23224,5577,983,5557,6790,3065,1062,54820,95681,11065,9133,9700	CCNE2,CEP70,HJURP,FOXM1,PSME2,CENPI,PTTG1,TP53,KIF23,PSMD10,NUF2,PSME1,LPIN3,PRKACA,BARD1,CDKN2C,PLK4,NEK2,CDKN1B,BUB1,CDKN2D,SUN2,CENPA,SYNE2,PRKAR2B,CDK1,PRIM1,AURKA,HDAC1,CENPE,NDE1,CEP41,UBE2C,CCNB2,ESPL1
R-HSA-156580	Phase II conjugation	0.579730418786823	-0.545192078687573	98	6	0.01171875	512	8202	2730,9060,2950,6820,2729,9061	GCLM,PAPSS2,GSTP1,SULT2B1,GCLC,PAPSS1
R-HSA-446203	Asparagine N-linked glycosylation	0.581772740903256	-0.541675387055359	181	11	0.021484375	512	8202	2673,2517,10484,5265,1075,11320,79868,2530,11282,5476,90411	GFPT1,FUCA1,SEC23A,SERPINA1,CTSC,MGAT4A,ALG13,FUT8,MGAT4B,CTSA,MCFD2
R-HSA-202403	TCR signaling	0.583279782410939	-0.539088306527958	115	7	0.013671875	512	8202	5716,5588,5720,5795,5721,4792,5295	PSMD10,PRKCQ,PSME1,PTPRJ,PSME2,NFKBIA,PIK3R1
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.585055159453783	-0.536049146530685	31	2	0.00390625	512	8202	7855,89780	FZD5,WNT3A
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.585055159453783	-0.536049146530685	31	2	0.00390625	512	8202	3065,7050	HDAC1,TGIF1
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.585055159453783	-0.536049146530685	31	2	0.00390625	512	8202	3159,11168	HMGA1,PSIP1
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	127281	FAM213B
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	9493	KIF23
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	1478	CSTF2
R-HSA-69166	Removal of the Flap Intermediate	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	5557	PRIM1
R-HSA-190322	FGFR4 ligand binding and activation	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	9965	FGF19
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	5557	PRIM1
R-HSA-69091	Polymerase switching	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	5557	PRIM1
R-HSA-877312	Regulation of IFNG signaling	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	9021	SOCS3
R-HSA-69109	Leading Strand Synthesis	0.594705348605797	-0.519689208521909	14	1	0.001953125	512	8202	5557	PRIM1
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.597298428982269	-0.515338409446115	66	4	0.0078125	512	8202	10484,90411,5265,1075	SEC23A,MCFD2,SERPINA1,CTSC
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.597298428982269	-0.515338409446115	66	4	0.0078125	512	8202	6737,4792,340061,23220	TRIM21,NFKBIA,TMEM173,DTX4
R-HSA-1169091	Activation of NF-kappaB in B cells	0.597298428982269	-0.515338409446115	66	4	0.0078125	512	8202	5716,5720,5721,4792	PSMD10,PSME1,PSME2,NFKBIA
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.598029755163458	-0.514114768470959	49	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.602558013593381	-0.506571330130937	32	2	0.00390625	512	8202	10681,801	GNB5,CALM1
R-HSA-111885	Opioid Signalling	0.608896543906628	-0.496106904345898	84	5	0.009765625	512	8202	5577,3710,10681,5566,801	PRKAR2B,ITPR3,GNB5,PRKACA,CALM1
R-HSA-5658442	Regulation of RAS by GAPs	0.609320896236735	-0.495410226834499	67	4	0.0078125	512	8202	5716,5720,5721,5922	PSMD10,PSME1,PSME2,RASA2
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.611898570262547	-0.49118874507047	50	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.611898570262547	-0.49118874507047	50	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-169911	Regulation of Apoptosis	0.611898570262547	-0.49118874507047	50	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-2980766	Nuclear Envelope Breakdown	0.611898570262547	-0.49118874507047	50	3	0.005859375	512	8202	64900,9133,983	LPIN3,CCNB2,CDK1
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.611898570262547	-0.49118874507047	50	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-195258	RHO GTPase Effectors	0.61435720342357	-0.487178755460875	285	17	0.033203125	512	8202	10398,10810,1058,2491,801,1730,83540,5585,9928,3984,147700,1027,699,1062,128239,54820,103910	MYL9,WASF3,CENPA,CENPI,CALM1,DIAPH2,NUF2,PKN1,KIF14,LIMK1,KLC3,CDKN1B,BUB1,CENPE,IQGAP3,NDE1,MYL12B
R-HSA-73847	Purine metabolism	0.619497641686119	-0.478846384722254	33	2	0.00390625	512	8202	1633,7498	DCK,XDH
R-HSA-113510	E2F mediated regulation of DNA replication	0.619497641686119	-0.478846384722254	33	2	0.00390625	512	8202	983,5557	CDK1,PRIM1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.619497641686119	-0.478846384722254	33	2	0.00390625	512	8202	9133,983	CCNB2,CDK1
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.619497641686119	-0.478846384722254	33	2	0.00390625	512	8202	2799,3074	GNS,HEXB
R-HSA-163359	Glucagon signaling in metabolic regulation	0.619497641686119	-0.478846384722254	33	2	0.00390625	512	8202	5577,5566	PRKAR2B,PRKACA
R-HSA-72187	mRNA 3'-end processing	0.619497641686119	-0.478846384722254	33	2	0.00390625	512	8202	1478,65109	CSTF2,UPF3B
R-HSA-3322077	Glycogen synthesis	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	5236	PGM1
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	167227	DCP2
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	54492	NEURL1B
R-HSA-391903	Eicosanoid ligand-binding receptors	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	5734	PTGER4
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	207	AKT1
R-HSA-159418	Recycling of bile acids and salts	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	2172	FABP6
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	54492	NEURL1B
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	9564	BCAR1
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.620048638972651	-0.477957354064149	15	1	0.001953125	512	8202	8322	FZD4
R-HSA-388841	Costimulation by the CD28 family	0.621120967227355	-0.476229421771646	68	4	0.0078125	512	8202	29126,7525,207,5295	CD274,YES1,AKT1,PIK3R1
R-HSA-199977	ER to Golgi Anterograde Transport	0.621120967227355	-0.476229421771646	68	4	0.0078125	512	8202	10484,90411,5265,1075	SEC23A,MCFD2,SERPINA1,CTSC
R-HSA-180534	Vpu mediated degradation of CD4	0.625443221068699	-0.469294726866495	51	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-1483255	PI Metabolism	0.625443221068699	-0.469294726866495	51	3	0.005859375	512	8202	5287,5293,5295	PIK3C2B,PIK3CD,PIK3R1
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.625443221068699	-0.469294726866495	51	3	0.005859375	512	8202	6102,27031,192668	RP2,NPHP3,CYS1
R-HSA-381119	Unfolded Protein Response (UPR)	0.629901613736691	-0.462191640464074	86	5	0.009765625	512	8202	2673,55062,10106,5611,167227	GFPT1,WIPI1,CTDSP2,DNAJC3,DCP2
R-HSA-1268020	Mitochondrial protein import	0.63866037808854	-0.448382455584608	52	3	0.005859375	512	8202	9512,1678,10165	PMPCB,TIMM8A,SLC25A13
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.63866037808854	-0.448382455584608	52	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.63866037808854	-0.448382455584608	52	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-69610	p53-Independent DNA Damage Response	0.63866037808854	-0.448382455584608	52	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-199991	Membrane Trafficking	0.639574658381871	-0.446951919848749	256	15	0.029296875	512	8202	1362,2799,5563,10484,6272,51422,5265,207,54885,1075,801,2495,90411,9882,4644	CPD,GNS,PRKAA2,SEC23A,SORT1,PRKAG2,SERPINA1,AKT1,TBC1D8B,CTSC,CALM1,FTH1,MCFD2,TBC1D4,MYO5A
R-HSA-193639	p75NTR signals via NF-kB	0.64381010187572	-0.440351469225123	16	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-1433559	Regulation of KIT signaling	0.64381010187572	-0.440351469225123	16	1	0.001953125	512	8202	7525	YES1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.64381010187572	-0.440351469225123	16	1	0.001953125	512	8202	64127	NOD2
R-HSA-446353	Cell-extracellular matrix interactions	0.64381010187572	-0.440351469225123	16	1	0.001953125	512	8202	54751	FBLIM1
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.64381010187572	-0.440351469225123	16	1	0.001953125	512	8202	7046	TGFBR1
R-HSA-69183	Processive synthesis on the lagging strand	0.64381010187572	-0.440351469225123	16	1	0.001953125	512	8202	5557	PRIM1
R-HSA-68949	Orc1 removal from chromatin	0.64403870438934	-0.439996454700268	70	4	0.0078125	512	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.64403870438934	-0.439996454700268	70	4	0.0078125	512	8202	23586,51191,3434,11274	DDX58,HERC5,IFIT1,USP18
R-HSA-69052	Switching of origins to a post-replicative state	0.64403870438934	-0.439996454700268	70	4	0.0078125	512	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-1169408	ISG15 antiviral mechanism	0.64403870438934	-0.439996454700268	70	4	0.0078125	512	8202	23586,51191,3434,11274	DDX58,HERC5,IFIT1,USP18
R-HSA-194068	Bile acid and bile salt metabolism	0.651697085493758	-0.428175417813143	35	2	0.00390625	512	8202	8309,2172	ACOX2,FABP6
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.664103952821216	-0.409316586305591	54	3	0.005859375	512	8202	10484,32,5465	SEC23A,ACACB,PPARA
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.664103952821216	-0.409316586305591	54	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-69300	Removal of licensing factors from origins	0.666027235258681	-0.406424715496073	72	4	0.0078125	512	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-2033519	Activated point mutants of FGFR2	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	2263	FGFR2
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	11065	UBE2C
R-HSA-1839126	FGFR2 mutant receptor activation	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	2263	FGFR2
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	2902	GRIN1
R-HSA-622312	Inflammasomes	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	598	BCL2L1
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	60559	SPCS3
R-HSA-69205	G1/S-Specific Transcription	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	983	CDK1
R-HSA-1482925	Acyl chain remodelling of PG	0.666088287555111	-0.406333053331002	17	1	0.001953125	512	8202	9926	LPGAT1
R-HSA-5655302	Signaling by FGFR1 in disease	0.666966445507564	-0.405015540917293	36	2	0.00390625	512	8202	2549,5295	GAB1,PIK3R1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.669184122943828	-0.401696035578554	142	8	0.015625	512	8202	3768,6196,10681,84254,6195,801,2902,5566	KCNJ12,RPS6KA2,GNB5,CAMKK1,RPS6KA1,CALM1,GRIN1,PRKACA
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	5295	PIK3R1
R-HSA-209776	Amine-derived hormones	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	53905	DUOX1
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	11065	UBE2C
R-HSA-5635838	Activation of SMO	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	23288	IQCE
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	5045	FURIN
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	11065	UBE2C
R-HSA-210993	Tie2 Signaling	0.686975617628517	-0.375456478468916	18	1	0.001953125	512	8202	5295	PIK3R1
R-HSA-69620	Cell Cycle Checkpoints	0.687956965296969	-0.374028993445606	179	10	0.01953125	512	8202	9134,5721,7157,5716,1027,5720,9133,580,11065,983	CCNE2,PSME2,TP53,PSMD10,CDKN1B,PSME1,CCNB2,BARD1,UBE2C,CDK1
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.69587967895269	-0.362578508660308	38	2	0.00390625	512	8202	8450,5886	CUL4B,RAD23A
R-HSA-69304	Regulation of DNA replication	0.697236285080956	-0.360630922684552	75	4	0.0078125	512	8202	1027,5716,5720,5721	CDKN1B,PSMD10,PSME1,PSME2
R-HSA-3000480	Scavenging by Class A Receptors	0.706558765691752	-0.347348901701344	19	1	0.001953125	512	8202	2495	FTH1
R-HSA-69618	Mitotic Spindle Checkpoint	0.706558765691752	-0.347348901701344	19	1	0.001953125	512	8202	11065	UBE2C
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.706558765691752	-0.347348901701344	19	1	0.001953125	512	8202	10681	GNB5
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.706558765691752	-0.347348901701344	19	1	0.001953125	512	8202	2571	GAD1
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.709541336801743	-0.343136522202181	39	2	0.00390625	512	8202	140766,170690	ADAMTS14,ADAMTS16
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.711019765823894	-0.341055049531704	58	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.711019765823894	-0.341055049531704	58	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.721928497743096	-0.325829178590282	59	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.722686510563783	-0.324779746200481	40	2	0.00390625	512	8202	4781,4784	NFIB,NFIX
R-HSA-1251985	Nuclear signaling by ERBB4	0.722686510563783	-0.324779746200481	40	2	0.00390625	512	8202	9542,3084	NRG2,NRG1
R-HSA-5675221	Negative regulation of MAPK pathway	0.722686510563783	-0.324779746200481	40	2	0.00390625	512	8202	11221,1846	DUSP10,DUSP4
R-HSA-74158	RNA Polymerase III Transcription	0.722686510563783	-0.324779746200481	40	2	0.00390625	512	8202	4781,4784	NFIB,NFIX
R-HSA-210745	Regulation of gene expression in beta cells	0.72491901400625	-0.321695335185876	20	1	0.001953125	512	8202	207	AKT1
R-HSA-190241	FGFR2 ligand binding and activation	0.72491901400625	-0.321695335185876	20	1	0.001953125	512	8202	2263	FGFR2
R-HSA-2028269	Signaling by Hippo	0.72491901400625	-0.321695335185876	20	1	0.001953125	512	8202	51421	AMOTL2
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.72491901400625	-0.321695335185876	20	1	0.001953125	512	8202	60559	SPCS3
R-HSA-418217	G beta:gamma signalling through PLC beta	0.72491901400625	-0.321695335185876	20	1	0.001953125	512	8202	10681	GNB5
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.726302919114856	-0.319788107219539	78	4	0.0078125	512	8202	688,8202,6837,5465	KLF5,NCOA3,MED22,PPARA
R-HSA-162906	HIV Infection	0.733656311766213	-0.309714600126776	221	12	0.0234375	512	8202	5721,5902,5045,2963,5716,5720,3159,2958,292,11168,60489,3105	PSME2,RANBP1,FURIN,GTF2F2,PSMD10,PSME1,HMGA1,GTF2A2,SLC25A5,PSIP1,APOBEC3G,HLA-A
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.735326307201407	-0.307440922912267	41	2	0.00390625	512	8202	32,5465	ACACB,PPARA
R-HSA-5620924	Intraflagellar transport	0.735326307201407	-0.307440922912267	41	2	0.00390625	512	8202	79809,83658	TTC21B,DYNLRB1
R-HSA-597592	Post-translational protein modification	0.74039410881785	-0.300572655070461	411	23	0.044921875	512	8202	2673,10484,5329,79695,11282,56648,5045,29071,90411,2591,2517,94025,5265,22901,1075,79868,11320,2530,140766,5476,411,170690,2650	GFPT1,SEC23A,PLAUR,GALNT12,MGAT4B,EIF5A2,FURIN,C1GALT1C1,MCFD2,GALNT3,FUCA1,MUC16,SERPINA1,ARSG,CTSC,ALG13,MGAT4A,FUT8,ADAMTS14,CTSA,ARSB,ADAMTS16,GCNT1
R-HSA-69239	Synthesis of DNA	0.74075514280942	-0.30008514984663	98	5	0.009765625	512	8202	1027,5716,5720,5721,5557	CDKN1B,PSMD10,PSME1,PSME2,PRIM1
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	5795	PTPRJ
R-HSA-211981	Xenobiotics	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	1543	CYP1A1
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	3105	HLA-A
R-HSA-500657	Presynaptic function of Kainate receptors	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	10681	GNB5
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	57176	VARS2
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	5566	PRKACA
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-69186	Lagging Strand Synthesis	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	5557	PRIM1
R-HSA-445144	Signal transduction by L1	0.742132588319433	-0.298227361320538	21	1	0.001953125	512	8202	3685	ITGAV
R-HSA-73856	RNA Polymerase II Transcription Termination	0.747472461014601	-0.291057815847998	42	2	0.00390625	512	8202	1478,65109	CSTF2,UPF3B
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.747472461014601	-0.291057815847998	42	2	0.00390625	512	8202	1478,65109	CSTF2,UPF3B
R-HSA-202733	Cell surface interactions at the vascular wall	0.748784437687167	-0.289304137037974	99	5	0.009765625	512	8202	7525,481,3685,3655,5295	YES1,ATP1B1,ITGAV,ITGA6,PIK3R1
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	65018	PINK1
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	10681	GNB5
R-HSA-5205647	Mitophagy	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	65018	PINK1
R-HSA-373753	Nephrin interactions	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	5295	PIK3R1
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	2041	EPHA1
R-HSA-166208	mTORC1-mediated signalling	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	6009	RHEB
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.758270971726761	-0.276714474732276	22	1	0.001953125	512	8202	5270	SERPINE2
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.759137212393058	-0.275572737433819	43	2	0.00390625	512	8202	3065,7050	HDAC1,TGIF1
R-HSA-15869	Metabolism of nucleotides	0.761756261381826	-0.27212864141682	82	4	0.0078125	512	8202	131870,1633,7498,978	NUDT16,DCK,XDH,CDA
R-HSA-68874	M/G1 Transition	0.761756261381826	-0.27212864141682	82	4	0.0078125	512	8202	5716,5720,5721,5557	PSMD10,PSME1,PSME2,PRIM1
R-HSA-69002	DNA Replication Pre-Initiation	0.761756261381826	-0.27212864141682	82	4	0.0078125	512	8202	5716,5720,5721,5557	PSMD10,PSME1,PSME2,PRIM1
R-HSA-68886	M Phase	0.762065636749335	-0.271722589538791	296	16	0.03125	512	8202	1058,5721,2491,9232,9493,5716,5720,83540,64900,983,699,1062,54820,9133,11065,9700	CENPA,PSME2,CENPI,PTTG1,KIF23,PSMD10,PSME1,NUF2,LPIN3,CDK1,BUB1,CENPE,NDE1,CCNB2,UBE2C,ESPL1
R-HSA-400253	Circadian Clock	0.762370047938643	-0.271323213958158	63	3	0.005859375	512	8202	2908,79365,5465	NR3C1,BHLHE41,PPARA
R-HSA-112315	Transmission across Chemical Synapses	0.76930812211383	-0.262263710775204	210	11	0.021484375	512	8202	3768,217,6196,10681,84254,6195,801,2902,6507,2571,5566	KCNJ12,ALDH2,RPS6KA2,GNB5,CAMKK1,RPS6KA1,CALM1,GRIN1,SLC1A3,GAD1,PRKACA
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.770333199230483	-0.260932131460066	44	2	0.00390625	512	8202	8450,5886	CUL4B,RAD23A
R-HSA-446652	Interleukin-1 signaling	0.770333199230483	-0.260932131460066	44	2	0.00390625	512	8202	57161,64127	PELI2,NOD2
R-HSA-70895	Branched-chain amino acid catabolism	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	64087	MCCC2
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	60559	SPCS3
R-HSA-389948	PD-1 signaling	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	29126	CD274
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-428930	Thromboxane signalling through TP receptor	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	10681	GNB5
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	1478	CSTF2
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	192670	AGO4
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.773401199417808	-0.256957348972532	23	1	0.001953125	512	8202	5557	PRIM1
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.787586134722465	-0.238782536838271	24	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-977606	Regulation of Complement cascade	0.787586134722465	-0.238782536838271	24	1	0.001953125	512	8202	1604	CD55
R-HSA-5260271	Diseases of Immune System	0.787586134722465	-0.238782536838271	24	1	0.001953125	512	8202	4792	NFKBIA
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.787586134722465	-0.238782536838271	24	1	0.001953125	512	8202	6507	SLC1A3
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.787586134722465	-0.238782536838271	24	1	0.001953125	512	8202	8309	ACOX2
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-73776	RNA Polymerase II Promoter Escape	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-167161	HIV Transcription Initiation	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-73893	DNA Damage Bypass	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	8450,124739	CUL4B,USP43
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.791370846716475	-0.233988588318035	46	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-68867	Assembly of the pre-replicative complex	0.79791338654244	-0.22575522559039	67	3	0.005859375	512	8202	5716,5720,5721	PSMD10,PSME1,PSME2
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.79791338654244	-0.22575522559039	67	3	0.005859375	512	8202	2673,5476,79868	GFPT1,CTSA,ALG13
R-HSA-69306	DNA Replication	0.799865290299329	-0.223311952618752	106	5	0.009765625	512	8202	1027,5716,5720,5721,5557	CDKN1B,PSMD10,PSME1,PSME2,PRIM1
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-5669034	TNFs bind their physiological receptors	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	970	CD70
R-HSA-977068	Termination of O-glycan biosynthesis	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	94025	MUC16
R-HSA-1296059	G protein gated Potassium channels	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	5329	PLAUR
R-HSA-380994	ATF4 activates genes	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	167227	DCP2
R-HSA-3295583	TRP channels	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	7220	TRPC1
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	10681	GNB5
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	2182	ACSL4
R-HSA-1296041	Activation of G protein gated Potassium channels	0.80088472840352	-0.222038251878349	25	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.800934348099188	-0.221976297695867	87	4	0.0078125	512	8202	3065,7088,6932,26108	HDAC1,TLE1,TCF7,PYGO1
R-HSA-69242	S Phase	0.800988432959005	-0.221908772768353	125	6	0.01171875	512	8202	9134,1027,5716,5720,5721,5557	CCNE2,CDKN1B,PSMD10,PSME1,PSME2,PRIM1
R-HSA-75109	Triglyceride Biosynthesis	0.806073036655252	-0.215580924383326	68	3	0.005859375	512	8202	2182,64900,10555	ACSL4,LPIN3,AGPAT2
R-HSA-112316	Neuronal System	0.807663728669397	-0.213609484476247	289	15	0.029296875	512	8202	3768,217,27345,6196,10681,3783,84254,6195,801,3790,2902,56666,6507,2571,5566	KCNJ12,ALDH2,KCNMB4,RPS6KA2,GNB5,KCNN4,CAMKK1,RPS6KA1,CALM1,KCNS3,GRIN1,PANX2,SLC1A3,GAD1,PRKACA
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.813352261614138	-0.2065909771574	26	1	0.001953125	512	8202	580	BARD1
R-HSA-1474165	Reproduction	0.813352261614138	-0.2065909771574	26	1	0.001953125	512	8202	928	CD9
R-HSA-264876	Insulin processing	0.813352261614138	-0.2065909771574	26	1	0.001953125	512	8202	4644	MYO5A
R-HSA-1187000	Fertilization	0.813352261614138	-0.2065909771574	26	1	0.001953125	512	8202	928	CD9
R-HSA-1483257	Phospholipid metabolism	0.814563957052411	-0.205102330938208	146	7	0.013671875	512	8202	5287,5293,64900,10555,9926,23446,5295	PIK3C2B,PIK3CD,LPIN3,AGPAT2,LPGAT1,SLC44A1,PIK3R1
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.821562012705087	-0.196547857189996	70	3	0.005859375	512	8202	1058,55355,2491	CENPA,HJURP,CENPI
R-HSA-774815	Nucleosome assembly	0.821562012705087	-0.196547857189996	70	3	0.005859375	512	8202	1058,55355,2491	CENPA,HJURP,CENPI
R-HSA-182971	EGFR downregulation	0.825040573988017	-0.192322713265246	27	1	0.001953125	512	8202	30011	SH3KBP1
R-HSA-192105	Synthesis of bile acids and bile salts	0.825040573988017	-0.192322713265246	27	1	0.001953125	512	8202	8309	ACOX2
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.825040573988017	-0.192322713265246	27	1	0.001953125	512	8202	219699	UNC5B
R-HSA-1368082	RORA activates gene expression	0.825040573988017	-0.192322713265246	27	1	0.001953125	512	8202	5465	PPARA
R-HSA-5663205	Infectious disease	0.826682347087309	-0.190334760420337	347	18	0.03515625	512	8202	5721,5611,801,5045,5716,5720,2958,84168,292,11168,3105,6136,6170,5902,2963,928,3159,60489	PSME2,DNAJC3,CALM1,FURIN,PSMD10,PSME1,GTF2A2,ANTXR1,SLC25A5,PSIP1,HLA-A,RPL12,RPL39,RANBP1,GTF2F2,CD9,HMGA1,APOBEC3G
R-HSA-5653656	Vesicle-mediated transport	0.82729178285387	-0.189597825321886	294	15	0.029296875	512	8202	1362,2799,5563,10484,6272,51422,5265,207,54885,1075,801,2495,90411,9882,4644	CPD,GNS,PRKAA2,SEC23A,SORT1,PRKAG2,SERPINA1,AKT1,TBC1D8B,CTSC,CALM1,FTH1,MCFD2,TBC1D4,MYO5A
R-HSA-112310	Neurotransmitter Release Cycle	0.828400518207841	-0.188258523908223	50	2	0.00390625	512	8202	6507,2571	SLC1A3,GAD1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	8450	CUL4B
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	3105	HLA-A
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	10681	GNB5
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-381042	PERK regulates gene expression	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	167227	DCP2
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-202040	G-protein activation	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	10681	GNB5
R-HSA-1483166	Synthesis of PA	0.835998277500245	-0.179128726305963	28	1	0.001953125	512	8202	10555	AGPAT2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.844605453956622	-0.16888567905983	52	2	0.00390625	512	8202	2673,5476	GFPT1,CTSA
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.846270956968418	-0.166915690550125	29	1	0.001953125	512	8202	63971	KIF13A
R-HSA-917977	Transferrin endocytosis and recycling	0.846270956968418	-0.166915690550125	29	1	0.001953125	512	8202	261729	STEAP2
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.846270956968418	-0.166915690550125	29	1	0.001953125	512	8202	4603	MYBL1
R-HSA-180786	Extension of Telomeres	0.846270956968418	-0.166915690550125	29	1	0.001953125	512	8202	5557	PRIM1
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.846270956968418	-0.166915690550125	29	1	0.001953125	512	8202	2950	GSTP1
R-HSA-1839124	FGFR1 mutant receptor activation	0.846270956968418	-0.166915690550125	29	1	0.001953125	512	8202	5295	PIK3R1
R-HSA-416476	G alpha (q) signalling events	0.84713467689876	-0.165895592366953	190	9	0.017578125	512	8202	10681,5295,5588,3710,10125,2915,8526,1909,10235	GNB5,PIK3R1,PRKCQ,ITPR3,RASGRP1,GRM5,DGKE,EDNRA,RASGRP2
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.853100900932911	-0.158877448998522	115	5	0.009765625	512	8202	3106,3107,5819,3134,3105	HLA-B,HLA-C,PVRL2,HLA-F,HLA-A
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.855901358287791	-0.155600145125635	30	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-5656169	Termination of translesion DNA synthesis	0.855901358287791	-0.155600145125635	30	1	0.001953125	512	8202	124739	USP43
R-HSA-420092	Glucagon-type ligand receptors	0.855901358287791	-0.155600145125635	30	1	0.001953125	512	8202	10681	GNB5
R-HSA-68962	Activation of the pre-replicative complex	0.855901358287791	-0.155600145125635	30	1	0.001953125	512	8202	5557	PRIM1
R-HSA-72086	mRNA Capping	0.855901358287791	-0.155600145125635	30	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.855901358287791	-0.155600145125635	30	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-1483206	Glycerophospholipid biosynthesis	0.858211157740963	-0.152905105179745	96	4	0.0078125	512	8202	64900,10555,9926,23446	LPIN3,AGPAT2,LPGAT1,SLC44A1
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.858211157740963	-0.152905105179745	96	4	0.0078125	512	8202	5716,970,5720,5721	PSMD10,CD70,PSME1,PSME2
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.864929564906896	-0.145107203218985	31	1	0.001953125	512	8202	9965	FGF19
R-HSA-167287	HIV elongation arrest and recovery	0.864929564906896	-0.145107203218985	31	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-1296065	Inwardly rectifying K+ channels	0.864929564906896	-0.145107203218985	31	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-352230	Amino acid transport across the plasma membrane	0.864929564906896	-0.145107203218985	31	1	0.001953125	512	8202	6542	SLC7A2
R-HSA-167290	Pausing and recovery of HIV elongation	0.864929564906896	-0.145107203218985	31	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-70171	Glycolysis	0.864929564906896	-0.145107203218985	31	1	0.001953125	512	8202	2026	ENO2
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.873393163338545	-0.13536946560209	32	1	0.001953125	512	8202	5902	RANBP1
R-HSA-392518	Signal amplification	0.873393163338545	-0.13536946560209	32	1	0.001953125	512	8202	10681	GNB5
R-HSA-186712	Regulation of beta-cell development	0.873393163338545	-0.13536946560209	32	1	0.001953125	512	8202	207	AKT1
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.873393163338545	-0.13536946560209	32	1	0.001953125	512	8202	10681	GNB5
R-HSA-1296071	Potassium Channels	0.873899685764791	-0.134789685926697	99	4	0.0078125	512	8202	3768,27345,3783,3790	KCNJ12,KCNMB4,KCNN4,KCNS3
R-HSA-162587	HIV Life Cycle	0.877756218197296	-0.130386379712267	140	6	0.01171875	512	8202	3159,2958,11168,5902,5045,2963	HMGA1,GTF2A2,PSIP1,RANBP1,FURIN,GTF2F2
R-HSA-69190	DNA strand elongation	0.881327398390072	-0.126326100751943	33	1	0.001953125	512	8202	5557	PRIM1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.881327398390072	-0.126326100751943	33	1	0.001953125	512	8202	580	BARD1
R-HSA-4085001	Sialic acid metabolism	0.881327398390072	-0.126326100751943	33	1	0.001953125	512	8202	5476	CTSA
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.883507577134084	-0.123855410989684	101	4	0.0078125	512	8202	4891,57181,64116,23446	SLC11A2,SLC39A10,SLC39A8,SLC44A1
R-HSA-113418	Formation of the Early Elongation Complex	0.888765318836313	-0.117922061629194	34	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.888765318836313	-0.117922061629194	34	1	0.001953125	512	8202	2263	FGFR2
R-HSA-177243	Interactions of Rev with host cellular proteins	0.888765318836313	-0.117922061629194	34	1	0.001953125	512	8202	5902	RANBP1
R-HSA-5693537	Resolution of D-Loop Structures	0.888765318836313	-0.117922061629194	34	1	0.001953125	512	8202	580	BARD1
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.888765318836313	-0.117922061629194	34	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-611105	Respiratory electron transport	0.889079726641805	-0.117568366227484	81	3	0.005859375	512	8202	4697,1345,55967	NDUFA4,COX6C,NDUFA12
R-HSA-432720	Lysosome Vesicle Biogenesis	0.89573791393922	-0.110107415559918	35	1	0.001953125	512	8202	2799	GNS
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.89573791393922	-0.110107415559918	35	1	0.001953125	512	8202	79661	NEIL1
R-HSA-73884	Base Excision Repair	0.89573791393922	-0.110107415559918	35	1	0.001953125	512	8202	79661	NEIL1
R-HSA-73886	Chromosome Maintenance	0.900828765246105	-0.104440089106886	105	4	0.0078125	512	8202	1058,55355,2491,5557	CENPA,HJURP,CENPI,PRIM1
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.902274241589991	-0.10283676789001	36	1	0.001953125	512	8202	10810	WASF3
R-HSA-192823	Viral mRNA Translation	0.90302164427607	-0.102008756554438	84	3	0.005859375	512	8202	6136,6170,5611	RPL12,RPL39,DNAJC3
R-HSA-5419276	Mitochondrial translation termination	0.90302164427607	-0.102008756554438	84	3	0.005859375	512	8202	28957,65080,64960	MRPS28,MRPL44,MRPS15
R-HSA-5389840	Mitochondrial translation elongation	0.90302164427607	-0.102008756554438	84	3	0.005859375	512	8202	28957,65080,64960	MRPS28,MRPL44,MRPS15
R-HSA-5368286	Mitochondrial translation initiation	0.90302164427607	-0.102008756554438	84	3	0.005859375	512	8202	28957,65080,64960	MRPS28,MRPL44,MRPS15
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.908401548524067	-0.0960687640801624	37	1	0.001953125	512	8202	124739	USP43
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.908401548524067	-0.0960687640801624	37	1	0.001953125	512	8202	580	BARD1
R-HSA-73857	RNA Polymerase II Transcription	0.908607116432995	-0.0958424933817673	107	4	0.0078125	512	8202	1478,65109,2958,2963	CSTF2,UPF3B,GTF2A2,GTF2F2
R-HSA-166658	Complement cascade	0.914145382835999	-0.0897656579932289	38	1	0.001953125	512	8202	1604	CD55
R-HSA-3214841	PKMTs methylate histone lysines	0.915812168923728	-0.0879439910949362	64	2	0.00390625	512	8202	84193,2122	SETD3,MECOM
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.91952969983758	-0.0838929354729022	39	1	0.001953125	512	8202	2915	GRM5
R-HSA-977444	GABA B receptor activation	0.91952969983758	-0.0838929354729022	39	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.91952969983758	-0.0838929354729022	39	1	0.001953125	512	8202	580	BARD1
R-HSA-991365	Activation of GABAB receptors	0.91952969983758	-0.0838929354729022	39	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.920100367205017	-0.0832725201013924	65	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-5696400	Dual Incision in GG-NER	0.924576961086066	-0.078418985447671	40	1	0.001953125	512	8202	8450	CUL4B
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.924576961086066	-0.078418985447671	40	1	0.001953125	512	8202	2495	FTH1
R-HSA-196854	Metabolism of vitamins and cofactors	0.926259830479966	-0.0766004892244177	90	3	0.005859375	512	8202	32,1528,64087	ACACB,CYB5A,MCCC2
R-HSA-5368287	Mitochondrial translation	0.926259830479966	-0.0766004892244177	90	3	0.005859375	512	8202	28957,65080,64960	MRPS28,MRPL44,MRPS15
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.926259830479966	-0.0766004892244177	90	3	0.005859375	512	8202	32,1528,64087	ACACB,CYB5A,MCCC2
R-HSA-5625740	RHO GTPases activate PKNs	0.926259830479966	-0.0766004892244177	90	3	0.005859375	512	8202	10398,5585,103910	MYL9,PKN1,MYL12B
R-HSA-167172	Transcription of the HIV genome	0.928067805643263	-0.0746504824392284	67	2	0.00390625	512	8202	2958,2963	GTF2A2,GTF2F2
R-HSA-72163	mRNA Splicing - Major Pathway	0.928790939520709	-0.0738716036840326	113	4	0.0078125	512	8202	1478,65109,3188,2963	CSTF2,UPF3B,HNRNPH2,GTF2F2
R-HSA-168325	Viral Messenger RNA Synthesis	0.929308227423072	-0.0733148111027433	41	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.931764616814642	-0.0706750532602873	68	2	0.00390625	512	8202	9261,259217	MAPKAPK2,HSPA12A
R-HSA-212436	Generic Transcription Pathway	0.931901400359209	-0.0705282634990829	553	27	0.052734375	512	8202	7068,5563,7050,860,207,2908,3164,7067,5465,7157,84441,1345,7005,6009,9668,7626,143686,51422,1490,619279,3065,4929,4306,55762,5916,29959,7181	THRB,PRKAA2,TGIF1,RUNX2,AKT1,NR3C1,NR4A1,THRA,PPARA,TP53,MAML2,COX6C,TEAD3,RHEB,ZNF432,ZNF75D,SESN3,PRKAG2,CTGF,ZNF704,HDAC1,NR4A2,NR3C2,ZNF701,RARG,NRBP1,NR2C1
R-HSA-379724	tRNA Aminoacylation	0.933743246122616	-0.0685537756294181	42	1	0.001953125	512	8202	57176	VARS2
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.933743246122616	-0.0685537756294181	42	1	0.001953125	512	8202	5465	PPARA
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.933743246122616	-0.0685537756294181	42	1	0.001953125	512	8202	580	BARD1
R-HSA-375280	Amine ligand-binding receptors	0.933743246122616	-0.0685537756294181	42	1	0.001953125	512	8202	3352	HTR1D
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.937900532650723	-0.0641113775489461	43	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-1296072	Voltage gated Potassium channels	0.937900532650723	-0.0641113775489461	43	1	0.001953125	512	8202	3790	KCNS3
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.937900532650723	-0.0641113775489461	43	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-167169	HIV Transcription Elongation	0.937900532650723	-0.0641113775489461	43	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-69473	G2/M DNA damage checkpoint	0.938626042055171	-0.0633381303694213	70	2	0.00390625	512	8202	580,983	BARD1,CDK1
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.941797447373694	-0.0599650515461864	44	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.941797447373694	-0.0599650515461864	44	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-112382	Formation of RNA Pol II elongation complex	0.941797447373694	-0.0599650515461864	44	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-72172	mRNA Splicing	0.947200868223949	-0.0542440982312484	120	4	0.0078125	512	8202	1478,65109,3188,2963	CSTF2,UPF3B,HNRNPH2,GTF2F2
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.948874254687173	-0.0524789921154934	46	1	0.001953125	512	8202	2182	ACSL4
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.950434395178429	-0.0508361408156135	74	2	0.00390625	512	8202	580,7157	BARD1,TP53
R-HSA-5693606	DNA Double Strand Break Response	0.953028934033401	-0.0481100147883998	75	2	0.00390625	512	8202	580,7157	BARD1,TP53
R-HSA-1221632	Meiotic synapsis	0.953028934033401	-0.0481100147883998	75	2	0.00390625	512	8202	25777,23224	SUN2,SYNE2
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.955092073031663	-0.045947531597222	48	1	0.001953125	512	8202	3065	HDAC1
R-HSA-390466	Chaperonin-mediated protein folding	0.957911898712852	-0.0429994690054928	49	1	0.001953125	512	8202	63971	KIF13A
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.958159351712472	-0.0427411769394326	102	3	0.005859375	512	8202	4697,1345,55967	NDUFA4,COX6C,NDUFA12
R-HSA-72165	mRNA Splicing - Minor Pathway	0.96055498812833	-0.0402440489293097	50	1	0.001953125	512	8202	2963	GTF2F2
R-HSA-429914	Deadenylation-dependent mRNA decay	0.96055498812833	-0.0402440489293097	50	1	0.001953125	512	8202	167227	DCP2
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.96055498812833	-0.0402440489293097	50	1	0.001953125	512	8202	65109	UPF3B
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.961158627468469	-0.0396158186299635	127	4	0.0078125	512	8202	6136,6170,5611,2963	RPL12,RPL39,DNAJC3,GTF2F2
R-HSA-162599	Late Phase of HIV Life Cycle	0.961158627468469	-0.0396158186299635	127	4	0.0078125	512	8202	2958,5902,5045,2963	GTF2A2,RANBP1,FURIN,GTF2F2
R-HSA-69481	G2/M Checkpoints	0.963812798260917	-0.0368581959048276	105	3	0.005859375	512	8202	580,9133,983	BARD1,CCNB2,CDK1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.965531963710121	-0.0350760717991823	106	3	0.005859375	512	8202	6136,65109,6170	RPL12,UPF3B,RPL39
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.965531963710121	-0.0350760717991823	106	3	0.005859375	512	8202	6136,65109,6170	RPL12,UPF3B,RPL39
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.967174026615428	-0.0333768342445459	107	3	0.005859375	512	8202	60559,6136,6170	SPCS3,RPL12,RPL39
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.969571018670279	-0.0309015540990754	54	1	0.001953125	512	8202	8450	CUL4B
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.969571018670279	-0.0309015540990754	54	1	0.001953125	512	8202	65109	UPF3B
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.96958646525322	-0.0308856228680437	83	2	0.00390625	512	8202	8450,5886	CUL4B,RAD23A
R-HSA-156902	Peptide chain elongation	0.971209997475898	-0.0292125647884746	84	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-391251	Protein folding	0.971483099975517	-0.0289314061208748	55	1	0.001953125	512	8202	63971	KIF13A
R-HSA-977443	GABA receptor activation	0.971483099975517	-0.0289314061208748	55	1	0.001953125	512	8202	3768	KCNJ12
R-HSA-6784531	tRNA processing in the nucleus	0.971483099975517	-0.0289314061208748	55	1	0.001953125	512	8202	1478	CSTF2
R-HSA-72764	Eukaryotic Translation Termination	0.972749865708519	-0.0276283051709203	85	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-380108	Chemokine receptors bind chemokines	0.973275250808893	-0.0270883479949532	56	1	0.001953125	512	8202	58191	CXCL16
R-HSA-168255	Influenza Life Cycle	0.974100307192046	-0.02624099584541	136	4	0.0078125	512	8202	6136,6170,5611,2963	RPL12,RPL39,DNAJC3,GTF2F2
R-HSA-2980736	Peptide hormone metabolism	0.974210162305351	-0.0261282262276915	86	2	0.00390625	512	8202	60559,4644	SPCS3,MYO5A
R-HSA-3371556	Cellular response to heat stress	0.974210162305351	-0.0261282262276915	86	2	0.00390625	512	8202	9261,259217	MAPKAPK2,HSPA12A
R-HSA-977225	Amyloid formation	0.976907498647538	-0.0233633103904335	88	2	0.00390625	512	8202	3339,5045	HSPG2,FURIN
R-HSA-156842	Eukaryotic Translation Elongation	0.976907498647538	-0.0233633103904335	88	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.978151832460479	-0.0220903730824303	89	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.983037386885824	-0.0171081261036723	63	1	0.001953125	512	8202	8450	CUL4B
R-HSA-72689	Formation of a pool of free 40S subunits	0.98346156601519	-0.0166767207013779	94	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-3214815	HDACs deacetylate histones	0.98346156601519	-0.0166767207013779	94	2	0.00390625	512	8202	3065,10362	HDAC1,HMG20B
R-HSA-6782135	Dual incision in TC-NER	0.984104453841537	-0.0160232352856537	64	1	0.001953125	512	8202	8450	CUL4B
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.984104453841537	-0.0160232352856537	64	1	0.001953125	512	8202	5585	PKN1
R-HSA-168254	Influenza Infection	0.984443948466497	-0.0156783165344276	147	4	0.0078125	512	8202	6136,6170,5611,2963	RPL12,RPL39,DNAJC3,GTF2F2
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.985104517697517	-0.0150075341016651	65	1	0.001953125	512	8202	580	BARD1
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.987743388734913	-0.0123323429705277	68	1	0.001953125	512	8202	580	BARD1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.988291662488992	-0.0117774198503045	153	4	0.0078125	512	8202	1478,65109,3188,2963	CSTF2,UPF3B,HNRNPH2,GTF2F2
R-HSA-2299718	Condensation of Prophase Chromosomes	0.989915509093993	-0.0101356838450398	71	1	0.001953125	512	8202	983	CDK1
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.990587187187484	-0.00945739330748691	104	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.99110707824464	-0.00893269978825691	105	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-3214858	RMTs methylate histone arginines	0.992225929293178	-0.00780444632504826	75	1	0.001953125	512	8202	6595	SMARCA2
R-HSA-68875	Mitotic Prophase	0.992439041773602	-0.00758968717491494	136	3	0.005859375	512	8202	64900,9133,983	LPIN3,CCNB2,CDK1
R-HSA-5696398	Nucleotide Excision Repair	0.992920345148327	-0.00710483452070557	109	2	0.00390625	512	8202	8450,5886	CUL4B,RAD23A
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.993174661587856	-0.00684873756657615	77	1	0.001953125	512	8202	8450	CUL4B
R-HSA-157579	Telomere Maintenance	0.993604762920819	-0.00641577421455389	78	1	0.001953125	512	8202	5557	PRIM1
R-HSA-4839726	Chromatin organization	0.993674834597643	-0.00634525401504012	261	8	0.015625	512	8202	79960,6595,84193,10362,3065,9643,23338,2122	JADE1,SMARCA2,SETD3,HMG20B,HDAC1,MORF4L2,JADE2,MECOM
R-HSA-3247509	Chromatin modifying enzymes	0.993674834597643	-0.00634525401504012	261	8	0.015625	512	8202	79960,6595,84193,10362,3065,9643,23338,2122	JADE1,SMARCA2,SETD3,HMG20B,HDAC1,MORF4L2,JADE2,MECOM
R-HSA-72737	Cap-dependent Translation Initiation	0.994037865361681	-0.0059799791258856	112	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-72613	Eukaryotic Translation Initiation	0.994037865361681	-0.0059799791258856	112	2	0.00390625	512	8202	6136,6170	RPL12,RPL39
R-HSA-3214847	HATs acetylate histones	0.994763846100198	-0.00524991059609865	143	3	0.005859375	512	8202	79960,9643,23338	JADE1,MORF4L2,JADE2
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.994763846100198	-0.00524991059609865	143	3	0.005859375	512	8202	4697,1345,55967	NDUFA4,COX6C,NDUFA12
R-HSA-1500620	Meiosis	0.994982161341052	-0.00503047028470859	115	2	0.00390625	512	8202	25777,23224	SUN2,SYNE2
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.995289386807164	-0.00472174309736754	145	3	0.005859375	512	8202	3065,4781,4784	HDAC1,NFIB,NFIX
R-HSA-72766	Translation	0.995532602927589	-0.00447740571020877	146	3	0.005859375	512	8202	60559,6136,6170	SPCS3,RPL12,RPL39
R-HSA-418555	G alpha (s) signalling events	0.99749712997693	-0.0025060074383682	127	2	0.00390625	512	8202	10681,5734	GNB5,PTGER4
R-HSA-72306	tRNA processing	0.997745312122107	-0.00225723351373605	94	1	0.001953125	512	8202	1478	CSTF2
R-HSA-211000	Gene Silencing by RNA	0.997899460754125	-0.00210274847269049	130	2	0.00390625	512	8202	192670,4603	AGO4,MYBL1
R-HSA-392499	Metabolism of proteins	0.998127544018589	-0.00187421121852359	943	40	0.078125	512	8202	3489,3339,79695,5611,10165,29995,94025,22901,1075,6170,79868,11320,2530,3485,10106,4644,10970,2650,2673,10484,9512,5329,56648,11282,5045,29071,63971,90411,167227,2591,2517,6136,5265,1678,55062,140766,5476,60559,411,170690	IGFBP6,HSPG2,GALNT12,DNAJC3,SLC25A13,LMCD1,MUC16,ARSG,CTSC,RPL39,ALG13,MGAT4A,FUT8,IGFBP2,CTDSP2,MYO5A,CKAP4,GCNT1,GFPT1,SEC23A,PMPCB,PLAUR,EIF5A2,MGAT4B,FURIN,C1GALT1C1,KIF13A,MCFD2,DCP2,GALNT3,FUCA1,RPL12,SERPINA1,TIMM8A,WIPI1,ADAMTS14,CTSA,SPCS3,ARSB,ADAMTS16
R-HSA-5693607	Processing of DNA double-strand break ends	0.998146087453373	-0.00185563316941023	97	1	0.001953125	512	8202	580	BARD1
R-HSA-427413	NoRC negatively regulates rRNA expression	0.998826086798031	-0.00117460277779238	104	1	0.001953125	512	8202	3065	HDAC1
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.999034993309714	-0.000965472609009289	107	1	0.001953125	512	8202	3065	HDAC1
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.999034993309714	-0.000965472609009289	107	1	0.001953125	512	8202	3065	HDAC1
R-HSA-73864	RNA Polymerase I Transcription	0.999153211193248	-0.000847147534919672	109	1	0.001953125	512	8202	3065	HDAC1
R-HSA-418594	G alpha (i) signalling events	0.99928948285893	-0.000710769678002599	236	5	0.009765625	512	8202	58191,2852,10681,3352,8601	CXCL16,GPER1,GNB5,HTR1D,RGS20
R-HSA-500792	GPCR ligand binding	0.999627186506531	-0.000372883005696379	444	13	0.025390625	512	8202	58191,1604,10681,8322,5734,2852,7855,89780,8323,2915,8324,3352,1909	CXCL16,CD55,GNB5,FZD4,PTGER4,GPER1,FZD5,WNT3A,FZD6,GRM5,FZD7,HTR1D,EDNRA
R-HSA-375276	Peptide ligand-binding receptors	0.99965914325114	-0.000340914853725304	193	3	0.005859375	512	8202	58191,2852,1909	CXCL16,GPER1,EDNRA
R-HSA-212165	Epigenetic regulation of gene expression	0.999682569668072	-0.00031748072360001	124	1	0.001953125	512	8202	3065	HDAC1
R-HSA-5693532	DNA Double-Strand Break Repair	0.999685052040275	-0.000314997566249293	162	2	0.00390625	512	8202	580,7157	BARD1,TP53
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.999771216632403	-0.000228809542504278	129	1	0.001953125	512	8202	580	BARD1
R-HSA-372790	Signaling by GPCR	0.999785201065565	-0.000214822007030483	1230	51	0.099609375	512	8202	50650,5721,6195,5922,8601,5716,9542,5720,5566,6710,9965,8323,27237,2915,3352,5154,58191,6196,10681,53358,11221,5293,2065,89780,221002,7074,10125,10817,1604,207,8322,9693,801,5295,2902,5734,5588,5577,1846,3710,8526,29,8324,1909,10235,8660,2263,3084,2852,7855,50649	ARHGEF3,PSME2,RPS6KA1,RASA2,RGS20,PSMD10,NRG2,PSME1,PRKACA,SPTB,FGF19,FZD6,ARHGEF16,GRM5,HTR1D,PDGFA,CXCL16,RPS6KA2,GNB5,SHC3,DUSP10,PIK3CD,ERBB3,WNT3A,RASGEF1A,TIAM1,RASGRP1,FRS3,CD55,AKT1,FZD4,RAPGEF2,CALM1,PIK3R1,GRIN1,PTGER4,PRKCQ,PRKAR2B,DUSP4,ITPR3,DGKE,ABR,FZD7,EDNRA,RASGRP2,IRS2,FGFR2,NRG1,GPER1,FZD5,ARHGEF4
R-HSA-5693538	Homology Directed Repair	0.999845604199963	-0.000154407720295834	135	1	0.001953125	512	8202	580	BARD1
R-HSA-73894	DNA Repair	0.999919123518144	-8.08797525346333e-05	306	6	0.01171875	512	8202	79661,580,8450,7157,5886,124739	NEIL1,BARD1,CUL4B,TP53,RAD23A,USP43
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.9999904231209	-9.57692495881384e-06	318	5	0.009765625	512	8202	58191,2852,3352,1909,5734	CXCL16,GPER1,HTR1D,EDNRA,PTGER4
R-HSA-74160	Gene Expression	0.999999304575765	-6.9542447630808e-07	1330	47	0.091796875	512	8202	5563,860,65109,5721,7067,7157,5716,5720,57176,1345,7005,9668,7626,143686,1490,6170,2963,5600,4603,7181,7068,7050,207,2908,3164,5465,192670,84441,2958,4781,167227,6009,4784,9261,51422,6136,3188,619279,1478,3065,4929,60559,3315,4306,55762,5916,29959	PRKAA2,RUNX2,UPF3B,PSME2,THRA,TP53,PSMD10,PSME1,VARS2,COX6C,TEAD3,ZNF432,ZNF75D,SESN3,CTGF,RPL39,GTF2F2,MAPK11,MYBL1,NR2C1,THRB,TGIF1,AKT1,NR3C1,NR4A1,PPARA,AGO4,MAML2,GTF2A2,NFIB,DCP2,RHEB,NFIX,MAPKAPK2,PRKAG2,RPL12,HNRNPH2,ZNF704,CSTF2,HDAC1,NR4A2,SPCS3,HSPB1,NR3C2,ZNF701,RARG,NRBP1
R-HSA-388396	GPCR downstream signaling	0.999999999297781	-7.0221902683078e-10	928	21	0.041015625	512	8202	50650,207,5295,8601,5734,5588,3710,8526,27237,2915,29,3352,10235,1909,58191,10681,2852,5293,7074,10125,50649	ARHGEF3,AKT1,PIK3R1,RGS20,PTGER4,PRKCQ,ITPR3,DGKE,ARHGEF16,GRM5,ABR,HTR1D,RASGRP2,EDNRA,CXCL16,GNB5,GPER1,PIK3CD,TIAM1,RASGRP1,ARHGEF4
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.999999999980511	-1.94893626526621e-11	19	0	0	512	8202
R-HSA-110320	Translesion Synthesis by POLH	0.999999999980511	-1.94893626526621e-11	19	0	0	512	8202
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999980511	-1.94893626526621e-11	19	0	0	512	8202
R-HSA-190861	Gap junction assembly	0.999999999980511	-1.94893626526621e-11	19	0	0	512	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999980511	-1.94893626526621e-11	19	0	0	512	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999980511	-1.94893626526621e-11	19	0	0	512	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-110312	Translesion synthesis by REV1	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-5218859	Regulated Necrosis	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-190242	FGFR1 ligand binding and activation	0.999999999986372	-1.36278504890156e-11	16	0	0	512	8202
R-HSA-166663	Initial triggering of complement	0.999999999987144	-1.28556718471703e-11	20	0	0	512	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999987347	-1.26530782536572e-11	18	0	0	512	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5653890	Lactose synthesis	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-70350	Fructose catabolism	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-1483152	Hydrolysis of LPE	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-77108	Utilization of Ketone Bodies	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-111458	Formation of apoptosome	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-193681	Ceramide signalling	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-977347	Serine biosynthesis	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-198745	Signalling to STAT3	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-110331	Cleavage of the damaged purine	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-1296067	Potassium transport channels	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-73927	Depurination	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999988191	-1.18086161508824e-11	3	0	0	512	8202
R-HSA-75893	TNF signaling	0.999999999988709	-1.12912096634484e-11	41	0	0	512	8202
R-HSA-70153	Glucose transport	0.999999999988709	-1.12912096634484e-11	41	0	0	512	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-549132	Organic cation/anion/zwitterion transport	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-5358508	Mismatch Repair	0.999999999989088	-1.09120064030942e-11	15	0	0	512	8202
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-916853	Degradation of GABA	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-168268	Virus Assembly and Release	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-1483101	Synthesis of PS	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-192905	vRNP Assembly	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-844623	The IPAF inflammasome	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-156582	Acetylation	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-165160	PDE3B signalling	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-198765	Signalling to ERK5	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-187042	TRKA activation by NGF	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-75094	Formation of the Editosome	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-1483226	Synthesis of PI	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999989243	-1.07566711614326e-11	2	0	0	512	8202
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-388479	Vasopressin-like receptors	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-500753	Pyrimidine biosynthesis	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-171052	LDL-mediated lipid transport	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-190370	FGFR1b ligand binding and activation	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-1482798	Acyl chain remodeling of CL	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-1566977	Fibronectin matrix formation	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-171319	Telomere Extension By Telomerase	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-77111	Synthesis of Ketone Bodies	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-187015	Activation of TRKA receptors	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-3065679	SUMO is proteolytically processed	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-73942	DNA Damage Reversal	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-428808	Na+-dependent glucose transporters	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-166662	Lectin pathway of complement activation	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-3000484	Scavenging by Class F Receptors	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-189483	Heme degradation	0.99999999999048	-9.52008083787702e-12	6	0	0	512	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-3248023	Regulation by TREX1	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-169131	Inhibition of PKR	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1483076	Synthesis of CL	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-140180	COX reactions	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1300645	Acrosome Reaction	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5619084	ABC transporter disorders	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999990844	-9.1555374392982e-12	1	0	0	512	8202
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-3371568	Attenuation phase	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-428540	Activation of Rac	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-418885	DCC mediated attractive signaling	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-5682910	LGI-ADAM interactions	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-5675482	Regulation of necroptotic cell death	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999991379	-8.6213839463007e-12	14	0	0	512	8202
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999992734	-7.26635040714509e-12	24	0	0	512	8202
R-HSA-70268	Pyruvate metabolism	0.999999999992734	-7.26635040714509e-12	24	0	0	512	8202
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.999999999992734	-7.26635040714509e-12	24	0	0	512	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-156587	Amino Acid conjugation	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-196108	Pregnenolone biosynthesis	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-70635	Urea cycle	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-390696	Adrenoceptors	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-193697	p75NTR regulates axonogenesis	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-447041	CHL1 interactions	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-3215018	Processing and activation of SUMO	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-1462054	Alpha-defensins	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999993796	-6.2039811408925e-12	9	0	0	512	8202
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-164944	Nef and signal transduction	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-428643	Organic anion transporters	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-1483115	Hydrolysis of LPC	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-400451	Free fatty acids regulate insulin secretion	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-196783	Coenzyme A biosynthesis	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-444821	Relaxin receptors	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-72731	Recycling of eIF2:GDP	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-5632681	Ligand-receptor interactions	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-192456	Digestion of dietary lipid	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-1483148	Synthesis of PG	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.99999999999466	-5.3400522322312e-12	8	0	0	512	8202
R-HSA-5423646	Aflatoxin activation and detoxification	0.99999999999506	-4.94034685700578e-12	22	0	0	512	8202
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.99999999999506	-4.94034685700578e-12	22	0	0	512	8202
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.99999999999506	-4.94034685700578e-12	22	0	0	512	8202
R-HSA-3371571	HSF1-dependent transactivation	0.99999999999506	-4.94034685700578e-12	22	0	0	512	8202
R-HSA-381753	Olfactory Signaling Pathway	0.999999999995367	-4.63323930446622e-12	381	0	0	512	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-75157	FasL/ CD95L signaling	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-5652084	Fructose metabolism	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-2161541	Abacavir metabolism	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-446205	Synthesis of GDP-mannose	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-167827	The proton buffering model	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-444209	Free fatty acid receptors	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-2142850	Hyaluronan biosynthesis and export	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-197264	Nicotinamide salvaging	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-114516	Disinhibition of SNARE formation	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-390651	Dopamine receptors	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-71032	Propionyl-CoA catabolism	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-187024	NGF-independant TRKA activation	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-111463	SMAC binds to IAPs	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-561048	Organic anion transport	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-391906	Leukotriene receptors	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-68911	G2 Phase	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-426048	Arachidonate production from DAG	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-167826	The fatty acid cycling model	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.99999999999596	-4.04004505542029e-12	5	0	0	512	8202
R-HSA-1461957	Beta defensins	0.999999999996421	-3.57877248321248e-12	42	0	0	512	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-168799	Neurotoxicity of clostridium toxins	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-381183	ATF6-alpha activates chaperone genes	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-419771	Opsins	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-549127	Organic cation transport	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-399997	Acetylcholine regulates insulin secretion	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-419812	Calcitonin-like ligand receptors	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-2562578	TRIF-mediated programmed cell death	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-190873	Gap junction degradation	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999996953	-3.04727788566229e-12	10	0	0	512	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-71262	Carnitine synthesis	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-173736	Alternative complement activation	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-1296061	HCN channels	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-75072	mRNA Editing	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-6783984	Glycine degradation	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-888593	Reuptake of GABA	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-209563	Axonal growth stimulation	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-417973	Adenosine P1 receptors	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-433692	Proton-coupled monocarboxylate transport	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-140179	Amine Oxidase reactions	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-428776	Class II GLUTs	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-165158	Activation of AKT2	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-390650	Histamine receptors	0.999999999997885	-2.1146777888216e-12	4	0	0	512	8202
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.999999999998675	-1.32482489446584e-12	27	0	0	512	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.999999999998675	-1.32482489446584e-12	27	0	0	512	8202
R-HSA-168253	Host Interactions with Influenza Factors	0.999999999998979	-1.02099816364699e-12	40	0	0	512	8202
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.999999999999072	-9.27882401705593e-13	36	0	0	512	8202
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999999072	-9.27882401705593e-13	36	0	0	512	8202
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999999552	-4.47753829184217e-13	31	0	0	512	8202
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.999999999999552	-4.47753829184217e-13	31	0	0	512	8202
R-HSA-5357905	Regulation of TNFR1 signaling	0.999999999999552	-4.47753829184217e-13	31	0	0	512	8202
R-HSA-180746	Nuclear import of Rev protein	0.999999999999552	-4.47753829184217e-13	31	0	0	512	8202
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-71288	Creatine metabolism	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-199997	COPI Mediated Transport	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-3371378	Regulation by c-FLIP	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-1980148	Signaling by NOTCH3	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-5218900	CASP8 activity is inhibited	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-211999	CYP2E1 reactions	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-193048	Androgen biosynthesis	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-71240	Tryptophan catabolism	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-69416	Dimerization of procaspase-8	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-189451	Heme biosynthesis	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-196807	Nicotinate metabolism	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-1980150	Signaling by NOTCH4	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.999999999999663	-3.36611082141641e-13	11	0	0	512	8202
R-HSA-202433	Generation of second messenger molecules	1.00000000000237	2.3698279543048e-12	32	0	0	512	8202
R-HSA-5654726	Negative regulation of FGFR1 signaling	1.00000000000237	2.3698279543048e-12	32	0	0	512	8202
R-HSA-73863	RNA Polymerase I Transcription Termination	1.00000000000237	2.3698279543048e-12	32	0	0	512	8202
R-HSA-376176	Signaling by Robo receptor	1.00000000000237	2.3698279543048e-12	32	0	0	512	8202
R-HSA-159227	Transport of the SLBP independent Mature mRNA	1.00000000000237	2.3698279543048e-12	32	0	0	512	8202
R-HSA-429947	Deadenylation of mRNA	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-1482839	Acyl chain remodelling of PE	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-211976	Endogenous sterols	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-191273	Cholesterol biosynthesis	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-201451	Signaling by BMP	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	1.00000000000243	2.42805926327663e-12	23	0	0	512	8202
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	1.00000000000244	2.4366030833186e-12	33	0	0	512	8202
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-447043	Neurofascin interactions	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-111471	Apoptotic factor-mediated response	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-75158	TRAIL  signaling	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-429593	Inositol transporters	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-74182	Ketone body metabolism	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-427601	Multifunctional anion exchangers	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000326	3.25990067554581e-12	7	0	0	512	8202
R-HSA-5656121	Translesion synthesis by POLI	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-5655862	Translesion synthesis by POLK	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-140534	Ligand-dependent caspase activation	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-1482801	Acyl chain remodelling of PS	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-189445	Metabolism of porphyrins	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000349	3.49440045844663e-12	17	0	0	512	8202
R-HSA-399719	Trafficking of AMPA receptors	1.00000000000735	7.3493592823345e-12	30	0	0	512	8202
R-HSA-157858	Gap junction trafficking and regulation	1.00000000000735	7.3493592823345e-12	30	0	0	512	8202
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	1.00000000000735	7.3493592823345e-12	30	0	0	512	8202
R-HSA-975298	Ligand-gated ion channel transport	1.00000000000757	7.56533606679971e-12	26	0	0	512	8202
R-HSA-77387	Insulin receptor recycling	1.00000000000757	7.56533606679971e-12	26	0	0	512	8202
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	1.00000000000757	7.56533606679971e-12	26	0	0	512	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000000757	7.56533606679971e-12	26	0	0	512	8202
R-HSA-5334118	DNA methylation	1.00000000000834	8.3418752356742e-12	62	0	0	512	8202
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	1.00000000000963	9.63374603644151e-12	74	0	0	512	8202
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	1.00000000000963	9.63374603644151e-12	74	0	0	512	8202
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1.00000000000969	9.68794248103434e-12	45	0	0	512	8202
R-HSA-2022854	Keratan sulfate biosynthesis	1.00000000001026	1.0258836148277e-11	28	0	0	512	8202
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.00000000001026	1.0258836148277e-11	28	0	0	512	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000001026	1.0258836148277e-11	28	0	0	512	8202
R-HSA-190828	Gap junction trafficking	1.00000000001026	1.0258836148277e-11	28	0	0	512	8202
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	1.00000000001026	1.0258836148277e-11	28	0	0	512	8202
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-428790	Facilitative Na+-independent glucose transporters	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-977441	GABA A receptor activation	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-209543	p75NTR recruits signalling complexes	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-209822	Glycoprotein hormones	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-2995410	Nuclear Envelope Reassembly	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-75892	Platelet Adhesion to exposed collagen	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-177504	Retrograde neurotrophin signalling	1.0000000000107	1.06980959803781e-11	13	0	0	512	8202
R-HSA-171306	Packaging Of Telomere Ends	1.00000000001135	1.13525614892719e-11	49	0	0	512	8202
R-HSA-5673000	RAF activation	1.00000000001169	1.16909194636189e-11	25	0	0	512	8202
R-HSA-162588	Budding and maturation of HIV virion	1.00000000001169	1.16909194636189e-11	25	0	0	512	8202
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000001169	1.16909194636189e-11	25	0	0	512	8202
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	1.00000000001262	1.26159422655569e-11	48	0	0	512	8202
R-HSA-73887	Death Receptor Signalling	1.00000000001262	1.26159422655569e-11	48	0	0	512	8202
R-HSA-3214842	HDMs demethylate histones	1.00000000001262	1.26159422655569e-11	48	0	0	512	8202
R-HSA-1461973	Defensins	1.00000000001323	1.32285154810772e-11	51	0	0	512	8202
R-HSA-5674135	MAP2K and MAPK activation	1.00000000001427	1.4265551394297e-11	38	0	0	512	8202
R-HSA-168276	NS1 Mediated Effects on Host Pathways	1.00000000001427	1.4265551394297e-11	38	0	0	512	8202
R-HSA-5578749	Transcriptional regulation by small RNAs	1.00000000001429	1.42938866193994e-11	101	0	0	512	8202
R-HSA-176187	Activation of ATR in response to replication stress	1.00000000001456	1.45626990447887e-11	37	0	0	512	8202
R-HSA-6783310	Fanconi Anemia Pathway	1.00000000001498	1.49766307539867e-11	39	0	0	512	8202
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000001498	1.49766307539867e-11	39	0	0	512	8202
R-HSA-390522	Striated Muscle Contraction	1.00000000001564	1.56389876697511e-11	34	0	0	512	8202
R-HSA-1222556	ROS production in response to bacteria	1.00000000001564	1.56389876697511e-11	34	0	0	512	8202
R-HSA-189200	Hexose transport	1.00000000001605	1.60454445625411e-11	47	0	0	512	8202
R-HSA-156581	Methylation	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-1839130	Signaling by activated point mutants of FGFR3	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-3371511	HSF1 activation	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-73621	Pyrimidine catabolism	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-176974	Unwinding of DNA	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-190239	FGFR3 ligand binding and activation	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-417957	P2Y receptors	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-2033514	FGFR3 mutant receptor activation	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-844456	The NLRP3 inflammasome	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-381033	ATF6-alpha activates chaperones	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-190372	FGFR3c ligand binding and activation	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-432047	Passive transport by Aquaporins	1.00000000001614	1.61419162178994e-11	12	0	0	512	8202
R-HSA-73777	RNA Polymerase I Chain Elongation	1.00000000001739	1.73870037163577e-11	88	0	0	512	8202
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000001766	1.7660610338006e-11	29	0	0	512	8202
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000001766	1.7660610338006e-11	29	0	0	512	8202
R-HSA-5654732	Negative regulation of FGFR3 signaling	1.00000000001766	1.7660610338006e-11	29	0	0	512	8202
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000001766	1.7660610338006e-11	29	0	0	512	8202
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000001769	1.76893129700578e-11	21	0	0	512	8202
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000001769	1.76893129700578e-11	21	0	0	512	8202
R-HSA-156588	Glucuronidation	1.00000000001769	1.76893129700578e-11	21	0	0	512	8202
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000001769	1.76893129700578e-11	21	0	0	512	8202
R-HSA-5620916	VxPx cargo-targeting to cilium	1.00000000001769	1.76893129700578e-11	21	0	0	512	8202
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	1.00000000001769	1.76893129700578e-11	21	0	0	512	8202
R-HSA-2990846	SUMOylation	1.00000000001864	1.86356148042626e-11	79	0	0	512	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000001887	1.88677873870577e-11	65	0	0	512	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000001942	1.94246239137858e-11	60	0	0	512	8202
R-HSA-912446	Meiotic recombination	1.00000000001963	1.96287862011461e-11	84	0	0	512	8202
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000001981	1.98090684649146e-11	70	0	0	512	8202
R-HSA-76046	RNA Polymerase III Transcription Initiation	1.00000000002004	2.00353049705707e-11	35	0	0	512	8202
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.00000000002004	2.00353049705707e-11	35	0	0	512	8202
R-HSA-72702	Ribosomal scanning and start codon recognition	1.00000000002061	2.06144462966003e-11	55	0	0	512	8202
R-HSA-72649	Translation initiation complex formation	1.00000000002061	2.06144462966003e-11	55	0	0	512	8202
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1.00000000002249	2.24922922746276e-11	56	0	0	512	8202
R-HSA-191859	snRNP Assembly	1.00000000002906	2.90644819107635e-11	50	0	0	512	8202
R-HSA-194441	Metabolism of non-coding RNA	1.00000000002906	2.90644819107635e-11	50	0	0	512	8202
